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INTRODUCTION 
Introduction 
1.1 HYPERTENSION-ASSOCIATED RENAL FAILURE 
1. 1. 1 Clinical settings 
The question why not all patients with hypertension develop end-stage renal 
failure (ESRF) has become a major issue in nephrology and hypertension 
research over the past decade. There are indications for a relationship between 
hypertension and impaired renal fimction in individuals with no underlying renal 
disease.31 It is widely believed that genetic factors play an important role in the 
susceptibility to hypertension-induced renal failure.18.IOO Epidemiological studies 
indicate that the risk for hypertension-associated renal failure varies with the 
ethnic background. 14.28 For instance, the presence of ESRF in an African-
American individual results in a nine-fold increased risk of ESRF in a first-
degree relative, even after controlling hypertension in the relative.32 
Most information on familial clustering of renal failure and hypertension is 
derived from studies in patients with diabetic nephropathy, for which Seaquist et 
al. recently showed the involvement of genetic factors in its pathogenesis. I08 
Other studies have reported a greater prevalence of hype11ension and/or 
cardiovascular disease in the parents of children who developed diabetic 
nephropathy later in Iife.27•133 Furthermore, Schmidt et al. found that a familial 
history of hypertension is not only more frequent in patients who develop chronic 
renal failure caused by diabetes but also in patients with different histologic types 
of primary glomel1llonephritis. lo7 
The factors responsible for an association between blood pressure and renal 
failure are not known, but an increased blood pressure is: (a) necessmy and 
sufficient to cause ESRF, or (b) necessmy but not sufficient to cause ESRF, or (c) 
neither nec~ssmy nor sufficient to cause ESRF; it accelerates the risk in 
individuals who are otherwise predisposed. Renal failure is hypertension-induced 
in the first two suppositions and hypertension-associated in the latter. 12 
In this context, we have to consider the possibility that hypertension and the 
predisposition to develop glomel1llar damage due to hypertension are influenced 
by different genes. Gene-gene and gene-environment interactions determine the 
final phenotype. It could be that hype11ension alone and renal failure due to 
hypertension are two different phenotypes. 
The genetic basis of complications in human diseases deserves more attention, 
and it would be usefill to asce11ain a large number of hypertensive affected sib-
pairs to study whether risk of renal failure correlates between these sib-pairs and, 
if so, to map human susceptibility factors. Using the candidate gene approach, an 
insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) 
gene was recently discovered, significantly influencing circulating ACE levels. 
2 
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These levels might playa role in the development of target organ damage, such as 
left ventricular hYfelirophy in essential hypeliension and microalbuminuria in 
diabetes mellitus. I .29.83 However, simple comparisons do not provide answers to 
these complex problems. Combining physiology and genetics, we might be able 
to dissect the susceptibility to hypeliension and renal damage. 
1. 1.2 Physiology and genetics. 
An important discovery of genetics research is that gene products, rather than 
acting alone, form complex webs of molecular interactions. Although this 
principle was already known, the ability to identifY the genes involved in a given 
trait and the way in which simple molecules collaborate to create complex traits 
remain major research challenges. Accomplishing this task requires knowledge of 
gene identities, protein functions and interactions, and developmental and 
physiological pathways. 
The original goal of the Human Genome Project was to provide the reagents, 
technologies and information, which would be the foundation for discovering 
disease genes and, ultimately, for exploring the pathways that would link genes 
and traits. Using this concept, gene discovery is now routine, especially for 
genetically simple Mendelian traits, like some forms of monogenic hypeliension. 
With the sequence of an entire genome (the complete set of chromosomes and 
their genes) available and with the identity of many disease genes established, 
attention shifts to studies of gene function and to genotype and phenotype 
dissection of complex traits. Recent 'technological developments are now creating 
new opportunities for defining gene functions in developmental and physiological 
pathways. 
Genetic analysis of developmental and physiological pathways will benefit 
both from the ability to analyze whole genomes and from the integration with 
traditional genetic, biochemical, computational and engineering paradigms. The 
approach to find the products generated by different genes and the way in which 
these products contribute to functional processes on the cellular or whole 
organism level can be indicated as physiological genomics.79 Whole-genome 
methods enable integrated rather than individual approaches to complex 
problems. Integration of these approaches will close the phenotype gap between 
the information encoded by individual genes and the complex biological 
functions that emerge from interactions of gene products. 
Physiological genomics represents a new phase of genome analysis and 
specifically refers to the development and application of genome-wide 
experimental approaches to study genes and their fimction. This way the 
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likelihood for a celiain trait to be linked to a gene or gene product can thus be 
established. Physiology and genetics is going to bind sequence and function 
together and to provide new insights into the behavior of biological 
systems. 37,41,84 In general, the fhnctional information will provide a basis for 
furthcr analysis, much like a primaty genetic screen identifies candidate genes for 
a certain disease that requires extensive subsequent validation,JO,79 
The definition of physiological genomics is not "official", but rather a concept 
or strategy that combines the strengths of genomics and physiology. For example, 
defining gene function via the use of positional cloning and physiology in 
congenic rats or expression profiling after giving a drug and comparing this to 
physiological changes. Finally, it is attaching biological processes to the genome 
via mapping, sequencing of genes or interference using transgenic technologies. 
In this thesis, the concept of physiological genomics is simplified. What is 
known about the physiology and the genetics of an animal model is combined to 
come up with putative candidates for the genes of interest, rather than using a 
large-scale experimental methodology combined with statistical and 
computational analysis of the results. 
1.1.3 Animal models for hypertension and renal failure 
As humans, inbred rat strains also differ in the development of renal failure 
and genetic factors are suspected to affect the susceptibility to hypertension-
induced or to hypertension or diabetic accelerated renal failure,9,12,18,39,ll9,134 For 
instance, rats of the Milan Normotensive Strain (MNS) develop renal failure, but 
no hypertension, whereas rats of the Milan Hypertensive Strain (MHS) and the 
Spontaneously Hypertensive Rat (SHR) develop hypeliension and no renal 
failure.9,43 Other strains develop neither hypertension nor renal failure, not even 
after high protein intake, increases in blood pressure or reduction of renal mass, 
such as the Wi star Kyoto, the ACIlNmh, and the PVO/c rat.75 ,lll,134,IJ8 In fact, the 
ACI rat we use in our genetic and physiological studies as normotensive 
background is also resistant to the development of renal damage (chapters 2 
tlu'ough 5 of this thesis), 
The mode of inheritance of renal failure has only been documented in a few 
strains of rats. Lozzio el al. found that a mutant strain of Ounn rats developed 
hydronephrosis, which was inherited as an autosomal dominant trait.68 
Development of severe nephrosis in Koletsky obese hypertensive rats and in 
nephrose Shionogi (NPS) rats has been assumed to be regulated by a single 
autosomal recessive gene, I Studies on the genetic regulation of glomerular 
sclerotic lesions in a cross of BUF/Mna and ACIINMs rats and high proteinuria 
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and glomerular defects in the FGS/Nga mouse suggest the presence of two 
I . 44 75 autosoma recessive genes. . 
An example for the dissociation between hypeltension and renal failure might 
be the MHS rat in whose selection process not only the genetic mechanisms that 
increase blood pressure and glomerular filtration rate, but also a specific 
susceptibility of the afferent arteriole to develop hypel1rophy may have been 
selected by chance.9 This would protect the glomerulus from exposure to 
increased pressure levels and hyperfiltration and thus prevent the development of 
glomerular damage.IO·14.43 From this viewpoint, studies of renal damage in 
primary hypertension should investigate the genetics of primary hypertension 
with renal hyperfiltration as well as the genetic background that, in the presence 
of hypel1ension and hyperfiltration, cause renal failure. Regarding the first type 
of studies, Cusi ef al. have identified a point mutation in a gene encoding the a 
and p subunit of adducin, which has been linked to the development of 
h .. MHS d' h 818 ypeltenslOn III rats an III umans.· 
To dissect the genetics of both hypel1ension and renal failure, it was decided to 
study renal impairment in a hypertensive animal model, the Fawn-Hooded rat, 
which is the focus of this thesis. Combining physiology and genetics in this 
animal model may help to better understand the role of genetic factors in 
hypertension-associated renal failure. So far, physiological as well as genetic 
studies have been carried out in this rat model, which are described below. 
1.1.4 Scope 
Studies in the rat model of hypertension-associated renal failure used in our 
laboratory, the Fawn-Hooded Hypertensive (FHH) rat, showed that hypertension 
and renal failure have a genetic basis. 12 Because the genes and their products 
responsible for these phenotypes in the FHH rat are not known yet, we designed 
experiments to investigate the interaction between blood pressure and the 
susceptibility to renal damage in the FHH strain and related strains, and in a 
normotensive control strain. 
To be able to come up with candidate genes for the loci identified in the 
genetic studies, we performed physiological experiments on the mechanism of 
renal failure in the FHH rat. The outcome of these studies, which are mainly in 
the area of renal autoregulation, will bring us closer to the identification of the 
genes for renal failure that are present in the FHH rat. IdentifYing the 
homologous genes of the FHH rat genes in man will enable us to better 
understand and treat the development of end-stage renal failure in humans. 
5 
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1.2 PHYSIOLOGY OF THE FAWN-HOODED RAT 
1.2. 1 History of the Fawn-Hooded rat 
The Fawn-Hooded Rat (FHR) originates from the Department of Physiology, 
University of Michigan, Ann Harbor, as a mutant resulting from unplarmed cross-
breeding of various populations of laboratory rats.72•127 Researchers from the 
Museum of Natural History in New York have made the FHR available for 
biomedical research into various diseases. This thesis concentrates on the FHR as 
a model for hypertension-associated renal failure. 
Introduced into Europe by Dr. Tschopp,124.126 the breeding nucleus was 
provided for the FHR colony kept at Unilever Research Laboratories in 
Vlaardingen, where the spontaneous presence of systemic hypertension was 
observed.59.64 From this strain, two inbred strains were developed on the basis of 
differences in awake systolic blood pressure (SBP) and urinary protein excretion 
(Up V). These strains were transferred to the animal facilities of the Erasmus 
University Rotterdam (EUR), where they were fully inbred. The strain with the 
highest SBP and UeV was named FHHlEUR and the strain with the lowest 
values FHLIEUR.91 , 2,95 From this point forward, these strains will simply be 
indicated as FHH and FHL. For a complete review of the FHR and its history, the 
reader is referred to the theses of Kuijpers60 and Simons."o 
1.2.2 The Fawn-Hooded rat in biomedical research 
Congenital hemorrhagic diathesis was the first-described abnormality in the 
FHR.97 Later, this was found to be associated with a defective platelet release 
pool of adenosine di-phosphate (ADP), tri-phosphate (A TP) and 
serotonin.87,120,124,125 This bleeding disorder resembles storage pool deficiency 
found in humans.33,38,114 Both the uptake and release of serotonin in platelets is 
reduced and associated with a defect in membrane glycoproteins,3,,, Because of 
an abnormal brain serotonin and tryptophan metabolism,19,5I the FHR is thought 
to be a genetic model for psychiatric disorders of serotonergic dysfunction, 
including depression,87,ss anxiety,2 and eating disorders,5,m Moreover, the FHR 
is being used as a model for alcohol preference,6,17,19.77,86,99,I06 
The outbred FHR has been tried as model for experimental atherosclerosis, 121 
However, Verseput et al. found that hyperlipidemia was secondary to UpV in the 
FI-!I-{ raL 131 
Although the coat color pattern is the same, FHR strains differ genetically as 
well as physiologically,95 Currently, at least four subs trains of Fawn-Hooded rats 
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are used in biomedical research.95 In this thesis, if known, the appropriate strain 
abbreviation will be used. The abbreviation FH will be used for the original 
random bred Fawn-Hooded strain, which came to Europe from the Museum of 
Natural History, being the ancestors of the inbred FHH and FHL strains. The 
same FH rat was used by W. Jean Dodds for a limited inbreeding program at the 
New York State Department of Health, Albany (NY) to generate the FHlWjd 
strain. 127 Another Fawn-Hooded strain, the Fawn-Hooded Iowa Reactive (FHlIR) 
strain, seems only partly related to the other strains and is used mainly in research 
on pulmonary hypel1ension and in some behavioral studies. Overstreet and 
Rezvani observed significant behavioral differences between the FHlWjd and 
FHlIR strains.87 Recently, we also noted marked strain differences with regard to 
blood pressure and renal damage.95 Thus, characteristics of one strain are not 
necessarily present in the other. 
1.2.3 Systemic blood pressure 
Elevated systemic blood pressure has been reported in 5.5-mo-old male 
outbred FH rats with a level of about 150 mmHg up to levels around 170 mmHg 
at one year of age.59-64 The FHH rat we use in our studies develops moderate 
systolic hypertension as measured by tail-cuff with levels around 160 mmHg at 
one year of age, compared with 125 mmHg in FHL rats.92.112.130 Under anesthesia, 
mean at1erial pressure in FHH rats is between 130 and 140 mmHg, compared 
with 120 mmHg in FHL rats."I-I13.128.129 
Outbred FH rats with the highest level of systemic hypel1ension had a higher 
mean daily water intake and urine output between 7 and II weeks of age, the 
period during which systemic hypel1ension develops.93 Moreover, enhanced 
sodium and water excretion in the FH/Wjd rat was observed by Gilboa ef al., 
compared with Wistar rats.34.35 The same authors reported reduced kallikrein 
activity in the FHlWjd rat preceding the onset of hypertension. This suggested 
that the renal kallikrein system is involved in the pathogenesis of hypertension in 
the FHlWjd rat. Moreover, plasma renin activity and plasma angiotensin II levels 
were found to correlate with the active form of kallikrein, as well as with 
conversion of inactive to active kallikrein, in contrast to Wistar rats.34.35 These 
observations suggest a close relationship between the renin-angiotensin and 
kallikrein systems in the FHlWjd rat. 
Early studies showed hypertension in the FHlWjd strain was of a 
hyporeninemic type.34,35 Jung ef al. found that plasma and renal renin 
concentration were elevated in young FHH rats.53 Also, an immature pattern of 
renin expression was found in the afferent arteriole in these rats with moderate 
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systemic hypertension. Aging of FHH rats is accompanied by a decline in renal 
and plasma renin, whereas renal immunostaining for angiotensin converting 
enzyme and angiotensinogen increases. Moreover, upregulation of angiotensin II 
(AT,) receptors was found in the FHH rat.52 These changes are associated by 
increases in Up V and focal glomerulosclerosis (FGS). 
FU11hermore, increased urinary catecholamine, as indicated by increased 
dopamine and noradrenaline levels, were measured in the outbred FH strain, 
indicating increased activity of the sympathetic nervous system.7'.136 
1.2.4 Proteinuria and glomerulosclerosis 
Renal damage in the FHR was described by Kreisberg and Karnovsky for the 
first time: they found that upon aging male FHlWjd rats developed progressive 
UpV and FGS.56 Subsequently, UpV was also found in the random bred FH rat.59-
64 The severity of UpV was quite variable in the randomly bred strain. The 
variance coincided with variances in blood pressure, actually providing the basis 
for the inbreeding and generation of the FlU-! and FHL strains. Additional studies 
showed that the Up V almost exclusively consists of albuminuria (Ua V). Studying 
four different FHR strains showed that FHH and FH/Wjd rats develop severe 
progressive Up V, whereas FHL and FH/!R rats do not.95 
Detailed histopathological studies in the FHH rat by Kriz et al. showed that the 
development of FGS is consistently associated with the vascular pole of the 
glomerulus due to an elevated glomerular capillary pressure (P Gel. 57 The initial 
injury involves the expansion of primary branches of the afferent arteriole. 
Podocytes serving these largest glometular vessels (in which wall tension would 
be greatest) are exposed to increased strain. Podocyte insufficiency in 
counteracting the expansile forces will lead to fU11her capillary dilation, finally 
causing podocyte detachments. This triggers parietal cells to attach to bare areas 
of the glomerular basement membrane, establishing a starting point of parietal 
endothelium on the tuft. These events represent the initial lesion inevitably 
progressing to segmental sclerosis and eventually to ESRF.57 In this process, fluid 
leakage into the periglomerular interstitium from perfused capillaries contained in 
a tuft adhesion plays a prominent role. A second study by Kriz et al. suggests that 
severely injured glomeruli continue to filter along interstitial routes, accounting 
for interstitial progression of the disease. Similar histopathologic phenomena in 
human kidneys showing FGS suggest that the pathogenetic pathways defined in 
rat models such as the FHH rat and the MNS rat'operate in human renal disease 
as well.5S 
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Male FHlWjd rats develop significantly more hypel1ension and renal damage 
compared with female FH/Wjd rats, similar to FHH rats. 94 This suggests that 
there may be a protective effect of estrogens or, alternatively, a negative 
influence of androgens, as in other animal models and humans. 127 However, 
recent studies in male and female FHH rats did not show an influence of 
gonadectomy on the development of hypertension or renal damage in the FHH 
rat, suggesting some other form of sex-specific protective mechanism.94 
1.2.5 Interaction between blood pressure and renal damage 
As in several other experimental models of kidney disease, challenging the 
kidney by reducing the number of nephrons by unilateral nephrectomy (UNX) or 
an increase in dietary protein augments the progression of UpV and FGS in the 
FHH rat.2I ,112 
Provoost et al. showed that two-kidney FHH and FH/Wjd rats had similar SBP 
and Up V levels, whereas both FHL and FHlIR rats did not show elevated SBP or 
UpV. After UNX, FH/Wjd rats developed more UpV and FGS compared with 
FHH rats despite similar SBP levels. FHL rats also developed some Up V after 
UNX, but showed no increases in SBP, whereas FHIIR rats did not exhibit any 
increases in SBP or UpV.95 
The effects ofUNX on renal damage and SBP at about five weeks of age were 
also assessed in hypel1ensive SHR rats, nOlmotensive FHL rats, and F I crosses of 
(SHR x FHH) and (SHR x FHL) rats, all differing in basal blood pressure level. 
UNX had no significant effect on blood pressure in any of the strains. In this 
study, genetic differences appeared to determine the severity of renal damage 
after UNX. FI-U-I and FHL rats developed renal damage, although FHL rats 
developed less renal damage than FHH rats, the differences being related to the 
different blood pressure levels. Renal damage in the F I rats in this study was 
markedly less than in both Fawn-Hooded strains. Despite high blood pressure, the 
SHR rat was quite resistant to renal damage.96 
The relation between UpV and SBP was also investigated by Simons et al., 
who showed a significant correlation between blood pressure and UpV in 12-wk-
old FHH rat rats. Moreover, the incidence of FGS was also correlated with blood 
pressure and Up V. III Recent renal transplantation studies using kidneys of the 
FHH rat showed that renal damage, and not hypel1ension, travels with the FHH 
kidney, indicating that the renal abnormalities observed in this rat strain have 
their origin in the kidney and not in the systemic circulation.9o The results suggest 
that an independent genetic mechanism is present for the development of renal 
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failure independent of the development of hypertension, which may be related to 
the regulation of Pac. 
Furthermore, studies by Oliver et al. showed that increased UaV in UNX-FHH 
rats results from a specific defect in glomerular charge selectivity, rather than size 
selectivity, induced by chronic glomerular hypeltension.85 
1.2.6Intrarenal hemodynamics 
De Keijzer et al. found that the glomerular filtration rate (OFR) was 
significantly higher in 12-wk-old FH rats compared with age and weight matched 
control Wistar rats, whereas effective renal plasma flow was similar among 
groupS.23 Because the number of glomeruli in FH rats was similar to that in 
Wistar rats, OFR pel' glomerulus was one third higher in FH rats compared with 
Wi star rats. This suggests that in FH rats, hyperfiltration is present at a single-
nephron level which coincided with enhanced urinary eicosanoid excretion. 2o The 
elevated levels of UpV together with the glomerular h~perfiltration were thought 
to be the result of glomerular capillary hypertension.2o. 36 
Micropuncture studies by Simons et al. revealed the presence of glomerular 
capillary hypertension in the FHH rat. They also observed hyperfiltration at the 
single nephron level in 12- and 22-wk-old FHH rats and to a lesser extent in FHL 
rats compared with normotensive Wistar rats. lI3 
In another set of experiments, Simons et al. found a close correlation between 
Pac and systemic blood pressure in 12-wk-old FHH rats. Moreover, an increased 
efferent arteriolar resistance was found in combination with a low afferent 
resistance. They concluded that the elevated efferent vascular resistance and the 
inability to modulate afferent vascular tone contribute to the transmission of 
alterial pressure elevations to the kidneys of FHH rats. lIO•11I These findings were 
confirmed by Verseput et al. in 11- and 26-wk-old FHH rats. 129.132 
Unilateral nephrectomy, which causes further increases in Pac without changes 
in systemic pressure, further reduces afferent arteriolar resistance in FHH rats, 
leading to even more pronounced renal damage compared with two-kidney FHH 
rats. 112 
10 
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1.2.7 Vascular abnormalities 
While the FHlWjd and FHHlEUR strains develop systemic hypel1ension and 
renal damage, the FHlIR strain develops pulmonary hypel1ension but no renal 
failure.4.s4.lo2 Abnormal responses of the aortic and pulmonmy vascular wall to 
ADP and serotonin in the FHlIR rat could be involved in the development of 
pulmonary hypertension in this strain, indicating altered endothelial function and 
vessel wall reactivity.104.IOS.IIS.1I7 Ashmore et al. studied vascular reactivity in 
isolated pulmonmy arteries of the FHlIR rat. They found that the responses to the 
platelet-derived endothelium dependent vasodilator ADP were markedly impaired 
in the pulmonalY artery, but mildly impaired in the aorta of these rats. 
Fm1hermore, they found that vasodilatOlY responses to acetylcholine were also 
impaired.4 
The production of endothelin-l was increased by epithelial cells in the airway 
of the FHIIR rat. 118 In addition, the conversion of arachidonic acid (AA) to 6-
keto-prostaglandin-F I" was reduced in the aorta of FHlIR rats. This could be 
partially normalized by cholesterol feeding. Accordingly, the AA-induced 
aggregation of platelet-rich plasma from FHlIR rats was also stimulated by 
cholesterol feeding, whereas collagen-induced aggregation remained absent 
despite high cholesterol intake. 139 Fm1hermore, abnormal urinary eicosanoid 
excretion was noted, consisting of increased levels of tromboxane B2, 6-keto-
prostaglandin F Iw and prostaglandin-E2. A shift in the pattern of excretion from 
vasodilatory to vasoconstrictor eicosanoids was observed over time, which was 
accompanied by progressive UpV.20 
Results of a study by Resch et al. 98 assessing the nitric oxide system in the 
macula dens a of FHH and FHL rats suggested an upregulated activity. Such 
dysregulation could explain low inflow resistance to the glomerulus. The nitric 
oxide system abnormality may be linked or associated to other vasoregulatory 
abnormalities. 
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1.3 IMPACT OF CHANGES IN BLOOD PRESSURE 
1.3. 1 Effects of antihypertensive treatment in the Fawn-Hooded rat 
Magro et al. first described antihypertensive effects of various classes of 
drugs, including angiotensin converting enzyme inhibition (ACEi) in FH/Wjd 
rats.n The response to captopril in FH/Wjd rats was stringer than that in 
normotensive Wistar control rats. The responses to nifedipine and furosemide 
suggested that hypertension in FH/Wjd rats is due to vasoconstriction rather than 
volume expansion. 
Weening et al. tested the antihypertensive effects of the serotonin receptor 
blocking agent, ketanserin, and found no beneficial effects of this drug on blood 
pressure or Up V in the FH rat. This led to the conclusion that hypeltension and 
renal disease in the FH rat are not due to abnormal serotonin metabolism in this 
strain. 135 
Westenend et al. studied the effects of ACEi using captopril in the FH rat and 
showed protection from stl1lctural renal damage even when treatment was statted 
after the development of glomel1llar injlllY. This effect was attributed to the 
antihypertensive effects of ACEL I37 
Verseput et al. studied the efficacy of ACEi in the prevention and treatment of 
chronic renal damage in FHH rats treated with lisinopril at different stages of 
renal failure. They concluded that early-onset ACEi treatment velY effectively 
protects against renal damage in the FHH rat and that this protection is associated 
with normalization of PGc. ACEi could not completely prevent progression of 
FGS in rats with established glomel1llar disease despite lowering PGc• Shott-term 
ACEi had no long-term effect on arterial pressure or PGC, and could not prevent 
the development ofFGS. 128,130,132 
Simons et al. suggested that the beneficial effect of enalapril after UNX in 
FHH rats primarily results from decreasing transcapillaty pressure and 
ameliorating Ua V by preserving glomerular charge-selectivity, rather than size-
selectivity,85,112 A lag of approximately one week was observed between the new 
level of blood pressure and Up V. This latter finding indicates that in addition to 
the direct hemodynamic effects of ACEi, alterations in the filtration membrane 
affect renal protein excretion. 
Verseput et al. studied the effects of four different classes of antihypeltensive 
drugs and showed that lowering blood pressure is not the exclusive 
reno protective mechanism of ACEi in the FHH rat. In the FHH rat, early-onset 
clonidine offers the same degree of renoprotection compared with ACEi despite 
higher blood pressure levels, and late-onset triple therapy offers no 
renoprotection despite equally effective blood pressure control by ACEi. 
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The ability of ACEi to reduce Pac and intrarenal angiotensin II levels in the FHH 
rat may be the most important renoprotective effect. 130 
Simons ef al. studied the effects of enalapril in UNX-FHH rats and found that 
with high levels of glomel1llar hyperfiltration and hypertension in addition to 
glomel1llar enlargement, treatment with ACEi prevents the rise in PGC but not in 
glomel1llar size and abolishes the development of renal damage. III 
Ziai ef al. and Mackenzie ef al. tested the efficacy of the angiotensin receptor 
antagonist (ATI) irbesatian, and enalapril in UNX-FHH rats and confirmed the 
results by Simons ef al. III Chronic treatment with both drugs in the FHH rat 
normalized systemic blood pressure and P GC, suggesting that the antihypertensive 
and renoprotective effects of enalapril were largely mediated by inhibiting the 
effects of angiotensin II on the ATI receptor.69.140 These findings support a 
critical role for angiotensin-dependent mechanisms in the development of 
hypertension and FGS in the FHH rat. 113.131 
1.3.2 L-NAME treatment and renal hemodynamics 
In general, systemic inhibition of nitric oxide synthase leads to dose-dependent 
increases in blood pressure and renal vascular resistance, a large fall in renal 
plasma flow and a slight reduction in GFR. The kidney is particularly sensitive to 
nitric oxide inhibition (NOi), which leads to increases in efferent alieriolar 
resistance, decreases in the ultrafiltration coefficient and a variable effect on the 
efferent arteriolar resistance. When systemic NOi leads to increases in blood 
pressure, efferent atieriolar resistance rises and causes marked elevations in Pac. 7 
The degree of renal damage after chronic NOi also differs among rat strains. 
The effects may be caused by increases in blood pressure or by the effects of the 
specific inhibitor used. Simons ef al. studied the effects of the NOi L-NAME in 
UNX-FHH rats. They found that rats treated with L-NAME exhibited high 
systemic blood pressure, heavy UpV and FGS, and further elevation of the 
ultrafiltration pressure with a decreased ultrafiltration coefficient after only eight 
weeks of treatment. I II Moreover, the elevated resistance of both the afferent and 
efferent arteriole caused an increase in Pac. In this study, L-NAME treatment 
which lowered values for single nephron GFR and glomel1llar volume but caused 
a further elevation in Pac did not reduce glomerular damage. On the contrary, 
FGS eight weeks after UNX in L-NAME rats was as severe as 12 weeks after 
UNX in control animals. Studies described in chapters 2 through 4 of this thesis 
deal with the subject of chronic NOi in rats with different genetic backgrounds. 
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1.3.3 Renal autoregulation 
The development of intraglomemlar hypertension is thought to be one of the 
key features in the development of renal damage. Regulation of filtration and 
pressure in the kidney is ensured by the autoregulation mechanism. This means 
the ability to maintain relative constancy of blood flow, GFR and PGC, despite 
variations in arterial pressure. The afferent arteriole is the primary source for the 
control of resistance changes. 
Renal autoregulation is thought to involve two processes: (a) the myogenic 
response and (b) tubuloglomerular feedback (TGF). The myogenic response 
involves an intrinsic property of arterial smooth muscle enabling it to contract or 
relax in response to increases or decreases in vascular wall tension, respectively. 
TGF is referred to as the negative feedback loop that is elicited by changes in 
volume and composition of the fluid entering the thick ascending limb of the loop 
of Henle and leads to vascular responses in the afferent arteriole. 101 This 
mechanism was recently found to be intact in 11-wk-old FHH rats. 129 Therefore, 
we surmised that the abnormalities might well be caused by an impairment in the 
myogenic response. 
The autoregulation mechanism controls the transmission of systemic pressure 
to the glomemli. Without this mechanism, increases in systemic blood pressure 
would parallel increases in Poc causing damage to the glomeruli, which is the 
case in several animal and human disease states. 
The SHR rat presents with early hypelirophy of the afferent arteriole, 
increasing its resistance which protects the glomerulus from increases in P GC. 
After UNX, Poc increases in the SHR kidney accelerating the development of 
UpV and FGS.26 In contrast, MHS rats have a reduced total number ofnephrons 
and elevated afferent arteriolar resistance and single nephron filtration rate before 
the development of hypertension. The development of renal damage does not 
further increase after hypertension is fully developed. This strain appears to be 
relatively resistant to the development of progressive glomerular damage, which 
seems to be prevented by hypertrophy of the afferent arteriole.9 The FHH rat, 
which has a normal number of nephrons,92 develops intraglomerular hypeliension 
due to the increased efferent arteriolar resistance without the ability to modulate 
afferent arteriolar tone. III The MNS rat, which is also thought to have an 
impaired modulation of afferent vascular tone,9 develops glomerular sclerotic 
lesions similar to those in the H-IH rat. Lesions in these animal models resemble 
some forms ofFGS observed in humans.58 
In general, hypertension produces hemodynamic and mechanical stress, which 
may lead to glomemlar endothelial dysfunction. Both of these mechanisms may 
lead to increased glomemlar leakiness, which may further damage the kidney. 
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Hypertension may also stimulate the production of many vasoactive substances 
that influence the tone of the afferent and efferent arterioles. They include a 
variety of vasoconstrictor and vasodilator hormones, which are potent stimulators 
for growth factors and cytokines, leading to the production of extracellular matrix 
proteins.50 
1.4 GENETICS OF THE FAWN·HOODED RAT 
The first study on the genetics of the FHR strain was performed by La Vail et. 
al., who described genes determining the coat and eye COIOr.65 Regarding these 
genes, the FHR was found to be homozygous for the non-agouti (aa), black (BB), 
non-albino (CC), and hooded (hh) genes. The fawn color was found to be due to 
the presence of the autosomal recessive red-eyed (1'1') dilution gene.&9 The 
bleeding diathesis and lack of ATP secretion were associated with homozygosity 
for this gene, which was found to be close to the albino gene (cc) on chromosome 
one. \22 The homozygous presence of the recessive aa, hh, and rr genes forms the 
basis for the unique coat color pattern of the FHR. 
1.4.1 Inheritance of hypertension and renal damage in the FHHIEUR rat 
The recessive coat color genes were used to start a search for the inheritance of 
hypertension and renal damage in the FHH rat. The outcome of this study has 
been reported by Brown et. al. 12 The August x Copenhagen Irish (AC!) rat was 
chosen because it is normotensive and resistant to renal damage and carries the 
dominant forms of the genes at the 1', a, and h loci. The mode of inheritance was 
determined by comparing the F 1 (FHH x ACI) with the two parental strains. F 1 
rats showed normal UpV levels, indicating that renal impairment was inherited as 
a recessive trait. Accordingly, it was decided to study the inheritance of the 
hypertension and renal failure in a (FHH x ACI) FHH backcross. Progression of 
renal impairment was mainly followed by UpV and by visible lesions at 
macroscopic examination of the kidneys. Systolic blood pressure was measured at 
six months of age. 
For genotyping, we used randomly chosen markers as well as markers 
representing genes that are known to be involved in blood pressure regulation 
(including angiotensin converting enzyme, atrial natriuretic factor, II-P-
hydroxylase, and renin) and in certain regions reported to show linkage to 
hypertension in other crosses (such as carboxypeptidase 8 and tumor necrosis 
factor). Moreover, markers flanking the SA locus and guanyl cyclase associated 
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with the atrial natriuretic factor receptor) were included.15.4o.42,46,IOJ Linkage 
analysis (analysis determining the degree of association between a marker and a 
phenotype) was used to detect quantitative trait loci (QTL) (genetic loci 
responsible for quantitative traits such as blood pressure) for renal impairment 
and blood pressure. 
By comparing the genetic variance for SBP and UpV in Fo, FI rats and in the 
backcross progeny, it was possible to determine the proportion of genetic 
variance in the backcross. Moreover, it was possible to determine the proportion 
of genetic variance in this cross and to estimate the effective number of genetic 
factors controlling the traits?4 Most of the backcross progeny showed some 
degree of hypertension and showed a weak, but statistically significant 
correlation between SBP and UpV. 
A gene involved in renal impairment was found on rat chromosome I. Linkage 
was clear for six of the seven phenotypes related to renal impairment, and this 
locus was referred to as Rfl (for renal{ailure-l). The strength of the evidence 
for linkage emerged from the correlation of genotypes with UpV: Rfl 
homozygotes had twice as much Up V as Rf 1 heterozygotes. Using the 
macroscopic index score of renal impairment, the Rfllocus accounted for almost 
half of the total variance. Although the Rf 1 locus was positively correlated with 
the measll1'es of renal impairment, it had no significant effect on SBP. There was 
also no significant difference in mean blood pressll1'e between Rfl homozygotes 
and heterozygotes, indicating that Rfl caused renal impairment through a 
mechanism other than increasing blood pressll1'e. When the Up V phenotype was 
adjusted by eliminating the effect of blood preSSll1'e, it showed similar correlation 
to Rf 1. This confirms that Rf 1 causes renal impairment through an independent 
mechanism and not simply by increasing blood pressure. 
Since Rfl explained only about half of the genetic component of renal 
impairment and did not explain a significant proportion of blood pressure, the 
genome was searched (a) for additional loci responsible for renal impairment and 
(b) [or loci responsible for systolic hypertension. Evidence was found for two 
additional loci, which were also on chromosome I, but were at a considerable 
distance from Rf1. The first had a significant effect on SBP, but less on renal 
impairment. This locus was referred to as Bpfh-l (for blood pressll1'e in fawn-
hooded I). The second locus, Rf2 (for renalj:1ilure-2) had a strong effect on one 
measure of renal impairment (plasma albumin level), as well as a significant but 
weaker effect on plasma creatinin levels and the macroscopic injury score. This 
region containing Rf2 also showed some linkage to blood pressure. 
The Rfl locus conld not be identical with the Bpfh-1 or Rf2 loci because the 
physical distance on chromosome I was sufficiently large to exclude a significant 
correlation between genotypes. The relationship between Bpfh-1 and Rf2 was 
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less clear. The most likely locations for both genetic loci did not overlap. 
Moreover, Bpjll-i proved to be close to an important candidate locus, the SA 
gene, a gene of unknown function that showed higher expression in the kidney of 
SHR compared with WKY rats45,66.8I.103 and cosegregates with blood pressure in 
a number of crosses.25•40,49 This provided additional confidence in the localization 
of Bpjl1-i and it was concluded that Bpjll-i and Rf2 represent distinct loci. 
Together, Rfi and Rf2 explained about 40% of the total variance in both UpV 
and renal injury score. Animals homozygous at both Rf i and Rf2 showed 
substantially higher indexes of renal impairment than animals heterozygous at 
either or both QTLs, indicating that both QTLs cumulatively contribute to the 
development of renal impairment. Rf i and Rf2 contrasted in that the fanner 
showed the strongest effect on UpV, but weak effects on plasma albumin 
concentration, whereas Rf2 exhibited the opposite pattern. These differences 
suggest that Rfi and Rf2 may act through different mechanisms. 
Brown ef al. recently revealed the presence of sexual dimorphism in the 
development of hypertension and Up V in FHH rats.1l They found that in females, 
SBP cosegregates close to the Rf I area and not to the locus previously mapped in 
males, '2 being close to Rf2. Moreover, no significant logarithm-of-the-odds 
score (lod; statistical measure for the correlation between a locus and a trait) for 
the Rf2 area in the female cohort was found. 
1.4.2 Additional F2 cross 
Subsequently, a new and larger F2 cross of FHH and ACJ rats was studied to 
extend the genetic analysis of loci involved in the regulation of blood pressure 
and those defining the susceptibility to develop renal damage in the FHH rat after 
UNx.'09 Compared with the backcross study described above, the density of the 
genetic map published by Jacob ef al. in 1995 was almost tripled:'? 
At the Rfi locus, significant linkage was found with UpV and FGS. The 
inheritance patterns at Rf i were consistent with the Fl-I1-J alleles acting in a 
recessive or additive manner to increase urinary protein levels. A lad score scan 
for Up V showed that Rf 1 may have two peaks, which could not be definitively 
ruled out from being independent. At the maximum-paint-likelihood position for 
Rf i, the lad score for SBP was below the threshold level, indicating that Rf i 
causes renal impairment through a mechanism independent from blood pressUl'e, 
confirming the backcross data. Rf2 also showed high lod scores for Up V. 
Suggestive linkage in the same area was found with SBP (Bpflt-i). Therefore, 
independence of these two loci could not be established. 
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In addition to Rf 1 and Rf2, significant evidence was obtained for additional 
QTLs affecting UpV on chromosome 3 (Rf3) and on chromosome 14 (Rf4). 
Two more QTLs on chromosome 17 (Rf5 and Bpfh-2) showed suggestive 
linkage for UpV and SBP, respectively, and were independent. Similarly, for 
FOS, the lod score was significant for Rf3 and suggestive for Rf4 and Rf5. 
Rf 1 proved to have the strongest effect on Up V among all other Rfloci. 
However, animals that were homozygous for FHH on Rf 1 and heterozygous or 
homozygous for ACI on other Rfloci did not develop marked UpV. Although Rf 
1 shows the strongest linkage, the effect was less pronounced when other Rfloci 
did not carry homozygous Rfalleles. This suggests that Rf 1 has a strong additive 
effect on other Rfloci. The combination of Rfl and one of the other Rfloci 
severely impaired renal function. The combinations of Rf 1 and Rf4 or Rf-5 
showed the highest Up V levels. 
The use of molecular genetics in the (FI-IH x ACI) F2 intercross progeny not 
only confirmed the presence of two loci for renal damage (Rfl and Rf2), but 
also identified three new gene loci, named Rf3, Rf4, and Rf-5. The susceptibility 
to develop renal failure in the FHH rat seems to be largely a recessive trait in that 
the FJ rats do not develop high UpV. Rfl appears to act through a mechanism 
independent of blood pressure and additive effects on other Rfloci. The data 
underscore the complexity of the development of progressive renal damage in the 
FHH rat model and the interaction between hypertension and renal failure. To 
understand the phenotype in light of the genotype, especially with regard to 
polygenic control,80 the strength of physiology and genetics have to be combined, 
which is the concept of physiological genomics and the scope of this thesis. 
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1.5 OUTLINE 
The studies described in this thesis were undertaken to combine physiology 
and genetics in the FHR model of hypertension-associated renal damage. This 
approach eventually requires the determination of the impact of each Rfregion 
separately and of the various combinations of the different regions on renal 
damage. This requires the generation of congenic strains. Congenic strains cany a 
part of the Fill'! genome containing an Rflocus on the ACI background. The 
generation of such strains requires at least three years of selective breeding. 
During this breeding process, we further investigated the impact of hypetiension 
on renal damage in different genotypes. Moreover, we studied the mechanism of 
renal autoregulation in the FHH rat because previous studies pointed towards 
impairments in this mechanism.23,11l,1l3 The outcome of these studies might effect 
the iuterpretation of the genetic studies. While most studies so far were focused 
on the role of lowering blood pressure, the studies described in this thesis 
describe the impact of elevating blood pressure on the development of renal 
damage in rats with different genetic background. First, we tested the role of L-
NAME-induced increases in blood pressure on the development of renal failure 
in the FHL and the ACI rat (Chapter 2). The FHL rat was used because it shares 
most of the markers in the Rfregions with the FHH rat, but does not develop 
hypertension.95 The ACI rat was used because it is little susceptible to renal 
damage. Secondly, we compared the impact of L-NAME-induced increases in 
blood pressure on the development of renal failure in ACI and FHH rats, and in 
the F I progeny of these two strains, which are heterozygous for the Rfgenes 
(Chapter 3). Thirdly, we studied the combination of UNX and increased blood 
pressure on the development of renal damage in ACI and F I (FHH x ACI) rats. In 
this study, we also investigated whether differences in susceptibility to 
developing renal damage were caused by increases in blood pressure alone or 
also by actions ofL-NAME itself (Chapter 4). 
Another set of experiments served to better characterize the mechanisms 
underlying the high susceptibility to develop renal failure in FHH rats. First, the 
autoregulation of renal blood flow and glomerular filtration rate in FHH and FHL 
rats were studied (Chapter 5). Secondly, similar studies were done regarding the 
autoregulation of intraglomerular pressure and in vitro studies of renal 
microvascular reactivity (Chapter 6) to evaluate the myogenic response in FHH 
rats. 
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CHAPTER 2 
DIFFERENCE IN SUSCEPTIBILITY OF DEVELOPING 
RENAL DAMAGE IN NORMOTENSIVE FAWN-HOODED (FHL) 
AND AUGUST X COPENHAGEN IRISH (ACI) RATS 
AFTER N"'-NITRO-L-ARGININE METHYL ESTER 
INDUCED HYPERTENSION 
American Journal of Hypertension 1997; 1 0: 1109-1116 
Richard P.E. van Dokkum, Howard J. Jacob, and Abraham P. Provoost 
Renal susceptibility to L-NAME in FHL and ACI rats 
ABSTRACT 
Previous studies using the Fawn-Hooded Hypeltensive (FHH) rat have 
indicated that genetic factors appear to be important in determining the 
susceptibility to develop renal damage. This was further investigated by 
comparing the effects of N"-nitro-L-arginine methyl ester (L-NAME) induced 
hypeltension on functional and structural renal damage in two normotensive 
strains, the resistant August x Copenhagen Irish (AC!) rat and the Fawn-Hooded 
Low blood pressure (FHL) rat, which also appears to carry a susceptibility locus 
for renal failure. Male rats were studied during chronic treatment with L-NAME 
in either a low dose (LD, 75 to 100 mg/L drinking fluid) or a high dose (HD, 175 
to 250 mgIL). Survival of FHL rats was adversely affected by L-NAME 
treatment. All FHL-HD and 6 out of 14 FHL-LD rats died before the end of the 
II weeks study period, whereas all but one of the treated ACI rats survived. In 
both strains, L-NAME caused a dose dependent increase in systolic blood 
pressure (SBP). However, at similar levels of SBP, the increase in albuminuria 
(Va V) was significantly higher in FHL compared with ACI, as was the incidence 
of focal glomerulosclerosis (FOS). Both the SBP and the blood pressure burden 
(SBP-Av), defined as SBP averaged over the study period, directly correlated 
with Va V and FOS in both strains. However, the increase in the degree of renal 
damage per millimeter of mercmy increase in SBP or SBP-Av was significantly 
higher in the FHL than in the ACI rats. Our findings clearly show that FHL rats 
are more susceptible to renal damage after induction of hypeltension by chronic 
L-NAME treatment. We conclude that there is an interaction between blood 
pressure and the genetic susceptibility to develop renal failure in the FHL rat. 
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INTRODUCTION 
The susceptibility of a hypel1ensive patient to developing end stage renal 
failure (ESRF) seems to vmy with ethnicity. Although only a minority of 
hypel1ensive patients develop ESRF, I hypel1ensives of Ali'ican decent cany a 16-
fold greater risk of developing renal failure than do hypel1ensives of Caucasian 
decent.2•6 This points towards differences in susceptibility to developing renal 
complications that may be genetically determined.5 A dissociation between 
hypertension and renal disease is also present in animal models of genetic 
hypertension. The Fawn-Hooded Hypertensive (FHH) rat, an inbred strain with a 
moderate level of systemic hypeltension, develops progressive proteinuria (Up V) 
and focal glomemlosclerosis (FGS) by 12 months of age, leading to premature 
death due to ESRF. 7-9 In contrast, the Spontaneously Hypel1ensive Rat (SHR) 
develops severe hypertension but does not develop renal failure until velY late in 
life. 10 One of the striking differences between the two strains is the presence of 
glomemlar hypel1ension in FHH rats, II whereas glomerular pressme in SHR rats 
is not different from that ofnonnotensive Wistar-Kyoto rats. 12,13 
Genetic factors influencing the development and progression of renal damage 
have been previously suggested, but specific genes have not been identified. 14 
Recently, however, we have studied the genetics of hypertension and renal 
disease in the FHH rat. 15 Using a backcross of (FHH x [Augnst x Copenhagen 
Irish]) F I x FHH rats, we localized three quantitative trait loci on chromosome I, 
one for SBP and two for renal disease in the FHH !'at. The locns for SBP was 
denoted BpJll-1, and the loci for renal damage were denoted as Rf-l and Rf-2, 
respectively. Bpfh-l mapped to the SA region, also known as an imp0l1ant gene in 
determining SBP in other crosses of genetic hypertensive rats. 16-18 The Rf-l locus 
might contain a major gene in the control of renal function and could be 
responsible for the high susceptibility to develop renal damage in FHH rats. 
During the inbreeding of the FHH strain, we also developed a strain of Fawn-
Hooded Low blood pressure (FHL) rats. Both were obtained by selective 
inbreeding from randomly bred strains of fawn-hooded rats. In contrast to the 
FHH rat, the FHL rat not only has a lower SBP level, but develops UpV, 
albuminuria (Ua V), and FGS much more slowly, resulting in a longer survival 
time.7-9 Comparison of the FHH and FI-IL genotypes, however, showed that the 
markers flanking the alleles of the Rf-l region were identical in both strains. 19 
This indicates that the mutation in the Rf-l gene is likely to be also present in the 
FHL strain. Consequently, FHL rats should also have an increased susceptibility 
to renal damage when compared with other normotensive rat strains. We smmise 
that progressive Up V and FGS should develop once FHL rats are exposed to high 
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levels of SBP, and that this damage should be more prevalent in FHL rats 
compared with August x Copenhagen Irish (ACI) rats, which we do not expect to 
develop marked renal damage. To test this hypothesis, we elevated SBP in both 
FHL and ACI rats by chronic administration of different doses of the nitric oxide 
synthase-inhibitor (NOi), N"'-nitro-L-arginine methyl ester (L_NAME).20.21 
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METHODS 
Animals 
Experiments were performed on 65 animals that were 7 weeks old at the start 
of the study. These animals were derived from our own breeding colonies ofFHL 
and ACI rats. Animals were housed in standard rat cages with lights on from 8 
AM to 8 PM. Standard commercial rat chow containing 56% carbohydrates, 26% 
digestible protein, 7% fat, 4% fiber, and 5% minerals (AM II; Hope Farms, 
Woerden, The Netherlands) and drinking fluid (tap water, acidified to pH 3.0) 
were provided ad libitum. 
Induction of hypertension 
Hypertension was induced by chronic treatment with L-NAME (Sigma 
Chemical Co., St. Louis, MO) dissolved in the drinking water at a concentration 
either of 75 to 100 mglL (low dose, LD) or 175 to 250 mglL (high dose, HD). 
Age-matched control animals were provided with normal drinking fluid. 
Animals from each strain were randomly divided into three groups. The three 
ACI-groups initially consisted of nine control, eight LD treated, and eight HD 
treated rats. In about 20% of the cases, ACI rats presented with only one kidney, 
known as congenital unilateral renal agenesis (URA)."·23 Animals with URA 
were excluded from data analysis. The three FHL groups initially consisted of 12 
control, 14 LD treated, and 14 HD treated rats. 
Absolute L-NAME intake of the individual rats was determined at the time of 
the metabolic studies. The mean dosages, calculated from fl uid intake and body 
weight, for the various L-NAME-treated groups of rats are presented in Table l. 
Systolic blood pressure 
Systolic blood pressure (SBP) was measured with the tail-cuff method using a 
plethysmography (IITC Life Science, Woodland Hills, CA) in awake, restrained 
animals. Every Thursday between noon and 2 PM, at least three consecutive 
measurements were recorded and averaged. To investigate the relation between 
SBP and renal damage over a certain period of time, we calculated the SBP 
average (SBP-Av), by averaging all SBP data obtained from week 3 until the end 
of the protocol. 
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Functional studies 
Measurement of water and food intake and 24-h urine collections were done at 
3, 7, and II weeks of follow-up, by placing the animals in polycarbonate 
metabolic cages (Tecniplast Gazzada, Buguggiate, Italy). The animals were 
allowed to adapt over the weekend. Actual measurements were done on two 
consecutive days. 
Autopsy 
Moribund rats (that is, rats showing a rapid decrease in body weight over 
several days to below 300 g) were autopsied at the time of detection, whereas 
surviving animals were killed after the II-wk protocol. A laparotomy was 
performed under ethyl ether anesthesia and a blood sample was taken from the 
abdominal aOtia. After bleeding the animals, hemi and kidneys were removed, 
washed with saline, and weighed. Heart and kidneys of rats that died before the 
end of the II-wk protocol were weighed and processed if possible, that is, when 
obtained shOtily after death. 
Tissue processing 
Kidneys were fixed by immersion for 48 h in a 3.6% buffered formaldehyde 
solution (Lommerse Pharma, Oss, The Netherlands) after longitudinal bisection. 
Subsequently, they were dehydrated in alcohol and blocked in paraffin wax. 
Sections of 3 11m were stained with periodic acid Schiff (PAS) and hemotoxylin 
and eosin (HE) counterstain. 
The kidney sections were microscopically evaluated by determining the 
incidence of FGS. For each animal, 50 glomeruli were examined in the inner and 
outer cOtiical region and the number of sclerotic glomeruli were examined. 
Criteria on which glomeruli were designated as sclerotic consisted of adhesion of 
the glomerulus to Bowman's capsule, thickening of Bowman's capsule, the 
presence of increased amounts of PAS-positive material in the mesangial region, 
and folding of the glomemlar basement membrane with entrapment of amorphous 
material. Interstitial changes were not assessed. All sections were evaluated 
without knowledge of the group to which individual rats belonged. 
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Analytic procedures 
Plasma and urinary samples were analyzed with the ELAN system (Eppendorf-
Merck, Hamburg, Germany) using colorimetric assays for total protein with 
molybdate red, albumin with bromocresol green, and creatinine with the Jaffe 
method without deproteinization. 
Statistics 
Data are presented as mean ± SO in the tables in this article and as mean ± 
SEM in the figures. Differences in mean values between groups were compared 
using one way analysis of variance and a Student-Newman-Keuls test to identifY 
the groups that were different. In case of a nonnormal distribution of UaY, 
groups were compared using the Mann-Whitney rank sum test. In all tests p < 
0.05 was considered statistically significant. The relationship between SBP or 
SBP-Av and parameters of functional and structural renal damage was 
investigated by linear regression analysis. 
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RESULTS 
Dosage 
Table 1 shows the actual L-NAME intake at the time of the metabolic 
evaluation. No significant differences were present between the HD gronps of 
both strains at the three time-points evaluated. However, the LD treated FHL rats 
received slightly, but significantly more L-NAME at 3 and 7 weeks of follow-up. 
Table 1. Calculated values for L-NAME dose in mg/kg at 3,7, and 11 weeks of study. 
Group n Week 3 n Week 7 n Week 11 
ACI-LD 7 8.1 ± 0.5 7 7.0 ± 0.7 7 7.1 ± 0.9 
ACI-HD 7 18.0 ± 7.6 7 21.2 ± 5.3 6 18.1±4.7 
FHL-LD 14 9.5 ± 0.8 12 9.5 ± 0.9 6 8.9 ± 4.8 
FHL-HD 14 25.6 ± 7.0 6 23.4±17.1 No survivors 
p1/p2 sins sins ns 
Abbreviations: ACI, August x Copenhagen Irish rat; FHL, Fawn-Hooded Low blood 
pressure ral; HD, high dose; LD, low dose; pi, ACI-LD vs. FHL-LD; p2, ACI-HD VS. 
FHL-HD; s, P < 0.05; ns, not significant. Values are given as mean ± SD. 
Survival 
All ACI rats, except one in the HD group, survived for the duration of the 
experiment. In contrast, a large number of FHL rats died during the course of the 
study. In the LD group, only six out of 14 completed the ll-wk protocol. In the 
HD group, all 15 FHL rats died prematurely due to L-NAME-induced 
complications. These complications consisted of a decrease in body weight, 
severe vasoconstriction, and occasionally paralysis of the hind limbs. In general, 
animals showed signs of cardiac failure, i.e., coronary artery constriction and 
scarring of the heart muscle as was evaluated macroscopically at autopsy. 
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Systolic blood pressure and albuminuria 
Values for SBP, and UaV obtained at 3, 7 and II weeks are summarized in 
Table 2. In both ACI and FHL rats, a dose-dependent increase in SBP was 
observed. All SBP values in the L-NAME-treated rats were significantly different 
from the control ACI and FHL rats tJu'oughout the entire experiment. During the 
latter part of the follow-up, measurement of the SBP in FHL rats became 
extremely difficult due to the weak, or even lack of, pulsation in the tail arteries, 
caused by the severe L-NAME-induced vasoconstriction. At week 7 only two out 
of six in the FHL-HD group could be measured. At week 11, SBP could be 
determined in only one out of six rats in the FHL-LD group. 
Urinary protein excretion was measured simultaneously with Ua V in all rats. 
As changes in both parameters were almost identical; for brevity, only the 
analyses of the Ua V findings will be presented. Both strains differed greatly in 
the effects of L-NAME treatment on Ua V. Compared with ACI controls, the LD 
treated ACI rats showed hardly any increase in Ua V, whereas, at the end of the 
follow-up in the HD treated ACI rats, Ua V had increased threefold to a mean 
value of only 13 mg/day. In contrast, vety marked increases in UaV were 
observed in FHL rats. Compared with FHL controls, already at 7 weeks of 
follow-up there was a 24-fo1d increase in the FHL-HD rats to 191 mg/day. At the 
end of follow-up, the six surviving LD treated FHL rats showed a 16-fold 
increase in UaV, to a mean level of 121 mg/day. 
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Table 2. Sody weight (SW in g), systolic blood pressure (SSP in mmHg), and 
albuminuria (UaV in mg/day) in ACI and FHL rats at 3, 7, and 11 weeks of follow-up. 
Week 3 
Group n BW SBP UaV 
ACI-con 8 229 ± 17 130 ± 6 5.1±1.2 
ACI-LD 7 235 ± 8 159 ± 7 4.0 ± 0.7 
ACI-HD 7 213 ± 6 170 ± 7 5.2 ± 0.9 
p1/p2/p3 nslsls slsls nslnslns 
FHL-con 12 283 ± 29 119 ± 10 7.6 ± 1.3 
FHL-LD 14 263 ± 14 145 ± 10 12.1 ± 10.2 
FHL-HD 14 267 ± 12 160 ± 13 13.1±9.9 
p1/p2/p3 slslns slsls nslnslns 
p4/p5/p6 slsls slnsls slsls 
Week 7 
Group n BW SSP UaV 
ACI-con 8 254 ± 22 119 ± 5 4.8 ± 1.4 
ACI-LD 7 259 ± 12 169 ± 9 5.2 ± 1.1 
ACI-HD 7 242 ± 7 172 ± 9 10.1 ±3.7 
p1/p2/p3 nslnslns slslns nslsls 
FHL-con 12 317 ± 6 122 ± 9 7.9 ± 2.4 
FHL-LD 12 301 ± 17 177 ± 7 26.5 ± 20.6 
FHL-HD 6 235 ± 21 199±11t 191 ± 72 
p1/p2/p3 nslsls slsls slsls 
p4/p5/p6 slnsls nslslns slsls 
Week 11 
Group n BW SBP UaV 
ACI-con 8 276 ± 24 128 ± 7 3.8 ± 0.7 
ACI-LD 7 278 ± 15 165 ± 9 6.3 ± 2.3 
ACI-HD 6 264 ± 7 206 ± 18 12.7 ± 9.0 
p1/p2/p3 nslnslns slsls slslns 
FHL-con 9 331 ± 19 121 ± 10 7.5 ± 2.3 
FHL-LD 6 270 ± 24 207' 121 ± 60 
FHL-HD No survivors 
p1/p2/p3 s/-I- s/-I- s/-I-
p4/p5/p6 ns/-/ns -I-l- si-Is 
p1, LD vs. con; p2, HD vS. con; p3, LD vS. HD; p4, ACI-LD vS. FHL-LD; p5, ACI-HD vs. 
FHL-HD; p6, FHL-LD vS. ACI-HD; s, P < 0.05; ns, not significant; con control. Other 
abbreviations as in Table 1; , SSP could be obtained in one rat only; f SSP could be 
obtained in two rats only; Values are given as mean ± SD. 
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Figure 1, Tail cuff systolic blood pressure (SBP) in millimeters of mercury (mmHg) in 
awake August x Copenhagen Irish control (ACI-con, 0) and high dose (ACI-HD, 0) 
rats, Fawn-Hooded Low blood pressure control (FHL-con, Ell) rats and low-dose (FHL-
LD, A) rats from 3 to 11 weeks of follow-up. Values are given as mean ± SEM (error 
bars). 
160 6 
:;; 140 /~ :!'! 120 '" E- 100 
'" 
80 
'c 
" / c 60 
'E 
" 
40 12/ 
.0 14 ~ « 20 ~ --=8=----=8 
0 
2 4 6 8 10 12 
Time after treatment start (weeks) 
Figure 2, Urinary albumin excretion (UaV) in mg/day in ACI-con (0), ACI-HD (0), 
FHL-con (Ell), and FHL-LD (A) rats with comparable systolic blood pressure (SBP) at 
3, 7 and 11 weeks of follow-up. Values are given as mean ± SEM. Numbers at 
markers represent the number of animals measured. 
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Autopsy findings 
Body and organ weights are summarized in Table 3. In the ACI rat, treatment 
with L-NAME had little effect on body and wet kidney weight. Both absolute and 
relative heart weight in the ACI-HD group were significantly increased when 
compared with the ACI-LD and ACI control groups. 
Body weight of the L-NAME-treated FHL rats was significantly reduced when 
compared with that of the FHL control rats. Total kidney weight was about the 
same in all three groups. However, due to the differences in body weight, relative 
kidney weight was higher in FHL-LD and FI-IL-HD rats compared with that of 
FHL control rats. In combination with the lower body weights of the treated rats, 
the differences in relative heart weight were even more pronounced. 
Table 3. Body. kidney and heart (absolute and retative) weights and incidence of 
glomerulosclerosis at autopsy at week 11 or after premature death. 
Group n BW TKW TKW/100g FGS (%) HW HW1 
ACI-con 8 279±12 1953±100 701±27 0.9±0.6 736±34 265±14 
ACI-LD 7 272±16 1784±74 658±21 3.7±1.3 756±42 279±11 
ACI-HD 7 261±18 1856±136 717±88 7.0±1.5 835±37 321±17 
p1/p2/p3 nslnslns nslnslns nslsls slsls nslsls nslsls 
FHL-con 12 329±19 2329±155 703±24 1.9±1.6 978±64 298±15 
FHL-LD 11 256±17 2467±328 958±169 17.2±4.0 1045±89 410±40 
FHL-HD 13 231±18 2519±225 1074±159 25.4±5.1 1132±89 495±62 
p1/p2/p3 slsls nslnslns slsls slsls slsls slsls 
BW. body weight in g; TKW, total wet kidney weight in mg; TKW/100g, total wet kidney 
weight per 100 g BW; FGS%, focal glomerulosclerosis incidence; HW, wet heart 
weight in mg; HW1, wet heart weight per 100 g BW; p1, LD VS. con; p2, HD VS. con; 
p3, LD VS. HD; s, p<0.05; ns, not significant. Other abbreviations as in Table 1. Values 
are given as mean ± SD. 
Focal glomerulosclerosis 
The incidence of FOS, presented in Table 3 and Figure 3, indicates a dose 
dependent increase in structural renal damage in both strains. However, the 
increase in L-NAME-treated ACI rats was much less marked than that observed 
in both groups of treated FHL rats. 
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Figure 3. The incidence of focal glomerulosclerosis (FGS) given as percentage of 
affecled glomeruli in ACI and FHL rats, Values are given as mean ± SE, Numbers at 
the different bars indicate the number of animals that were evaluated, • p < 0,05, FHL-
LO VS, ACI-HO, and FHL-con VS, ACI-con, 
Clinical chemistry 
Plasma creatinin levels in ACI-control (n=8), ACI-LD (n=7), and ACI-HD 
(n=6) rats were 46 ± 4, 52 ± 5, and 49 ± 7 fllnollL, respectively, The values of the 
L-NAME-treated ACI rats were not significantly different from those of ACI 
control rats. In contrast, when compared with FHL control rats, elevated levels of 
plasma creatinin were present at autopsy in both groups of L-NAME-treated FHL 
rats, indicative of a deteriorating glomelular filtration rate, The values for FHL-
control (n=12), FHL-LD (n=5) and FHL-HD (n=2) rats, were 41 ± 3, 75 ± 36, 
and 76 ± 8 f.unollL, respectively, 
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A CI rats with unilateral renal agenesis 
At autopsy we found that one rat in each of the ACI groups had URA. Values 
for SBP, Va V, and FGS of these rats were similar to those of two-kidney rats in 
the same group. Albeit with a small sample size, this indicates that, even with one 
kidney, L-NAME-treated ACI rats do not develop severe functional and 
structural renal damage. 
Comparison of FHL and ACI rats with similar SBP levels 
Because we were interested in detecting differences in the effects of a similar 
increase in SBP on the development of renal damage between the two inbred 
strains, we directly compared the ACI-HD and FHL-LD groups. As shown in 
Figure I, these rats developed similar levels of blood pressure throughout the 
follow-up period. Although the SBP was initially higher in ACI-HD than in FHL-
LD rats, there were no significant differences from week 6 onward. 
As shown in Figure 2, the FHL-LD rats developed significantly higher levels 
of VaV than the ACI-HD rats during the study period. Figure 3 shows that at 
autopsy, the incidence of FGS was significantly higher in the FHL-LD rats 
compared with the ACI-HD rats. This indicates that the structural renal damage 
after L-NAME-induced hypertension is also more prevalent in FHL than in ACI 
rats, even though SBP levels were equivalent. 
Comparison of FHL and ACI rats by regression analysis 
We also compared the two strains by examining the relationships between SBP 
and the parameters for functional and structural renal damage. The regression 
equations for FHL and ACI rats obtained by the lineal' regression analyses are 
summarized in Table 4. 
In the ACI rats, the correlation between SBP and Va V became significant only 
at week II. In contrast, for the FHL rats, statistically significant correlations 
between SBP and Va V were present at all time-points. Comparing the equations 
obtained at week 11 shows that in the ACI rats the increase in Va V pel' millimeter 
of mercury (mmHg) increase in SBP was 0.12 mg/day. For the FHL rats, the 
slope of this relationship is about 15 times higher, i.e., the increase in VaV is 1.80 
mg/day pel' mmHg. When correlating the Va V data obtained at week 11 with the 
SBP-Av (i.e., the systolic blood pressure averaged over the whole follow-up 
period), a similar picture emerges. For each nllnHg increase in SBP-Av, the 
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increase in UaV was 2.40 mg/day in FHL rats and 0.16 mg/day in ACI rats. This 
again indicates that the increase per mmHg increase in SBP is 15 times higher in 
FHL rats than in ACI rats. 
At autopsy, the incidence of FGS correlated with SBP-Av in both strains. 
However, the increase in FGS per mmHg was about fourfold larger in FHL (0.38 
% FGS incidence per mmHg) than in ACI (0.10 % FGS incidence per mmHg). At 
week II in the FHL rats, there was a significant conelation between Ua V and 
FGS (1' = 0.836, P < 0.001). In contrast, such a correlation was not present in the 
ACI rats (1' = 0.321, P = 0.156). 
Relative heart weight was also directly related to SBP-Av in both FHL (1' = 
0.810, P < 0.001) and ACI (1' = 0.751, P < 0.001) rats. Again the effects were 
more pronounced in FHL than in ACI rats. For each mmHg increase in SBP-Av, 
the increase in relative heart weight was 3.06 mglJOO g body weight (BW) in 
FHL versus 0.88 mg/IOO g BW in ACI rats. 
Table 4. Equations obtained from linear regression analysis between blood pressure 
and morphological parameters in ACI and FHL rats. 
Group n Week Equation r p 
SBPandUaV 
ACI 22 3 UaV = -0.01 x SSP + 6.0 -0.129 0.566"' 
22 7 UaV = 0.04 x SSP + 0.8 0.298 0.177"' 
21 11 UaV = 0.12 x SSP - 12.4 0.655 0.001 
FHL 41 3 UaV = 0.13 x SSP - 6.8 0.283 0.073"' 
31 7 UaV = 1.44 x SSP - 173 0.543 0.002 
15 11 UaV = 1.80 x SSP - 212 0.892 <0.001 
SBP-Av and UaVat week 11 
ACI 21 11 UaV11 = 0.16 x (SSP-Av) -17.0 0.612 0.003 
FHL 15 11 UaV11 = 2.40 x (SSP-Av) - 277 0.800 <0.001 
SBP-Av and FGS 
ACI 22 11 FGS = 0.10 x (SSP-Av) -11.3 0.842 <0.001 
FHL 22 11 FGS = 0.38 x (SSP-Av) - 43.5 0.891 <0.001 
SBP-Av and HWI100g BW (HW1) 
ACI 22 11 HW1 = 0.88 x (SSP-Av) + 152 0.751 <0.001 
FHL 36 11 HW1 = 3.06 x (SSP-Av) - 66.5 0.810 <0.001 
n, total number of animals included in the analysis; Week, time of measurement; r, 
correlation coefficient; p, p-value. Other abbreviations as in Table 1. 
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DISCUSSION 
The present study was performed to compare the susceptibility to develop 
renal damage in two normotensive rat strains during chronic L-NAME-induced 
increases in blood pressure. Because the genetic markers flanking a known 
susceptibility gene in the FHH strain are identical in the FHL strain, we surmised 
that the FHL rat would be more susceptible to develop renal damage than would 
the rather renal damage resistant ACI rat after an increase in blood pressure. 15,23 
Our data clearly support this hypothesis. It was demonstrated that, at similar 
levels of elevated blood pressure, FHL rats developed significantly more 
functional and stnlctural renal damage than did the ACI rats. Furthermore, the 
FHL rats showed correlations between SBP and Ua V or FGS that were present 
earlier and had steeper slopes than those calculated for the ACI rats. Using the 
SBP-Av instead of SBP at each time point, similar differences were observed, 
indicating that the same blood pressure burden caused more renal damage in the 
FHL than in the ACI rat. 
A major limitation of this study was the high mortality of the L-NAME treated 
FHL rats. This is in contrast to studies using Sprague-Dawley (SD) rats, in which 
even higher doses of L-NAME were used.24,25 In a previous study, we observed 
that unilaterally nephrectomized FHH rats also died prematurely during chronic 
L-NAME treatment,26 whereas others reported a very high mortality rate in L-
NAME-treated spontaneously hypertensive rats." As indicated by the moderately 
elevated plasma creatinin levels, none of the screened FHL rats suffered from 
terminal renal failure at the time of death. We think that cardiac or central 
nervous damage due to the severe L-NAME-induced vasoconstriction in 
combination with the very high blood pressure was the most likely cause of 
premature death. Therefore it appears that, apart from the kidney, other organ 
systems of the FHL rat are also more sensitive to the adverse effects of nitric 
oxide synthase inhibition. Relative heatl weight was increased in treated rats of 
both strains, but heart weights were significantly higher in treated FHL rats 
compared with treated ACI rats. Cardiac hYfertrophy after chronic L-NAME 
treatment has also been reported by others,28,2 although some authors claim the 
cardiac hypertrophy to be less than expected from the degree of blood pressure 
elevation.30,31 
An increase in systemic blood pressure appears to be a universal characteristic 
of chronic L-NAME treatment. Since the first studies in Munich-Wistar (MW) 
rats,20 a relatively large, dose dependent increase in blood pressure has been 
d .. . f 24·37 M' tu d' I h reporte to occur m vanous strams 0 rats. Icropunc re stu les lave sown 
that the elevation of systemic pressure is accompanied by an increase in 
intraglomenllar capillary pressure.20,26,33,37 The effects of the L-NAME-induced 
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hypertension on parameters of functional or stmctural renal damage have only 
occasionally been reported. In animals with two intact kidneys a relatively mild 
increase in UpY, UaY, or FGS, indicating a low degree of renal damage similar 
to that observed by us in the ACI rat, has been reported for MW20.21.33.36 and SD 
rats. 24.32 However, it should be noted that a study similar to ours (i.e., directly 
comparing various rats strains with regard to effects of L-NAME-induced 
hypertension on renal damage) has not been reported. 
The adverse renal effects of chronic treatment with L-NAME appears to 
manifest when the development of renal damage is accelerated by other 
procedures. We reported that L-NAME worsens the renal damage in the 
unilaterally nephrectomized FHH rat,26 whereas others reported similar findings 
in MW rats with subtotal nephrectomy.37 In addition, it has been reported that in 
MW rats sodium excess aggravates both the L-NAME-induced systemic and 
glomemlar hypertension, leading to more severe renal parenchymal injury.33 
We conclude that, in general, FHL rats are more vulnerable than are ACI rats 
to L-NAME-induced complications. At similar levels of hypertension, FHL rats 
develop more severe fimctional and shuctural renal damage than do ACI rats. 
Accordingly, the present study supports our previous observation that 
susceptibility to renal damage in rats appears to be genetically determined. 15 
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GENETIC DIFFERENCES DEFINE SEVERITY OF RENAL 
DAMAGE AFTER L-NAME-INDUCED HYPERTENSION IN RATS 
Journal of the American Society of Nephrology 1998;9:363-371 
Richard P.E. van Dokkum, Howard J. Jacob, and Abraham P. Pl'Ovoost 
Genetic susceptibility to renal damage in rats 
ABSTRACT 
Genetic factors are important in determining the susceptibility to develop renal 
damage. In a backcross of hypertensive and proteinuric Fawn-Hooded (FHH/EUR) 
with the normotensive, non-proteinlll'ic August x Copenhagen Irish (ACIlEUR) rat, 
two genes were genetically mapped for parameters of filllctional and structural 
renal damage, denoted Rfl and Rf2. The aim of the present study was to 
investigate the susceptibility to develop filllctional and structural renal damage in 
heterozygous (FHH x ACI) FI rats compared with the parental FHH and ACI 
strains at similar levels of systolic blood pressure (SBP). Blood pressure elevation 
was induced by chronic treatment with N'"-nitro-L-arginine methyl ester (L-NAME) 
in either a low dose (LD, 75 to 100 mgIL) or a high dose (HD, 175 to 250 mgIL) in 
the drinking fluid. Survival of FHH rats and, to a lesser extent, F I rats, was 
adversely affected by L-NAME treatment. All ACI rats except for one ACI-HD 
animal survived. In all strains, L-NAME caused a dose-dependent increase in SBP. 
At similar levels of SBP, the increase in fimctional renal damage, as indicated by 
the level of albuminuria (UaV), was higher in FI compared with ACI, but lower 
compared with FHH. The same differences were found for the level of structural 
renal damage, as indicated by the incidence of focal glomel'lllosclerosis (FGS). 
Both the SBP and the average BP burden (SBP-Av), defined as SBP averaged over 
the period of follow-up, directly correlated with the level of Ua V and the FGS 
incidence in all strains. However, the increase in the degree of renal damage per 
mmHg increase in SBP or SBP-Av was significantly higher in the F I rats compared 
with ACI, but lower compared with FHH rats. Values for these FI rats were closer 
to the ACI rats than to values for the FHH rats and increased above an SBP level of 
180 mmHg. The FI rats, being heterozygous for Rfl and Rf2, as well as for other 
potential genes responsible for renal disease, were largely, but not completely 
protected from hypertension-induced renal damage. It is concluded that complete 
susceptibility to hypertension-associated renal damage in rats primarily depends on 
the presence of predisposing genes for renal failure even after a significant increase 
in blood pressure. 
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INTRODUCTION 
Genetic factors appear to be important in determining the susceptibility to renal 
damage. In humans, the susceptibility of a hype11ensive patient to end-stage renal 
failure (ESRF) shows racial differences. Although African-Americans make up 
only 12% of the U.S. population, 28% of patients on hemodialysis are African-
Americans, I and the rate of developing ESRF is four times greater for African-
Americans than for Caucasians.2.6 This suggests that differences in susceptibility to 
develop renal complications may be genetically detennined.5 The increased 
susceptibility to renal failure in Afi'ican-American hypertensive patients is not 
accounted for solely by a higher prevalence of hypertension or severity of 
hypertension. I 
A dissociation between hypertension and renal disease is also present in animal 
models of genetic hypertension. The Fawn-Hooded Hypertensive (FHH) rat, an 
inbred strain with a moderate level of systemic hypertension, develops progressive 
proteinuria and focal glomel1llosclerosis (FGS) at a relatively young age, leading to 
premature death due to ESRD.7-9 In contrast, the Spontaneously Hype11ensive Rat 
(SHR) develops severe systemic hypertension, but remains without significant renal 
damage until late in life. lo A striking difference between the two strains is the 
presence of glomel1llar hypertension in FHH rats, II whereas in SHR rats 
glomel1llar pressure is normal. 12.13 
Genetic factors influencing the development and progression of renal damage 
have been suggested earlier, but specific genes have not yet been found. 14 
However, we have recently studied the genetics of hypertension and renal damage 
in the FHH rat. 15 Using a backcross of (Fill-I x August Copenhagen Irish [ACID FI 
x FHH rats, we genetically mapped three genes on chromosome I: one for SBP, 
and two for renal damage in the FHH rat. The gene for SBP, denoted Bpfh-l, maps 
to the SA region, which is also known as an imp0l1ant gene in determining SBP in 
other crosses of genetically hypertensive rats. 16.18 The genes for renal damage, 
denoted Rf 1 and Rf2, were found to be separate and distinct from each other. The 
~r-l gene with the highest logaritlllll-of-odds scores appears to be a major gene 
responsible for the high susceptibility to renal damage in FHH rats. 
Cross-breeding the FHH with the ACI rat results in an F I rat, which is 
heterozygous for all genes, including Rfl and Rf2. In the present study, we wanted 
to investigate the susceptibility of the heterozygous Firat to hypertension-induced 
renal damage compared with both parental strains. Hypertension was induced by 
clu'onic administration of different doses of the nitric oxide synthase-inhibitor 
(NOi) N'"-nitro-L-arginine methyl ester (L_NAME).19.21 
53 
Genetic susceptibility to renal damage in rats 
METHODS 
Animals 
Experiments were conducted in accordance with Dutch laws on animal 
experimentation. A total of 93 animals was used, 7 wk old at the start of the study. 
FHH and ACI rats were derived li-mn our own breeding colonies at Erasmus 
University Rotterdam (EUR). F I (FHH x ACI) rats were obtained by cross breeding 
FHHlEUR and ACIlEUR rats. Animals were housed in macrolon cages with lights 
on fi'om 8 AM to 8 PM. Standard commercial rat chow containing 56% 
carbohydrates, 26% digestible protein, 7% fat, 4% fiber, and 5% minerals (AM II, 
Hope Farms, Woerden, The Netherlands) and drinking fluid (tap water, acidified to 
pH 3.0) was provided ad libitum. 
Experimental groups 
Animals from each strain were divided at random into three groups, i.e., control 
rats and rats treated with either a low dose (LD) or high dose (HD) (see below). 
The three ACI-groups consisted initially of eight controls, seven LD-(reated, and 
seven HD-treated rats. Data from the ACI rats were obtained from the same groups 
in a previous study.21 ACI rats which presented with unilateral renal agenesis at 
autopsy were off line excluded from data analysis. The three FHH groups initially 
consisted of nine control rats, 17 LD-treated, and six HD-treated rats. From a total 
of 36 F I (FHH x ACI) rats, nine were used as controls, 17 were LD-treated, and 10 
were I-ID-treated. 
Induction of hypertension 
Hypertension was induced by chronic treatment with L-NAME (Sigma-Aldrich 
Chemicals, Zwijndrecht, The Netherlands) dissolved in the drinking water a( a 
concentration of either 75 to 100 mgIL (LD) or 175 to 250 mgIL (HD). Age-
matched control animals were provided with normal drinking fluid. Absolute L-
NAME intake of the individual rats was detennined at the time of the metabolic 
studies. The mean doses, calculated from fluid intake and body weight, are 
presented in Table I. 
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Systolic blood pressure 
Systolic blood pressure (SBP) was measured by the tail-cuff method using a 
plethysmograph (lITC Life Science, Woodland Hills, CA) in awake, restrained 
animals, which were prewarmed for approximately 30 min by ceramic lamps to 
obtain proper dilation of the tail vessels. Every Thursday between noon and 2 PM, 
at least three consecutive measurements were recorded and averaged. To 
investigate the relationship between SBP over time and renal damage, we 
calculated the SBP average (SBP-Av) by averaging all SBP data obtained from 3 
weeks until the end offollow-up. 
Metabolic studies 
Measurement of water and food intake and 24 hour urine collection were done at 
3, 7, and II wk of follow-up, by placing the animals in polycarbonate metabolic 
cages (Tecniplast Gazzada, Buguggiate, Italy). The animals were allowed to adapt 
over the weekend. 
Autopsy 
Moribund rats, i.e., rats showing a rapid decrease in body weight over several 
days to below 300 g, were autopsied at the time of detection, whereas surviving 
animals were sacrificed after the II week protocol. A laparotomy was performed 
under ethyl ether anesthesia, and a blood sample was taken from the abdominal 
aorta. After bleeding the animals, heati and kidneys were removed, washed with 
saline, and weighed. Rats that died before the end of the study period were weighed 
and processed if possible, i.e., when obtained shortly after death. 
Final glomerular filtration rate (GFR) 
The creatinine clearance (CCr) calculated from the creatinine concentrations in 
plasma from blood obtained at autopsy and in urine from the last metabolic 
measurement shortly before autopsy was used as measure for GFR. CCr (mllmin) 
was calculated using the fonnula: 
CCr = (OCr X V) / (PCr x 1.44), where OCr is the creatinine level in urine (mmollL), V 
is the urine excretion rate (mI/24h), and PCr the plasma creatinine level (mmollL). 
To correct for differences in body weight between strains, CCr was also calculated 
per 100 gram body weight (CerlIOOg). 
55 
Genetic susceptibility to renal damage in rats 
Tissue processing 
Kidneys were fixed by immersion for 48 hours in buffered formaldehyde 
solution (3.6% MN, Lommerse Pharma, Oss, The Netherlands, pH 7.4) after 
longitudinal bisection. Subsequently, pieces were dehydrated in alcohol and 
blocked in paraffin wax. Sections of 3 fun were stained with periodic acid-Schiff 
and hemotoxylin and eosin counterstain. 
The kidney sections were microscopically evaluated by determining the 
incidence ofFGS as a semiquantitative injury score. For each animal, SO glomeruli 
were examined in both the cortical and juxtaglomerular region, and the number of 
sclerotic glomeruli were counted, giving the incidence of FGS. Criteria on which 
glomeruli were designated sclerotic consisted of adhesion of the glomel1llus to 
Bowman's capsule, thickening of Bowman's capsule, the presence of increased 
amounts of periodic acid-Schiff-positive material in the mesangial region, and 
folding of the glomerular basement membrane with entrapment of amorphous 
material. Interstitial changes and vascular damage were not assessed at that time. 
All sections were evaluated without knowledge of the group to which individual 
rats belonged. 
Analytical procedures 
Plasma and urinary samples were analyzed with the ELAN system 
(EppendorflMerck, Darmstadt, Germany) for the following compounds, using 
colorimetric assays for total protein with molybdate red, albumin with bromocresol 
green, and creatinine with the Jaffe method without deproteinisation. 
Statistical analysis 
Data are presented as mean ± SO in tables and as mean ± SE in figures. 
Differences in mean values between groups were compared using one-way 
ANOVA and a Student-Newman-Keuls test to identify the groups that were 
different. In case of a non-normal data distribution, groups were compared using 
the Matul-Whitney rank sum test. In all tests, differences were considered 
statistically significant for p < 0.05. The relationship between SBP or SBP-Av and 
parameters of functional and stl1lctural renal damage was assessed by linear 
regression analysis. 
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RESULTS 
Survival 
All ACI animals except one in the HD group survived throughout the 
experiment. In contrast, a large number of FHH rats died during the protocol. In the 
LD group, only three out of 15 completed the II wk follow-up. In the HD group, 
all six FHH rats died prematurely due to L-NAME-induced complications. From 
the Fl-LD group, all animals completed the follow-up, but from the HD group, five 
of ten rats died prematurely. The L-NAME-induced complications consisted of a 
decrease in body weight, severe vasoconstriction, and occasionally paralysis of the 
hind limbs, probably due to constriction of nervous system arteries. In general, 
animals showed signs of cardiac failure, i.e., constriction of the coronary arteries 
and scarring ofheat1muscle as observed macroscopically. 
Table 1. Calculated L-NAME intake in mg/kg at 3, 7, and 11 wk of treatment. 
Group n Week 3 n Week 7 n Week 11 
ACI-LD 7 8.1 ± 0.5 7 7.0 ± 0.7 7 7.1 ± 0.9 
ACI-HD 7 18.0 ± 7.6 7 21.2 ± 5.3 6 18.1 ±4.7 
F,-LD 17 9.1 ± 1.9 17 8.4 ± 2.6 17 7.9 ± 2.7 
F,-HD 10 16.5±1.6 10 19.5 ± 3.7 5 27.2 ± 4.6 
FHH-LD 17 10.8 ± 2.2 15 8.9 ± 4.2 1 16.2 
FHH-HD 6 22.5 ± 5.9 4 15.4 ± 7.4 No survivors 
p1/p2/p3 ns/ns/ns ns/ns/ns ns/-/-
p4/p5/p6 ns/s/s ns/ns/ns s/-/-
Values are given as mean ± SD. L-NAME, N"-L-arginine methyl ester; ACI, August x 
Copenhagen Irish; LD, low dose; HD, high dose; FHH, Fawn-Hooded Hypertensive; ns, 
not significant; s, significant (p < 0.05); pi, ACI-LD VS. F,-LD; p2, ACI-LD VS. FHH-LD; 
p3, F,-LD VS. FHH-LD; p4, ACI-HD VS. F,-HD; p5, ACI-HD VS. FHH-HD; p6, F,-HD VS. 
FHH-HD. 
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Body weight 
Body weights, shown in Table 2, progressed normally over time in the ACl 
groups and showed no effect of L-NAME treatment. In FI rats, there was mild 
growth retardation but no deterioration in body weight in the HD-treated group 
over time. Body weight in control and LD-treated rats progressed normally. Body 
weight of the L-NAME-treated FHH rats were significantly reduced compared with 
control rats, although the decrease in body weight was only mild in the LD-treated 
group. 
Systolic blood pressure and albuminuria 
Values for SBP and albuminuria (UaV) obtained at 3, 7, and 11 wk are 
sunnnarized in Table 2. In all three strains, a dose-dependent increase in SBP was 
observed. All SBP values in the L-NAME-treated rats were significantly different 
from the control ACI, F" and FHH rats throughout the entire experiment. In the FI-
HD group, two of five rats could not be measured at week 11 due to 
vasoconstriction. In the FHH rats, measurement of the SBP became extremely 
difficult during the latter patt of the follow-up due to the weak, 01' even lack of, 
pulsation in the tail arteries caused by severe L-NAME-induced vasoconstriction. 
At week 7, only eight of 15 in the FHH-LD group and none in the HD group could 
be measured. At week 11, two of the three remaining FHH-LD animals could not 
have their SBP measUl'ed for the same reason. In Table 2 and Figures 3 and 4, we 
have used the last measured SBP, usually obtained 1 to 2 wk earlier, to calculate the 
mean values and the regression equations. 
Urinary protein excretion was measured simultaneously with Ua V in all rats. 
Because changes in both parameters were almost identical, for brevity only the 
Ua V data will be presented. All strains differed greatly in the effects of L-NAME 
treatment on UaV. The LD-treated ACI rats showed hardly any increase in UaV, 
while at the end of the follow-up in the HD-treated rats, Ua V had increased to a 
mean value of 13 mg/day. In the FI rats, UaV was moderately elevated to 30 
mg/day at week 7 and further increased to 94 mg/day at week 11. In contrast, a very 
marked increase in Ua V was observed in FHH rats already after 7 wk of follow-up. 
At that time, the mean Ua V in the LD- and HD-treated FHH rats had increased to 
more than 200 mg/day. After II wk of follow-up, the three surviving FHH-LD rats 
had a mean level of 269 mglday. 
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Table 2. Body weight (g), systolic BP (mm Hg), and albuminuria (mglday) in ACI, F1, and 
FHH rats at 3, 7, and 11 weeks of follow·up.' 
Week 3 
Group n BW SBP UaV 
ACI·con 8 229 ± 17 130 ± 6 5.1 ± 1.2 
ACI·LD 7 235 ± 8 159 ± 7 4.0 ± 0.7 
ACI·HD 7 213 ± 6 170 ± 7 5.2 ± 0.9 
p11p21p3 nslsls slsls nslnslns 
F,·con 9 284 ± 28 126 ± 2 5.5 ± 1.0 
F,·LD 17 287 ± 24 155 ± 7 6.6 ± 2.8 
F,·HD 10 274 ± 22 172 ± 4 6.0 ± 1.4 
p11p2/p3 nslnslns slsls nslnslns 
FHH·con 9 284 ± 26 144 ± 9 25 ± 18 
FHH·LD 17 282 ± 23 170 ± 8 64 ±47 
FHH·HD 6 267 ± 31 187 ± 12 46±45 
p1/p21p3 nslnslns slsls nslnslns 
p4/p5lp6 slslns nslsls nslsls 
p71p8/p9 slslns nslsls nslnslns 
p10/p111p12 slslns nslsls nslnslns 
Week? 
Group n BW SBP UaV 
ACI·con 8 254 ± 22 119 ± 5 4.8 ± 1.4 
ACI·LD 7 259 ± 12 169±9 5.2±1.1 
ACI·HD 7 242 ± 7 172 ± 9 10.1 ±3.7 
p1/p2Jp3 nslnslns slslns nslsls 
F,·con 9 315 ± 41 125 ± 5 5.6 ± 1.3 
F,·LD 17 327 ± 26 186 ± 13 9.5 ± 5.2 
F,·HD 10 300 ± 19 201 ± 16 30± 25 
p1/p21p3 nslnslns slsls nslsls 
FHH·con 9 330 ± 25 143 ± 8 43± 25 
FHH·LD 15 278 ± 41 209 ± 20' 211 ± 89 
FHH·HD 4 241 ± 15 210 ± 10' 223 ± 27 
p1/p21p3 slsls sls/· slslns 
p4lp5/p6 slnsls slsls nslsls 
p7/pSlp9 slnsls s/·l· nslsls 
p10/p11/p12 slsls nslsls nslnslns 
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Table 2 (continued) 
Week 11 
Group n BW SBP UaV 
ACI-con 8 276 ± 24 128 ± 7 3.8 ± 0.7 
ACI-LD 7 278 ± 15 165 ± 9 6.3 ± 2.3 
ACI-HD 6 264 ± 70 206 ± 18 12.7± 9.0 
p1/p2/p3 ns/ns/ns s/s/s s/s/ns 
F,-con 9 356 ± 31 134 ± 5 6.9± 1.1 
F,-LD 17 359 ± 25 187 ± 16 31 ± 40 
F,-HD 5 299 ± 21 210 ± 16b 94 ± 31 
p1/p2/p3 ns/s/s s/sls ns/s/s 
FHH-con 9 348 ± 25 151 ± 5 54 ± 32 
FHH-LD 3 267 ± 35 216 ± l' 269 ± 46 
FHH-HD No survivors 
p1/p2/p3 s s s 
p4/p5/p6 s/ns/s s/s/s ns/s/s 
p7/p8/p9 ns/-I- ns/-!- s/-I-
p10/p11/p12 s/s/ns ns/s/s ns/s/s 
'Values are given ± so. pi, LD vs. can; p2, HD vs. con; p3, LD vs. HD; p4, ACI-LD vs. 
F,-LD; p5, ACI-LD vs. FHH-LD; p6, F,-LD vs. FHH-LD; p7, ACI-HD vs. F,-HD; p8, ACI-
HD vs. FHH-HD; p9, F,-HD vs. FHH-HD; p10, ACI-con vs. F,-con; p11, ACI-con vs. 
FHH-con; p12, F,-con vs. FHH-con; s, p < 0.05; ns, not significant (p > 0.05). 
b At week 11, SBP could be obtained in 2 rats, only; for the other three rats, the last 
measured SBP obtained 1 wk earlier was used 
. , At week 7, SBP could be obtained in 8 rats, only; for the other seven rats, the last 
measured SBP (1 to 2 wk earlier) was used. 
, At week 11, SBP could be obtained in one rat, only; for the other two rats, the last 
measured SBP obtained 3 wk earlier was used. 
, At week 7, SBP could not be measured; data obtained at week 6 were used. 
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Autopsy findings 
Body and organ weights of autopsied animals are slllmnarized in Table 3. In 
ACI rats, treatment with L-NAME had little effect on body weight and wet kidney 
weight. Both absolute (not shown) and relative heart weight in the ACI-HD group 
were significantly increased when compared with those of the ACI-LD and ACI 
control rats. Total kidney weight (not shown) was about the same in all three 
groups. In the F I rats, body weights were significantly lower in HD- VS. LD-treated 
and controls. The same applies for the relative total kidney weight. The relative 
heatt weight was significantly increased in both treated groups compared with 
controls. In the FHH rats, body weight was severely reduced by L-NAME 
treatment. Relative kidney weight was significantly increased in FHH-LD and 
FHH-HD rats compared with FHH control rats. In combination with the lower body 
weights of the treated rats, the differences in relative heatt weight were even more 
pronounced. 
Table 3. Body, kidney and heart weights and incidence of glomerulosclerosis at autopsy 
after 11 weeks of follow-up or at premature death.' 
Group n BW (g) TKW/100g FGS (%) HW/100g 
ACI-con 8 279 ± 12 701 ± 27 0.9 ± 0.6 265 ± 14 
ACI-LO 7 272 ± 16 658 ± 21 3.7±1.3 279 ± 11 
ACI-HO 7 261 ± 18 717 ± 88 7.0±1.5 321 ± 17 
p1/p2/p3 ns/s/ns s/ns/ns s/s/s ns/s/s 
F,-con 9 362 ± 30 719 ± 31 2.0 ± 1.6 261 ± 11 
F,-LO 17 365 ± 32 698 ± 33 7.3 ± 4.4 295 ± 25 
F,-HO 8 265 ± 27 940 ± 98 19.5 ± 3.8 394 ± 31 
p1/p2/p3 ns/s/s ns/s/s slsls slsls 
FHH-con 9 342 ± 25 714 ± 26 4.2 ± 1.5 321 ± 59 
FHH-LO 16 245 ± 24 1016 ± 42 31.4±7.0 466 ± 55 
FHH-HO 4 240 ± 12 1123±98 51.0±5.7 451 ± 10 
p1/p2/p3 slslns slsls slsls s/s/ns 
p4/p5/p6 slnsls nslsls nslsls ns/s/s 
p7/p8/p9 ns/ns/ns slsls slsls s/s/s 
p10/p11/p12 slslns nslnslns ns/ns/ns ns/s/s 
a Values are given as mean ± SO. TKW/100g, TKW per 100 9 BW; HW/100g, wet HW 
per 100 9 BW; pi, LO VB. can; p2, HO VB. can; p3, LO VB. HO; p4, ACI-LO VB. F,-LO; p5, 
ACI-LO VB. FHH-LO; p6, F,-LO VB. FHH-LO; p7, ACI-HO VS. F,-HO; p8, ACI-HO VS. FHH-
HO; p9, F,-HO VB. FHH-HO; p10, ACI-con VB. F,-con; p11, ACI-con VB. FHH-con; p12, 
F,-con VB. FHH-con; s, p < 0.05; ns, not significant (p > 0.05) 
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Focal glomerulosclerosis 
The incidence of FGS presented in Table 3 indicates a dose-dependent increase 
in structural renal damage in all strains. However, the increase in L-NAME-treated 
ACI rats was much less marked than that observed in both groups of treated F I and 
FHH rats. The most severe structural damage was observed in the treated FHH rats. 
It must be stated that FGS of FHH controls was also higher compared with ACI 
and F I control rats. 
Creatinine clearance 
The final plasma creatinine and calculated Cc, values, as measure for GFR, are 
presented in Table 4. The mean Cc, values in L-NAME-treated ACI rats were not 
significantly different from controls. In contrast, mean Cc, was higher in control 
and treated F I rats compared with ACI rats. However, Cc, in the F I-HD was 
severely decreased compared with control and LD-treated rats, indicative of a 
deteriorating GFR. In the FHH control rats, Cc, was higher compared with F I and 
ACI control and treated rats. FHH rats treated with L-NAME all showed a 
significantly lower Cc, compared with control rats and ACI and F I control and 
treated rats. Differences are even greater when Cc, per 100 gram body weight 
(Cc.lIOOg, Table 4) is considered. 
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Table 4. Final plasma creatinine and calculated creatinine clearances. ' 
Group n Pc, Uc,xV CC, Cd100g 
ACI-con 8 46.3 ± 4.4 91.5 ± 21.1 1.39 ± 0.35 0.50 ± 0.11 
ACI-LO 7 51.7±5.3 103.2 ± 9.7 1.40±0.19 0.52 ± 0.06 
ACI-HO 6 49.3 ± 6.7 99.4 ± 5.9 1.44 ± 0.32 0.54 ± 0.11 
p1/p2/p3 ns/ns/ns ns/ns/ns ns/ns/ns ns/ns/ns 
F,-con 9 46.4 ± 2.2 125.9 ± 15.9 1.88 ± 0.20 0.52 ± 0.02 
F,-LD 17 51.3 ± 8.0 137.8 ± 17.2 1.91 ± 0.35 0.52 ± 0.06 
F,-HO 5 124.0 ± 62.9 111.4 ± 21.6 0.78 ± 0.34 0.28 ± 0.10 
p1/p2/p3 ns/s/s ns/ns/s ns/s/s ns/s/s 
FHH-con 9 40.0 ± 5.7 123.8 ± 8.5 2.18 ± 0.26 0.64 ± 0.07 
FHH-LO 9 83.1 ± 24.4 87.8 ± 21.6 0.80 ± 0.29 0.31 ± 0.09 
FHH-HO 2 129.5 ± 17.5 75.2 ± 4.1 0.41 ± 0.04 0.17± 0.03 
p1/p2/p3 s/s/s s/s/ns s/s/ns s/s/ns 
p4/p5/p6 ns/s/s s/ns/s s/s/s ns/s/s 
p7/p8/p9 s/s/ns ns/ns/ns s/s/ns s/s/ns 
p10/p11/p12 ns/ns/ns s/s/ns s/s/ns ns/s/s 
, Values are given as mean ± SO. Pc" plasma creatinine level (~mollL), Uc, x V, urine 
creatinine excretion (mmoll24 h); Cc" creatinine clearance (mllmin); Cc/100g, creatinine 
clearance per 100 gram body wt. Other abbreviations as in Tables 1 and 2. p1, LO vS. 
can; p2, HO vS. con; p3, LD vS. HO; p4, ACI-LO vS. F,-LO; p5, ACI-LO vS. FHH-LO; p6, 
F,-LD vS. FHH-LO; p7, ACI-HO vS. Fl'HO; p8, ACI-HO vS. FHH-HD; p9, F,-HO vS. FHH-
HO; p10, ACI-con vs. F,-con; p11, ACI-con vs. FHH-con; p12, F,-con vs. FHH-con; s, p < 
0.05; ns, not significant (p > 0.05). 
Comparison of groups with similar SBP levels 
Because we wanted to relate the development of renal damage in groups with 
approximately the same blood pressure levels, we compared the Ua V and OS in the 
ACI-HD and F I-HD, and the FHH-LD groups. All three groups developed 
hypertension, the final SBP level being approximately 210 mlllHg. The ACI rats, 
however, showed a more gradual rise than the F I and FHI-I rats (Table 2). 
Figure I shows the changes in Ua V in the three groups. FHH-LD rats already 
developed Ua V after 3 wk of treatment, progressing with time to approximately 
270 mglday at week II. ACI-HD rats developed no increase in UaV during the 
study. F I rats showed intermediate responses. At week 7, there was an increase 
from 30 to 95 mglday at week II. 
Figure 2 shows that at autopsy, the incidence of FOS was significantly higher in 
the FHH-LD rats compared with the ACI- and F,-HD rats. Hypertensive ACI-HD 
rats showed only a moderate degree of FOS, with F,-HD rats being intermediate. 
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This indicates that the structural renal damage at similar SBP levels is also more 
pronounced in Hili rats than in ACI and F I rats. 
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Figure 1. Urinary albumin excretion (UaV, mg/day) of August x Copenhagen Irish-high 
dose (ACI-HD, V) rats, Fawn-Hooded Hypertensive low-dose (FHH-LD, Il) rats, and F,-
HD (0) rats at 3, 7, and 11 weeks of follow-up. Numbers at the different markers 
represent the number of rats that were measured. Values are given as mean ± SE. * P < 
0.05, F,-HD rats vs. ACI-HD rats, •• p < 0.05, FHH-LD rats vs. ACI and F,-HD rats. 
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Figure 2. The incidence of focal glomerulosclerosis (FGS) in ACI-HD, F,-HD, and FHH-
LD rats. Values are given as mean ± SEM. Numbers above the bars indicate the number 
of animals that were evalualed. * p < 0.05, F,-HD rats vs. ACI-HD rats, .. p < 0.05, FHH-
LD rats vs. ACI and F,-HD rats. 
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Comparison of the three strains by regression analysis 
We also compared the three strains by examining the relationships between SBP 
and the parameters [or functional (i.e., UaV) and structural (i.e., incidence ofFGS) 
renal damage. Figures 3 and 4 show the scatter plots of the relationship between 
SBP and Ua V in the three strains at weeks 7 and II of the follow-up, respectively. 
In the ACI rats, the correlation between SBP and UaV became significant only at 
week II. In the FJll-! and F I rats, statistically significant correlations between SBP 
and UaV were present at weeks 7 and II of the follow-up. Slopes o[the regression 
lines differed between the three strains. At week 7, the rise in UaV was 0.04 
mg/day per mmHg in the ACI rats, 0.2 mg in the F I rats, and 2.0 mg in the FJll-! 
rats (Figure 3). Thus, already at week 7, increase in Ua V per mmHg increase in 
SBP in FJll-! rats was approximately 50 times higher than in ACI and 
approximately 10 times higher than in F I rats. The F I rats showed an increase in 
albumin loss five times higher than the ACI rats. 
When comparing the equations obtained at week II, as shown in Figure 4, it is 
clear that the rise in Ua V per mmHg increase in SBP was highest in the FJll-! rats, 
i.e., 3.1 mg/day. The rise was only 0.12 in the ACI rats. The Fl rats showed a 
biphasic distribution pattern. Up to an SBP level of 180 lmnHg, Ua V increased 
only with 0.2 mg per nunHg increase in SBP, which was similar to the situation at 
week 7. Above the SBP level of 180 lmnHg, the increase was eight times more, up 
to 1.7 mg/day. These data indicate that F I rats were protected against the 
development of severe Ua V up to an SBP level of 180 nllnHg. 
Comparing the UaV obtained at week 11 with SBP-Av, i.e., the SBP averaged 
over the entire follow-up period, showed a similar pattern. For each nunHg 
increase in SBP-Av, the increase in UaV was 3.4mg/day in FJll-!, 0.9mg/day in FJ, 
and 0.2 mg/day in ACI rats. 
At autopsy, the incidence of FGS correlated with SBP-Av in all strains. 
However, the increase in FGS per lmnHg in FHH (FGS = 0.7 x SBP-Av - 92, n = 
29, l' = 0.886, P < 0.001) was sevenfold larger than in ACI (FGS = 0.1 x SBP-Av-
II, n = 22, l' = 0.842, P < 0.001) and approximately fourfold larger than in Fl (FGS 
= 0.2 x SBP-Av - 25, n = 34, l' = 0.727, P < 0.01). The increase was twice as much 
in the F I rats compared with the ACI rats. Significant correlations were also present 
between the incidence ofFGS and UaV at week II in FJll-! (1' = 0.851, P < 0.001), 
and Fl rats (1' = 0.836, P < 0.001). Such a correlation was absent in the ACI rats (1' = 
0.321, P = 0.156). 
Relative heart weight was also directly related to SBP-Av in FHH (1' = 0.668, P < 
0.001), Fl (1' = 0.741, P < 0.001), and ACI (1' = 0.751, P < 0.001) rats. For each 
nnnHg increase in SBP-Av, the increase in relative heart weight was 2.5 mg/IOO g 
BW in FHH rats, 1.5 mg/IOO g BW in Fl rats, and 0.9 mg/IOO g BW in ACI rats. 
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Figure 3. Relationship between systolic blood pressure (SBP) and UaV at week 7. 
Slopes of the regression lines are indicated next to the different lines. ACI-HD (V); F,-HD 
(0); FHH-LD ("). See also the legend of Table 2. Equations: ACI, UaV = 0.04 x SBP + 
0.8 (n = 22, r = 0.298, P = 0.177); F" UaV = 0.2 x SBP - 15.9 (n = 36, r = 0.329, P = 
0.05); FHH, UaV = 2.0 x SBP - 215 (n = 28, r = 0.660, P < 0.001). 
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Figure 4. Relationship between systolic blood pressure (SBP) and UaV at week 11. 
Slopes of the regression lines are indicated next to the different lines. ACI-HD (V); F,-HD 
(0); FHH-LD (1'1). See also the legend of Table 2. Equations: ACI, UaV = 0.12 x SBP -
12.4 (n = 21, r = 0.655, P = 0.001); FI, UaV = 0.2 x SBP - 22.0 (first part, n = 21, r = 
0.814, P < 0.001), and UaV = 1.7 x SBP - 228 (last part, n = 22. r = 0.708, P < 0.001); 
FHH, UaV = 3.1 x SBP - 411 (n = 12, r = 0.896, P < 0.001). 
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DISCUSSION 
The present study was performed to compare the development of renal damage 
in the presence of L-NAME-induced increases in blood pressure in two rat strains 
differing in susceptibility and in the progeny of a cross between these strains. The 
presented data clearly suppOli the hypothesis that in the rats studied, the 
susceptibility to develop renal damage depends on genetic background. It was 
demonstrated that at similar blood pressure levels, FHH rats developed more severe 
functional and structural renal damage than did the ACI rats. (FHH x ACI) F 1 rats 
showed intermediate responses, but phenotypically closer to ACI than to FHH rats. 
The ACI rats were largely protected from developing marked Ua Y up to an SBP 
level of 225 mmHg. The F 1 rats were protected to a level of approximately 180 
mmHg, whereas FHH rats were not protected at all. Furthermore, the FHH and F 1 
rats showed correlations between SBP and UaY or FGS that were present earlier 
and hac! steeper slopes than those in the ACI rats, with the F 1 rats again being 
intermediate. Using the SBP-Av instead of SBP at each time point, similar 
differences were observed, indicating that a similar blood pressure burden over the 
treatment period caused more renal damage in the FHH and the F 1 than in the ACI 
rat. 
A major drawback was the high mortality of the L-NAME treated FHH rats. In 
previous studies we observed that unilaterally nephrectomized FHH rats and FHL 
rats with two kidneys also died premahlrely during chronic L-NAME treatment,21,22 
Others reported a very high mortality rate in L-NAME treated SHR rats. 23 A 
decrease in GFR, indicated by a decrease in Cc" was found in the F I-HD rats and 
both treated FHH groups. However, none of the screened FHH and F 1 rats that died 
before the end of the shldy did so because of terminal renal failure. We think that 
ischemic cardiac or central nervous damage due to the severe L-NAME induced 
vasoconstriction, in combination with the high blood pressure, would be the most 
likely cause of the premahlre death. Thus, apart from the kidney, other organ 
systems of heterozygous rats, are also more sensitive to the adverse effects of nitric 
oxide synthase inhibition. Relative heart weight was increased in treated rats of all 
strains, but heart weights were higher in treated FHH and F 1 rats compared with 
treated ACI rats, being most pronounced in FHH rats. Cardiac hypeltrophy after 
c1u'onic L-NAME treatment has also been repOlied by others24,25, although some 
authors found the increase in cardiac weight to be relatively mild,26,27 
An increase in SBP appears to be a universal characteristic of clu'onic L-NAME 
b 'h b d " tit' 19·33 treatment, ecause It as een reporte to occur m vanous ra s 'all1s. 
Micropuncture studies have shown that the elevation of systemic pressure is 
. db' " I I 'II 19222933 TI accompame y an ll1crease 111 ll1trag omeru ar capl ary pressure, ' " Ie 
effects of the L-NAME-induced increase in blood pressure on urinaty protein or 
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albumin excretion or on stl1lctural renal damage have only occasionally been 
repot1ed. However, in our previous study in Fawn-Hooded Low blood pressure 
(FHL) rats, we showed that renal damage occurs upon blood pressure elevation.21 
This strain is also susceptible to renal damage, and multiple gene interaction is 
likely to be involved. A relatively mild increase in proteinuria, Ua Y, or FGS, 
indicating a relative mild degree of renal damage similar to that observed by us in 
the ACI rat, has been reported after investigating Munich-Wistar (MW)19.20.29.32 or 
Sprague-Dawley rats28 with two intact kidneys. However, it should be noted that a 
study directly comparing various rats strains with regard to effects of L-NAME-
induced hypertension on renal damage, such as the one presented here, has not been 
reported. 
The effects of chronic treatment with L-NAME appear to be more distinct in rats 
with reduced renal mass or other models of renal damage. It has been reported that 
L-NAME worsens renal damage in the unilaterally nephrectomized Hili rat22 and 
in MW rats after subtotalnephrectomy.33 In addition, it has been repot1ed that in 
MW rats, sodium excess aggravates both the L-NAME-induced systemic and 
glomerular hypertension, leading to more severe renal parenchymal injUly.29 
In conclusion, F I rats, which are heterozygous for renal failure genes, are 
partially protected from hypertension-associated renal damage. At similar levels of 
hype11ension, (Hili x ACI) F I rats are more vulnerable than ACI rats to L-NAME-
induced complications, but less sllsceptible than the parental FHH rats. The present 
data suppot1 our previous observation that susceptibility to renal damage in rats is 
genetically detellllined. 15 
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BLOOD PRESSURE AND THE SUSCEPTIBILITY TO 
RENAL DAMAGE AFTER UNILATERAL NEPHRECTOMY 
AND L-NAME-INDUCED HYPERTENSION IN RATS 
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Blood pressure and renal damage in rats 
ABSTRACT 
Fawn-Hooded Hypertensive (FHH) rats carry several genes which determine 
the susceptibility to develop renal damage in contrast to the renal damage 
resistant August x Copenhagen Irish (ACI) rats. Kidneys from F I (FHH x ACI) 
rats, being heterozygous for the renal susceptibility genes, appeared to be largely, 
but not completely protected when blood pressure was increased with N"-nitro-L-
arginine methyl ester (L-NAME). In the present experiment, we examined the 
role of an increased hemodynamic burden on the development of renal damage by 
combining unilateral nephrectomy (UNX) and L-NAME induced hypertension in 
F I and ACI rats. Additionally, we investigated whether a general toxic effect of 
L-NAME, independent from a blood pressure elevation, caused renal damage in 
F I rats. Therefore, the rats were simultaneously treated with L-NAME and the 
angiotensin conve11ing enzyme inhibitor, lisinopril. 
Surgery was performed at the age of 15 weeks and L-NAME treatment (SO or 
150 mgIL) started immediately thereafter. Systolic blood pressure (SBP) and 
urinary albumin excretion (Ua V) were measured at 6 and 12 weeks post UNX, 
followed by autopsy to determine the incidence of focal glomerulosclerosis 
(FGS). A dose-dependent hypertension developed in the L-NAME treated rats of 
both strains. At similar L-NAME intake, F I rats developed more severe 
hypertension and more Ua V than ACI rats. Furthermore, the increase in Ua V per 
mmHg increase in SBP at was fivefold higher in F I compared with ACI rats. A 
significant relationship between functional and structural renal damage was 
present in both strains. However, in F I rats, the increase in Ua V per % incidence 
increase in FGS was three times higher. In lisinopril treated F I rats, no significant 
Ua V or FGS was measured at low blood pressure levels, indicating that renal 
damage in hypertensive F I rats is not a direct effect of L-NAME, but the result of 
the high blood pressure or another action depending on the activation of the 
renin-angiotensin system. 
We conclude that heterozygosity for the genes influencing the development of 
renal damage in the FHH strain increases the susceptibility of the kidney to 
develop damage after UNX combined with systemic hypertension. 
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INTRODUCTION 
The Fawn-Hooded Hypellensive (FHH) rat is a unique model of hypellension-
associated renal failureY Males develop mild systolic hypertension, progressive 
aibuminlll'ia (Ua V), and focal glomerulosclerosis (FGS) at a relatively young age. 
Previous studies in FHH rats showed the presence of hyperfiltration and 
glomerular hYf,ertension preceding the development of functional and structural 
renal damage. ,4 In the FHH rat, renal damage is greatly enhanced by unilateral 
nephrectomy (UNX),5,6 a procedlll'e that will further increase the hemodynamic 
burden to the glomeruli. A lineal' relationship was found between systolic blood 
pressure (SBP) and intraglomerular pressure in three groups of UNX rats with 
different SBP levels.4 A relatively high efferent mleriolar resistance in 
combination with a decreased ability to increase afferent tone was also found in 
the FHH rat, suggesting an impairment in the control of renal vascular 
resistance.4 
Genetic factors influencing the development and progression of renal damage 
are apparent in FHH rats. Using a backcross of (FHH x August Copenhagen Irish 
[ACID FIx FHH rats, we mapped two quantitative trait loci (QTLs) on 
chromosome I, influencing proteinuria and structural renal damage.7 These genes 
were denoted Rf-l and Rf-2. Rf-l appeared at least partly independent from blood 
pressure. In a subsequent study, the development of renal damage after UNX was 
assessed in a (FHH x ACI) F2 progeny.s Linkage analysis in this F2 cross not only 
confirmed the importance of Rf-l and Rf-2, but also revealed the presence of 
three additional QTLs (Rf-3, Rf-4, and Rf-5) influencing the development of 
proteinuria. Thus, susceptibility to renal damage after UNX is influenced by at 
least five susceptibility genes. 
Previously, we have studied the effects of hypertension induced by clu'onic 
nitric oxide inhibition (NOi) with L-NAME on the development of renal damage 
in F 1 (FHH x ACI) rats and in both parental strains with two kidneys. It was 
shown that despite similar SBP levels, severe Ua V and FGS were present in FHI-! 
rats, while ACI rats hardly developed any renal damage.9 The most important 
finding in the F I rats was that, although these hybrids developed less renal 
damage compared with FHH rats, being heterozygous for the susceptibility genes 
did not completely protect the kidney from developing Ua V and FGS. Compared 
with ACI rats, the severity of Ua V and FGS increased, especially at SBP levels 
above 180 mmHg. 
The purpose of the present study was to assess the genetic susceptibility to 
develop renal damage after UNX in combination with L-NAME-induced 
hypellension. The changes in UaV and SBP, 6 and 12 weeks after UNX and L-
NAME-induced hypellension were assessed in F I (PI-IH x ACI) and ACI rats. At 
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12 weeks after surgely, rats were sacrificed, creatinine clearance was measured, 
and morphologic studies were performed in kidney tissue to determine stmctural 
renal damage. FHH rats were not included in these studies because of their high 
susceptibility and mortality in response to chronic L-NAME treatment9, 
especially in combination with UNX.6 
A second study was carried out under a similar protocol to exclude the renal 
damage from being a direct toxic effect of L-NAME. In this study, F I rats were 
treated with L-NAME and the angiotensin converting enzyme inhibitor (ACEi), 
lisinopril, to keep SBP at a low level. The SBP and Ua V levels were measured 
12, 18, and 24 weeks after UNX in control and treated groups. 
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METHODS 
Experimental animals 
A total of 55 animals was used in study I, and a total of 25 animals was used 
in study 2. All animals were 15 weeks of age at the time the study was started. 
The FHH and ACI rats were all derived from our own breeding nuclei, and the F 1 
(FHH x ACI) rats were specially bred for the study. All rats were housed under 
standard conditions in the Animal Facilities of the Erasmus University Medical 
School, which is approved by the Dutch Veterinary Inspection. They had free 
access to food and water throughout the study. The protocol received approval 
from the animal ethical committee of the Erasmus University. 
Unilateral nephrectomy 
Laparotomy was carried out under ethyl ether (Sigma Chemical Co., St. Louis, 
MO) anesthesia, administered through an evaporation system connected to an 
airtight box. The right kidney was carefully separated from the adrenal gland and 
the surrounding connective tissue. The renal artery and vein, as well as the ureter, 
were ligated with a 4.0 silk suture (Braun AG, Melsungen, Germany) and cut. As 
previously reported, ACI rats presented with congenital unilateral agenesis 
(URA), in about 20% of the cases. lO All ACI rats were checked for this anomaly 
and the rats that presented with URA were excluded from analysis. For analgetic 
purposes, rats post-operatively received a subcutaneous injection of I: I diluted 
fentanyl (Hypnonn®, Janssen Cilag Ltd., Saunderton, England) at a dose of 5 
mg/kg and were allowed to recover from surgery in a warmed cage for I to 2 
hours. Treatment was stat1ed after the rats had recovered for 3 to 4 days. 
Study 1 
Chronic nitric-oxide inhibition was induced by treatment with N"-nitro-L-
arginine methyl ester (L-NAME, Sigma-Aldrich Chemicals, Zwijndrecht, The 
Netherlands) dissolved in the drinking water at a concentration of 50 or 150 
mg!L, based on previous experiments.9•11 This dose was slightly lower compared 
with previons studies in two-kidney rats, because some F 1 animals died in that 
study as a result of L-NAME-induced complications. Control animals were 
provided with normal drinking fluid. 
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Animals from each strain were divided into three groups, and were age- and 
body weight-matched. The F 1 groups (n=29) consisted of nine control rats, ten 
rats treated with 50 mg L-NAME, and ten rats treated with 150 mg L-NAME. 
The ACI groups (n=26) consisted of ten control rats, six rats treated with 50 mg 
L-NAME, and ten rats treated with 150 mg L-NAME. Actual L-NAME intake 
was calculated in mg/kg from the metabolic data at 6 and 12 weeks after UNX. 
Study 2 
Blood pressure was maintained at low levels by chronic ACEi, using lisinopril 
(Novatec®, Merck Sharp & Dome, Haarlem, The Netherlands) which was 
administered tln'ough the drinking water at a concentration of 50 mgIL. This dose 
was used because it had previously proven to provide adequate blood pressure 
reduction in FHH rats. 12 As in study I, hypertension was induced using L-
NAME. The F 1 rats were divided into three age- and body weight-matched 
groups, and were measured 12, 18, and 24 weeks after UNX The control (con) 
and L-NAME groups consisted of eight rats. The third group (NAME+LIS) 
consisted of nine rats that were simultaneously treated with L-NAME and 
lisinopril directly after UNX until the final measurement at 24 weeks after UNX. 
Also in this study, actual L-NAME intake was calculated in mg/kg from the 
metabolic data at 12, 18, and 24 weeks after UNX (Table I). 
SBP and metabolic measurements 
SBP was measured by the tail-cuff method, using a photoelectric oscillatory 
detection device (lITC Life Science, Woodland Hills, CAl, as previously 
described.9,11 The week before the measurement, animals were allowed to adapt 
to the equipment and the procedure to minimize stress-induced artifacts. 
Although SBP was measured every three weeks after UNX, only the values 
obtained at the time of the metabolic measurements will be presented. Urine 
excretion, food and water intake were determined gravimetrically at 6 and 12 
weeks after UNX in study I and 12, 18, and 24 weeks after UNX in study 2, by 
housing the animals in metabolic cages (Tecniplast Gazzada, Buggugiate, Italy), 
as described previously.9,11 
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Terminal procedure 
Shortly after the last metabolic measurement, rats were anesthetized by an 
intraperitoneal injection of sodium pentobarbital (Nembutal®, Sanofi Sante BV, 
Maassluis, The Netherlands, 50 mg/kg). A 21 gauge needle (B. Braun AG, 
Melsungen, Germany) was introduced into the dorsal aorta at the bifurcation of 
the right and left iliac attelY and a blood sample was taken. After sampling of the 
blood, the abdominal aorta was ligated above the renal arteries and the kidney 
was flushed with sterile 0.9% NaCI (Baxter BV, Utrecht, The Netherlands) 
containing 50 IUIL heparin (Leo Pharmaceutical Products, Weesp, The 
Netherlands) for 2 min after cutting the renal vein. The kidney was subsequently 
perfused for approximately 5 min with buffered formaldehyde solution (3.6 % 
MIV Lommerse Pharma, Oss, The Netherlands, pH 7.4). Both solutions were 
perfused at pressures similar to the SBP that was obtained at the last tail-cuff 
measurement. Both the heart and the kidney were removed and weighed. Animals 
that died prematurely were necropsied within 12 h and included in the stntctural 
damage analysis. 
Terminal analysis 
Processing of kidneys and the criteria for the assessment of the incidence of 
FGS, and methods and calculations for final creatinine clearance as a measure of 
glomentlal' filtration rate (GFR) were performed as previously described.9,1l 
Analytic procedures 
Plasma and urinary albumin concentration was measured with bromocresol 
green (Merck, Darmstadt, Germany), and creatinine with the Jaffe method 
without deproteinization using the semi automatic ELAN system (Merck-
Eppendorf, Hamburg, Germany). 
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Statistics 
Data are presented as mean ± SE in the figures and as mean ± SD in the text 
and tables. Differences in mean values between groups were compared by 
ANOVA and a subsequent Student-Newman-Keuls tcst to identifY the groups that 
were different. In case of a non-normal data distribution, groups were compared 
using the Mann-Whitney rank sum test. In all tests, statistical significance was 
defined as p < 0.05. 
The relationships between SBP and UaV, and between the level of UaV at 
week 12 and the incidence of FGS was assessed by linear regression analysis. All 
tests were done using the Primer of Biostatistics (S.E. Glantz) software package. 
Table 1. Actual L-NAME intake adapted from metabolic measurements in F, and ACI 
rats in mg/kg at 6 and 12 weeks of treatment in study 1 and 2. 
Group n Week 6 Week 12 Week 18 Week 24 
F,-50 10 3.3 ± 0.6 3.0 ± 0.7 nm nm 
F,-150 10 9.4 ± 1.8 9.4 ± 2.1 nm nm 
ACI-50 6 3.1 ± 0.4 2.7±0.7 nm nm 
ACI-150 10 8.6 ± 1.5 7.9 ± 3.1 nm nm 
p1/p2 ns/ns ns/ns 
F,-NAME 8 nm 8.3 ± 1.5 8.1 ± 2.9 8.7 ± 4.7 
F,-NAME + LIS 9 nm 8.6 ± 2.8 7.3 ± 3.3 6.3 ± 2.7 
p3 ns ns ns 
Values are given as mean ± SD. L-NAME, NW-nitro-L-arginine methyl ester; LIS, 
lisinopril; F" F, (FHH x ACI) rats; ACI, August x Copenhagen Irish rats; pi, ACI-50 vs. 
F,-50; p2, ACI-150 vs. F,-150; p3, F,-NAME vs. F,-NAME + LIS; nm, no measurement; 
s, p < 0.05; ns, not significant (p > 0.05). 
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RESULTS 
Study 1 
Blood pressure and albuminuria 
The actual L-NAME intake was calculated from the fluid intake at the 
metabolic measurements and is given in Table I. No statistical significant 
differences between both strains at the measured time-points lVas detected. 
The values for SBP in both F I and ACI control rats and after L-NAME 
treatment are summarized in Table 2. SBP in control F I rats was significantly 
higher compared with control ACI rats and averaged around 130 and 110 nunHg, 
respectively. Chronic L-NAME treatment induced dose-dependent differences in 
SBP that were already statistically significant at the first time-point. Treated F I 
rats developed significantly higher SBP levels than treated ACI rats. These 
significant differences between F I and ACI remained present during the entire 
follow-up. From the first time-point onwards, SBP levels increased, although not 
dramatically, in both the ACI-50 and in ACI-150 groups, respectively. The 
increase in SBP was also modest in the F I-50 group. In contrast, SBP more 
steeply increased in the F I-ISO group. The groups that developed similar levels of 
SBP were the PI-con and the ACI-50, and the FI-50 and the ACI-150 groups. 
The level of functional renal damage, as indicated by the level of Ua V, rose in 
a dose-dependent fashion in all strains, and is also shown in Table 2. The rise in 
Ua V in control and treated P I rats was significantly higher than in the ACI rats, 
and was highest in the FI-150 group. In contrast, ACI rats showed small increases 
in Ua V during the follow-up, even after 12 weeks of ISO mg L-NAME treatment. 
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Table 2. Body weight (g), systolic blood pressure (SBP, mmHg), and albuminuria 
(UaV, mg/24h) in ACI, and F, rats at 6 and 12 weeks of follow-up. 
Week 6 
Group n BW SSP UaV 
F,-con 9 349 ± 41 129 ± 3 9.6 ± 3.8 
F,-50 10 345 ± 39 160 ± 9 12.3 ± 8.6 
F,-150 10 351 ± 38 182 ± 10 18.1 ± 11.8 
p1/p2/p3 nslnslns slsls nslslns 
ACI-con 10 262 ± 19 109 ± 6 3.4 ± 1.6 
ACI-50 6 254 ± 19 133 ± 10 5.6 ± 1.8 
ACI-150 10 262 ± 20 158± 14 9.2 ± 3.0 
p1/p2/p3 nslnslns slsls nslnslns 
p4/p5/p6 slsls slsls nslnsls 
Week 12 
Group n BW SSP UaV 
F,-con 9 387 ± 38 134 ± 7 16.5 ± 8.6 
F,-50 10 382 ± 45 170 ± 13 27.1 ± 14.8 
F,-150 10 366 ± 38 212 ± 12 109 ± 48 
p1/p2/p3 nslnslns slsls nslsls 
ACI-con 10 286 ± 21 113 ± 6 5.3 ± 2.3 
ACI-50 6 272 ± 31 148 ± 11 10.9 ± 3.0 
ACI-150 10 276 ± 24 165 ± 15 21.6 ± 8.9 
p1/p2/p3 nslnslns slsls nslnslns 
p4/p5/p6 slsls slsls nslnsls 
Values are given as mean ± SD. BW, body weight; SSP, systolic blood pressure; UaV, 
albuminuria; can, control; Other abbreviations as in Table 1. pi, can vs. 50 mg; p2, can 
vs. 150 mg; p3, 50 mg vs. 150 mg; p4, ACI-con vs. F,-con; p5, ACI-50 vs. F,-50; p6, 
ACI-150 vs. F,-150; s, p < 0.05; ns, not significant (p > 0.05). 
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Figure 1A. Tail-cuff systolic blood pressure (SBP) and B. urinary albumin excretion 
(UaV) in F, (FHH x ACI) rats at 12, 18, and 24 weeks after UNX. Groups are: untreated 
controls (con, III, n=8), rats treated with 150 mg/L L-NAME (NAME, A, n=8), and rats 
treated with 50 mg/L Iisinopril and 150 mg/L L-NAME directly after UNX (NAME + LIS, 
T, n=9). Values are given as mean ± SE. 
83 
Blood pressure and renal damage in rats 
Structural renal damage and final GFR 
The level ofstmctural damage, as indicated by FOS, is shown in Table 3. Both 
strains showed a dose-dependent increase in POS. The incidence of POS in the 
PI-ISO group was significantly higher compared with all other groups. The 50 mg 
treated groups of both strains showed similar FOS incidence. 
At autopsy, the calculated creatinine clearance, used as an estimate for final 
OPR, was significantly higher in all groups of F I rats compared with ACI control 
and treated rats, as shown in Table 4. In contrast, OFR was significantly lower in 
the 150 mg treated groups of both strains compared with the 50 mg treated 
groups. By comparing the creatinine clearance in the present study with those 
obtained in a previous study performed in F I and ACI rats with two kidneys (2K) 
after similar L-NAME intake,9 we were able to calculate the compensatory 
increases after UNX in both strains. It appears that the compensatOlY increase in 
F I rats was significantly higher compared with ACI rats. In control F I rats, the 
final OFR after UNX on average increased by 59% compared with 2K-PI rats. In 
control ACI rats, the level after UNX was only 17% higher than in 2K-ACI rats. 
This data indicates that F I rats were less efficiently protected from an increase in 
OFR than ACI rats. 
Table 3. Body, kidney, and heart weights and incidence of glomerulosclerosis at 
autopsy after 12 weeks of follow-up. 
Group n BW (g) LKW LKW/g FGS (%) HW HW/g 
Freon 9 388±47 1920±214 495±18 6.2±3.1 988±145 254±14 
F,-50 10 398±60 1908±243 481±27 9.6±3.7 980±103 248±15 
F,-150 10 358±48 1944±313 533±40 23.4±13.3 1138±110 314±16 
p1/p2/p3 nslnslns nslnslns nslnsls nslsls nslsls nslsls 
ACI-con 10 289±25 1385±134 480±24 3.2±2.7 715±57 248±10 
ACI-50 6 259±37 1302±116 509±65 8.5±2.1 685±71 266±21 
ACI-150 10 279±26 1343±129 481±15 10.9±6.0 745±73 267±20 
p1/p2/p3 nslnslns nslnslns nslnslns nslnslns nslnslns nslslns 
p4/p5/p6 slsls slsls nslnsls nslnsls slsls nslnsls 
n, number of rats; BW, body weight; LKW, left kidney weight in mg; LKW/100g, LKW 
per 100 9 BW; FGS, focal glomerulosclerosis; HW, heart weight in mg; HW/100g, HW 
per 100 g BW. Other abbreviations as in Table 1. pi, con VS. 50 mg; p2, con VS. 150 
mg; p3, 50 mg VS. 150 mg; p4, ACI-con VS. F,-con; p5, ACI-50 VS. F,-50; p6, ACI-150 
VS. F,-150; s, p < 0.05; ns, not significant (p > 0.05). 
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Renal damage in groups with similar SBP levels 
The groups that develop similar levels of SBP appeared to be the F I-con and 
the ACI-50, and the FI-50 and the ACI-150 groups, respectively. The SBP level 
in these groups averaged 132 ± 2 and 139 ± 5, and 165 ± 7 and 160 ± 6 nuuHg, 
averaged over all measured time-points. The Ua V level in the F I rats over the 
same period was higher, although not statistical significantly different from ACI 
rats due to the large variation. However, when we compared the groups that 
received the same amount of L-NAME (Table I), the level of Ua V in the F 1-150 
group was significantly higher compared with evelY ACI group at 6 and 12 weeks 
post UNX. The incidence of FGS in the FI-150 group was also significantly 
higher compared with all other groups. 
Comparison of strains by linear regression analysis 
To determine whether a difference in the relationship between SBP and Ua V 
was present between F I and ACI rats after UNX, lineal' regression analysis was 
performed on the data obtained at 6 and 12 weeks after statt of the experiment. 
All control, 50-, and 150-mg treated rats were included in this analysis. Already 
at 6 weeks, the slope of the best-fit regression line was significantly higher in F I 
compared with ACI rats, and averaged 0.17 ± 0.07 (I' = 0.397, P = 0.033) and 0.10 
± 0.02 (I' = 0.709, P < 0.01) mg/24h per mmHg. At week 12 after UNX, the 
increase in Ua V pel' mmHg increase in SBP was five times more in F I than in 
ACI rats. Values averaged 1.24 ± 0.18 and 0.25 ± 0.05 mg/24h pel' mmHg, 
respectively, and indicate that the amount of functional damage between week 6 
and 12 was sevenfold in F 1> and almost threefold in ACl. 
Furthermore, a significant correlation between FGS and Ua V was present in 
both strains. The increase in Ua V per percent increase in FGS incidence was 
three times higher (p < 0.001) in FI compared with ACI rats and averaged 3.98 ± 
0.49, and 1.31 ± 0.27 mg/24h, respectively. FUtthermore, pel' percent increase in 
FGS, FI rats showed an increase in LKW/IOO g BW of 0.25 ± 0.03, whereas ACI 
rats did not show a significant correlation between those parameters. 
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Study 2 
Blood pressure and albuminuria 
The actual L-NAME intake of the F I rats used in this study are also given in 
Table I, and showed no significant differences between both F I groups. 
Longitudinal values for the tail-cuff SBP and Ua V at 12,18, and 24 weeks 
after UNX are shown in Figure IA and B, respectively. Also in this study, SBP in 
L-NAME treated rats was significantly higher than that of the control group. In 
contrast, SBP in the rats that were simultaneously treated with L-NAME and 
Iisinopril was significantly lower compared with the control rats. The SBP in the 
L-NAME group increased to around 200 mmHg at week 24 after UNX. The SBP 
levels in the control and NAME+LIS group remained stable around 135 and 100 
llllnHg, respectively. 
A similar picture emerged for the Ua V levels, which increased steeply with 
time in the NAME treated gl'OUp. Ua V in the control gl'OUp also progressively 
increased, although much less than in the L-NAME treated gl'OUp. The rats 
treated simultaneously with L-NAME and Iisinopril did not develop any 
significant Ua V during the entire period, the average level being around 2 
mg/24h. 
Final GFR and structural renal damage 
Final creatinine clearance as an indicator of final GFR is summarized in Figure 
2A. Final GFR in the control group was slightly, but not significantly higher than 
in the NAME and NAME+LIS gl'OUps. 
The level of stmctural damage, indicated by the incidence of FGS, is shown in 
Figure 2B, and was significantly higher in the NAME group compared with all 
other groups. Long-term concomitant ACEi treatment completely prevented the 
development of FGS after UNX and L-NAME treatment. Furthermore, as 
evidenced by the significantly lower incidence in the NAME + LIS group, ACEI 
also reduced the incidence of FGS compared with the control group. Thus, the 
lower SBP levels in NAME+LIS treated F I rats appears to prevent the 
development of both functional (UaV) and stmctural (FGS) renal damage. 
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Figure 2A, Final creatinine clearance (Ce,), and B. incidence of focal 
glomerulosclerosis (FGS, % of damaged glomeruli) in F, (FHH x ACI) rats, Values are 
given as mean ± SE, * P < 0,05, NAME + LIS vs. con and NAME, .. P < 0,05, NAME 
VS, con and NAME + LIS, 
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Table 4. Final plasma creatinine levels and calculated creatinine clearances. 
Group n Pc, Cc, Cc.f100 9 
F,-con 9 59.9 ± 7.3 1.49 ± 0.23 0.39 ± 0.08 
F,-SO 10 57.7 ± 3.2 1.61 ±0.14 0.42 ± 0.06 
F,-150 10 70.1 ± 6.4 1.20 ± 0.21 0.33 ± 0.05 
p1/p2/p3 ns/s/s ns/s/s ns/ns/s 
ACI-con 10 66.0 ± 6.2 0.81 ± 0.12 0.28 ± 0.04 
ACI-50 6 64.2 ± 3.2 0.88 ± 0.18 0.32 ± 0.06 
ACI-150 10 68.9 ± 8.1 0.80 ± 0.13 0.28 ± 0.04 
p1/p2/p3 ns/ns/ns ns/ns/ns ns/ns/ns 
p4/p5/p6 ns/ns/ns s/s/s s/s/ns 
Values are given as mean ± SO. Pc" plasma creatinine (j.lmoI/L); Cc" creatinine 
clearance (ml/min); Ce,/100 g, creatinine clearance per 100 9 BW. Other abbreviations 
as in Tables 1 and 2. p1, can vs. 50 mg; p2, can VS. 150 mg; p3, 50 mg VS. 150 mg; 
p4, ACI-con vs. F,-con; p5, ACI-50 vs. F,-SO; p6, ACI-1S0 VS. F,-1S0; s, p < 0.05; ns, 
not significant (p > O.OS). 
Regression analysis study 2 
Linear regression analysis using the SBP and UaV data obtained at 12, 18, and 
24 weeks after UNX showed significant relationships between these parameters 
(1' = 0.787, P < 0.001; l' = 0.828, P < 0.001; l' = 0.825, P < 0.001). Furthermore, a 
significant correlation between FGS and UaV was present at 24 weeks after UNX 
(1' = 0.805, P < 0.001). This indicates that in this group, even a stronger 
correlation was present between the SBP level and Ua V compared with study I. 
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DISCUSSION 
The primary finding of the first study was that in FI and ACI rats, L-NAME in 
combination with UNX caused a dose-dependent increase in blood pressure and 
renal damage, However, with the same L-NAME dose, F I rats developed more 
severe hypertension and more functional and structural renal damage per mmHg 
increase in SBP than did the treated ACI rats, Additional regression analysis 
showed significant linear relationships between functional and structural 
parameters 12 weeks post-UNX in both strains, being three times more severe in 
F I than in ACI rats, The primary finding of the second stndy was that the 
development of renal damage in F I rats appeared to depend on the L-NAME 
induced hypertension and not on a direct toxic effect of L-NAME, With a similar 
L-NAME intake, prevention of the rise in blood pressure by lisinopril completely 
prevented the development of functional and structmal renal damage, 
In rats, the susceptibility to renal damage with aging or after renal mass 
reduction differs among strains, 13 Based on studies in Munich Wistar (MW) rats 
after renal ablation, Brenner and coworkers postulated in the early 1980s, that the 
intraglomerular circulatOlY adaptation to nephron loss andlor injUlY, notably an 
increase in glomerular capillaty pressure (Poc), is the main driving force for 
continuous progressive glomerular damage,I4,I5 The impact of an increased Poc 
was thought to be more important than that of a systemic blood pressure 
elevation, Since, this glomerular hypertension hypothesis has been confirmed in 
numerous additional studies with renal ablation,16,17 as well as in other 
experimental models, such as the FHH rat and experimental diabetes,.J.6,12,18 
The male FHH rat, the parental strain of the F I rats used in the present study, 
develops mild systolic, but marked glomerular hypertension, and is extremely 
susceptible to develop renal damage,I,4 Glomerular hypertension and the severity 
of renal damage in the FHH is TI1l1her increased by UNX,5,6 The Poc level in 
UNX-FHH rats was found to be higher than those rep0l1ed following UNX in 
MW or Wistar Kyoto (WKY) rats,19,20 strains that are less susceptible to the 
development of renal damage than the FHH rat. However, the glomerular 
hypertension in UNX-FHH is comparable to that rep0l1ed for MW rats with 
remnant kidneys, 14,16,17 In general, normotensive rat strains appear less 
susceptible than hypertensive ones, We have previously studied the normotensive 
WAG,21 in which survival time after UNX is only slightly reduced compared with 
the two-kidney WAG,21 In the present study, the normotensive ACI rat, the other 
parental strain of the F I rats, hardly develops any renal damage even after a 
substantial elevation of systemic blood pressure, However, normal blood pressure 
is no gUaJ'antee for low susceptibility, Rats of the Milan Normotensive Strain 
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(MNS), in contrast to the rats of the Milan Hypertensive Strain (MHS) 
spontaneously develop renal damage without hypertension.22,23 
The relative resistance of the MNS already indicates that systemic 
hypertension pel' se, is not sufficient to induce to renal damage. Similar to male 
FHH rats, male Munich-Wistar-Fromter (MWF) rats spontaneously develop 
glomerular and systemic hypertension?4 Again, the development of renal damage 
in MWF rats is greatly worsened by UNX.25 In contrast to the FHH and MWF rat, 
systemic hypertension in the Spontaneously Hypeltensive Rat (SHR) is much 
higher. However, the high level of systemic blood pressure in SHR is not 
transmitted to the glomerular capillary network, and glomerulosclerosis and renal 
failure are not early findings in this rat strain,20,26 When renal mass is reduced, the 
resistance of the afferent arteriole decreases in SHR and allows the transmission 
of systemic hypertension into the glomerular capillaty network. 17 Subsequent 
proteinuria develops albeit much slower than in FHH and MWF rats following 
UNX.20 Even a further increase in systemic pressure using L-NAME, alone 01' in 
combination of both, does not severely impair renal function in SHR rats, due to 
adequate control of afferent arteriolar resistance.27 Thus, it appears that adequate 
renal autoregulation is of major importance in protecting the glomerulus from the 
transmission of systemic pressure into the capillary bed. We recently observed 
such an impaired renal autoregulation leading to hlperperfusion, glomerular 
hypeltension, and hyperfiltration in the FHH rat,2 These studies are also 
described in chapters 5 and 6 of this thesis. 
Regulation of renal vascular resistance, intraglomerular pressure and 
glomerular filtration might be genetically determined and thereby predispose to 
renal failure if Pac is excessively high, The recent findings that genes 
determining renal failure and blood pressure in the FHH rat are separate and 
distinct from each other, could be a possible explanation for the strain differences 
in the susceptibility to develop glomerular damage. Experiments in which rats of 
an F2 cross between ACI and FHH rats were studied after UNX, not only 
confirmed the results of an earlier study in a backcross of both strains, but also 
revealed the presence of three additional loci for renal failure. 7,8 These findings 
underscore the complexity of the genetics to progressive renal failure and might 
point towards additional genetically regulated mechanisms related to changes 
induced by UNX. 
Alterations in the glomerular permeability of proteins, allowing the 
development of Up V, can occur while glomerular filtration rate (GFR) remains 
within normal limits in different renal diseases both in animals and humans.29 
The persistence of Up V in the presence of normal GFR can be considered an 
independent risk factor for the development of renal failure since no correlations 
were found between Up V and GFR in the rats used in the first study after UNX 
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and in the second study after L-NAME and ACEi treatment. This phenomenon 
was also found in other studies.3o The levels of final GFR in the present study 
showed that, compared with ACI rats, the compensatory increase in GFR after 
UNX in F 1 rats is larger than the decrease in GFR caused by NOi. When we 
compare the present GFR data with those obtained in 2K F 1 and ACI rats, the 
compensatOly increase in creatinine clearance after UNX in F 1 rats is much 
higher than in ACI rats after UNX.9 This might indicate differences in renal 
hemodynamic regulatory mechanisms between both strains. 
When Ang II formation is chronically inhibited with ACEi, glomerular 
hypertension is controlled while glomerular hyperfiltration is usually unaffected. 
In contrast, when Ang II activity is increased by chronic infusion, intraglometular 
pressure, proteinuria, and FGS are further elevated.31 •34 Although the role of the 
renin-angiotensin system (RAS) in chronic NOi remains somewhat controversial, 
the development of hypetiension in this model is though to be renin-dependent 
and may result patily from increased vascular Ang II receptor expression.35•36 
Various reports suggest that the endothelial NO synthase system and the RAS 
interact as regulators of the glomerular microcirculation and are under the 
. fl fd'f~ . I I' 37·39 lll· uence 0 1 lerent genettc contro mec lalllsms. 
In conclusion, after UNX and chronic NOi, the F 1 (FHH x ACI) rat, which is 
heterozygous for genes that determine the susceptibility to renal damage in the 
FHH rat, is not completely protected from developing hypertension-associated 
renal damage. 
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IMPAIRED AUTOREGULATION OF RENAL 
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Renal blood flow in Fawn-Hooded rats 
ABSTRACT 
The responses to changes in renal perfusion pressure (RPP) were compared in 
12-wk-old Fawn-Hooded Hypertensive (FHH) rats, Fawn-Hooded Low blood 
pressure (FHL) rats, and August x Copenhagen Irish (ACI) rats to determine 
whether autoregulation of renal blood flow (REF) is altered in the FHH rat. Mean 
arterial pressure was significantly higher in conscious, chronically instnnnented 
FHH rats compared with FHL rats (121 ± 4 vs. 109 ± 6 mmHg). Baseline a11erial 
pressures measured in ketamine-Inactin-anesthetized rats averaged 147 ± 2 
nunHg (n=9) in FHH rats, 132 ± 2 mmHg (n=IO) in FHL rats, and 123 ± 4 
mmHg (n=9) in ACI rats. Baseline REF was significantly higher in FHH rats than 
in FHL and ACI rats and averaged 9.6 ± 0.7, 7.4 ± 0.5 and 7.8 ± 0.9 ml/min/gkwt, 
respectively. REF was autoregulated in ACI and FHL rats but not in FHH rats. 
Autoregulatory indexes in the range of RPPs from 100 to 150 mmHg averaged 
0.96 ± 0.12 in FHH rats vs. 0.42 ± 0.04 in FHL rats and 0.30 ± 0.02 in ACI rats. 
Glomerular filtration rate was 20-30% higher in FHH rats than in FHL and ACI 
rats at every RPP studied. Elevations in RPP from 100 to 150 mmHg increased 
urinary protein excretion in nIH rats from 27 ± 2 to 87 ± 3 fIg/min, whereas it 
was not significantly altered in FHL or ACI rats. The incidence of glomemli 
exhibiting histological evidence of injury was not significantly different in the 
three rat strains. These results indicate that autoregulation of RBF is impaired in 
FHH rats before the development of glomerulosclerosis and suggest that an 
abnormality in the control of renal vascular resistance may contribute to the 
development of proteinuria and renal failure in this strain of rats. 
96 
Chapter 5 
INTRODUCTION 
The Fawn-Hooded H~peltensive (FHH) rat is a model of hypertension-
associated renal damage. 9.20 This strain develops mild hypertension and severe 
proteinuria and glomerulosclerosis at a young age. A second inbred control strain 
has been developed from the same ancestry. This Fawn-Hooded Low blood 
pressure (FHL) strain remains normotensive and does not develop proteinuria or 
glomerular damage until late age.20 
Recently, independent genes for hypertension and renal disease have been 
identified on chromosome one in a backcross of FI-I1-I and August x Copenhagen 
Irish (AC!) rats.l One of the renal failure genes, Rfl, lies between markers 
DlMghl2 and DIMit6. Another region, Bpfh-l, which exhibits positive linkage 
with systolic blood pressure (SBP), is located neal' the SA-region which has been 
linked to the development of hypertension in a variety of genetic rat 
models,10,17,18 However, the functional significance of the genes residing in this 
region and the gene products involved in the development of hypeltension and 
.. . b d . d 142527 P' b . h I I protelllUl'la remam to e eternune . " revtous 0 servattons t at g omeru ar 
filtration rate (GFR), renal blood flow (REF), and Poc are elevated in FHH rats 
suggest that control of renal vascular resistance may be altered in this 
strain.6,7,24,25 If true, one might expect to find an impaired ability to autoregulate 
REF and GFR, which could contribute to the elevated Poc and the development 
of glomerulosclerosis. 
The present study compared autoregulation ofRBF and the pressure natriuresis 
responses in FHH, FHL, and ACI rats. FHL rats were chosen as a closely related 
control strain of fawn-hooded rats that do not develop hypertension or renal 
damage. ACI rats were used as a second control strain because they have been 
previously used in cosegregation studies and in the development of congenic 
strains.3 Furthermore, ACI rats are known to be one of the strains most resistant 
to the development of proteinuria and renal failure. 28 
97 
Renal blood flow in Fawn-f-Iooded rats 
METHODS 
General 
Experiments were performed on 52 male FHH, FHL, and ACI rats. The rats 
were studied at 12 weeks of age, when none of the strains show evident 
functional and structural renal damage. Body weights averaged 263 ± 29, 260 ± 
21, and 194 ± 8 g in FHH, FHL, and ACI rats, respectively. The FHH and FHL 
rats were obtained from colonies maintained at the Medical College of Wisconsin 
that were derived from the original colony maintained by Dr. Provoost at the 
Erasmus University in Rotterdam (FHHlEUR and FHLIEUR). ACI rats were 
purchased from Harlan Sprague-Dawley Laboratories (Indianapolis, IN). The rats 
were housed in an animal care facility at the Medical College of Wisconsin, 
which is approved by the American Association for the Accreditation of 
Laboratmy Animal Care, and had free access to food and water throughout the 
study. The day before the acute experiments were performed, food was 
withdrawn overnight to facilitate surgical procedures. 
Acute studies 
Rats were anesthetized with a 10 mg/kg Lm. injection of ketamine (Ketajet; 
Phoenix Scientific; St. Joseph, MO) and a 30 mg/kg Lp. injection of 5-sec-butyl-
5-ethyl-2-thiobarbituric acid (Inactin; Byk-Gulden, Konstanz, Germany). The 
animals were placed on a thermostatically controlled warming table to maintain 
body temperature at 37°C. A PE-50 cannula was placed in the femoral artelY, and 
alierial pressure was recorded with a model P23 Gould Statham pressure 
transducer (Gould, Cleveland, OH) connected to a model RPS 7C8A Grass 
amplifier (Grass Instruments, Quincy, MA). APE-50 call1lllla was also placed in 
the left carotid mielY to allow for measurement of arterial pressure when the amia 
below the renal arteries was ligated to raise renal perfllsion pressure (RPP). The 
trachea was call1llllated with PE-240 tubing to facilitate breathing. The left 
external jugular vein was catheterized for the infusion of I % bovine serum 
albumin in a 0.9% NaCI solution at a rate of 100 fil/min throughout the 
experiment. Both ureters were cannulated using PE-50 tubing pulled to a tip 
diameter of 200 fllll for timed urine collections. A 1.5 01' 2.0-mm flow probe was 
placed around the left renal artelY to measure RBF using an electromagnetic 
flowmeter (Carolina Medical Electronics, King, NC). A micro-Blalock clamp 
(Medical College of Wisconsin, Milwaukee, WI) was placed on the aorta above 
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the renal arteries, and ligatures were placed around the superior mesenteric and 
celiac mtelY to allow for manipulation ofRPP. 
Neural and hormonal influences on the kidney were controlled as follows. The 
kidney was denervated by stripping the visible renal nerves and by coating the 
renal artely with a 5% solution of phenol in ethanol. Circulating levels of 
vasopressin and norepinephrine were fixed at high levels by i.v. infusion 
(vasopressin: 2.4 U/mlimin, norepinephrine: 100 ng/min). eH]Inulin (2 J.lCilml) 
was also included in the infusion solution to allow for the measurement of GFR. 
Experimental protocol 
After surgery, 30 min were allowed for stabilization of urine flow and mterial 
pressure, and RPP was lowered to 100 mmHg by tightening the aOltic clamp 
above the renal arteries. After a 20-min equilibration period, urine and plasma 
samples were collected during a 20-min clearance period. The aortic clamp was 
then released to allow RPP to return to -120 mmHg, and urine and plasma 
samples were collected during an additional 20-min clearance period. RPP was 
then increased to 150 mmHg by tightening the ligatures around the superior 
mesenteric and celiac arteries and by tightening the clamp on the lower aOlta 
below the renal mteries when necessmy. After a lO-min equilibration period, 
urine and blood samples were collected during a 20-min clearance period. In 
most, but not all rats, a REF autoregulatory curve was generated after the 
pressure diuresis experiment. However, this experiment could not be completed 
in evelY fawn-hooded rat because RPP often could not be maintained at a high 
level, caused by a bleeding disorder in these rats. Therefore, additional rats had to 
be included in the blood flow autoregulation studies only to obtain enough 
animals for adequate statistics. 
In these experiments, the renal artery was briefly occluded distal to the flow 
probe to obtain a zero-flow signal. REF was then continuously recorded as RPP 
was lowered from 150 to 50 mmHg in steps of 10-20 mmHg. The kidney was 
perfused at each pressure step for 3 min until a steady-state level of REF was 
recorded. 
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Measurement of arlerial pressure in conscious rats 
Alterial pressure was measured in conscious 12-wk-old FHH (n~5) and FI-IL 
(n~5) rats fed a normal (I % NaCl) diet. Studies were also performed in a group 
of 36-wk-old FHH rats (n~5) that had advanced glome11110sclerosis. These rats 
were also measured after they were fed a high salt (8% NaCI) diet for 7 days. 
Animals were anesthetized with ketamine, xylazine, and acepromazine (56, 3.2, 
0.8 mg/kg, i.m.), and a catheter (MRE-025/Tygon) was implanted in the femoral 
artery. The catheter was routed subcutaneously to the scapular region, 
exteriorized through a Dacron mesh button (lnstecll), and protected with a 
stainless-steel spring that also served to tether the rats to a swivel. 
After surgery, the rats were housed in individual cages in a quiet, air-
conditioned room with a 12: 12-h light-dark cycle and were allowed I wk to fully 
recover from surgely. The catheter was flushed daily with 0.2 ml of heparinized 
saline solution (100 USP/ml). 
Mean arterial pressure (MAP) and heart rate (HR) were measured for 24 h on 
3-4 consecutive days. Pulsatile mterial pressure signals were amplified, digitized, 
and analyzed with a computerized Apollo software system. The analog signal was 
sampled at 30 Hz, and the minute averages were used for calculation of daily 
MAP, SBP, diastolic blood pressures (DBP), and HR. 
Analytic techniques 
eH]inulin concentrations of urine and plasma samples were determined using 
a liquid scintillation counter (Delta 300 model 6891 Liquid Scintillation System; 
Tracor Analytic, Elk Grove Village, IL). Urine flow rate was determined 
gravimetrically. Sodium and potassium concentrations of the samples were 
determined using a flame photometer (model 480; Ciba Corning Diagnostics, 
Medfield, MA). Plasma and urine protein concentrations were measured 
spectrophotometric ally using the Bradford method (Bio-Rad Protein Assay; Bio-
Rad Laboratories, Hercules, CAl and bovine se1'l1l1l albumin as a standard. GFR 
and sodium excretion were calculated using standard formulas described 
previously.'I)' Urinary excretion data, RBF, and GFR were factored per gram 
kidney weight to normalize for strain di fferences in kidney size. RBF 
autoregulatOlY indexes over the range of pressures from 100 to 150 mmHg were 
calculated by the method of Semple and de Wardener'3 using the following 
formula: 
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The autoregulatory indexes were calculated assuming that RPP was reduced in 
a single step from a high pressure (RPP 1) to a lower pressure (RPP2 ). According 
to this analysis, an autoregulatOlY index of a indicates perfect autotegulation of 
RBF. An index of I is characteristic of a circulation with a fixed vascular 
resistance. An autoregulatory index> I is indicative of a compliant system in 
which vascular resistance decreases as RPP increases.23 
Assessment of glomerular injury 
At the end of each study, both kidneys from each rat were collected and 
weighed. Coronal sections of the kidneys were immersed in 3% Formalin. After 
fixation, 2- to 3-mm slices of the tissue were embedded in paraffin and prepared 
for light microscopy. The extent of glomerular damage was determined in 3-flm 
sections stained with periodic acid-Schiff reagent. In each animal, 50 glomeruli 
were evaluated for the presence of sclerotic lesions, i.e., segmental glomerular 
scarring, obliteration of glomerular capillaries, mesangial matrix expansion, and 
adhesion formation between tuft and Bowman's capsule. The extent of 
glomerular damage is expressed as the percentage of the glomeruli exhibiting one 
or more of these features. 
Statistical analysis 
Differences in mean values measured at different perfusion pressures between 
and within groups were compared using a two-factor ANOYA for repeated 
measures followed by Duncan's multiple range test. II Linear regression analysis 
was used to calculate the relationship between urine 1I0w, sodium excretion, and 
RPP in each group. Differences in the slopes of these relationships were 
compared using a one-way ANOYA. Throughout the study, a p value < 0.05 was 
considered significant. 
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RESULTS 
Autoregulation of RBF 
A comparison of the RBF autoregulatory curves for FHH, FHL, and ACI rats 
is presented in Figure IA. Baseline MAP measured under ketamine-Inactin 
anesthesia was significantly higher in these animals than that measured in 
conscious FHH and FHL rats and averaged 147 ± 3 mmHg (n=9) in FHH rats, 
132 ± 2 mmHg (n=lO) in FHL rats, and 123 ± 4 mmHg (n=9) in ACI rats. 
Baseline RBF was 35% higher in FHH rats compared with FHL and ACI rats 
(Figure IA). There was no significant difference in RBF between FHL and ACI 
rats. RBF was autoregulated over a range of pressures from 100 to 150 ImnHg in 
FHL and ACI rats. Autoregulatory indexes over the pressure range between 100 
and 150 mmHg averaged 0.42 ± 0.04 in FHL and 0.30 ± 0.02 in ACI rats. In 
contrast, RBF was not autoregulated in FHH rats. The autoregulatory index 
averaged 0.96 ± 0.12 in FHH rats, and it was significantly higher than the 
corresponding values measured in FHL and ACI. A similar picture emerges when 
the data are evaluated in 25-mmHg pressure steps (Figure 1B). Below a RPP of 
100 mmHg, none of the three strains exhibited any autoregulation of REF 
(autoregulatOlY indexes were -I). However, in the range ofRPP from 100 to 125 
mmHg, the RBF autoregulatory index in the FHH rats was significantly greater 
than that seen in FHL and ACI rats. 
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Figure 1A, Relation between renal blood flow (RBF) and renal perfusion pressure 
(RPP) in 3-mo-old Fawn-Hooded Hypertensive (FHH, A, n=9) rats, Fawn-Hooded Low 
blood pressure (FHL, +, n=10) rats, and August x Copenhagen Irish (ACI, III, n=9) rats, 
Kidney weights (kwt) averaged 2,50 ± 0,03 9 in FHH, 2,51 ± 0,06 9 in FHL, and 1,94 ± 
0,02 9 in ACI rats, Values are means ± SE (error bars), • p < 0.05, FHL compared with 
ACI. .. p < 0.05, FHH compared with FHL and ACI. B. Renal blood flow (RBF) 
autoregulatory indexes for several RPP ranges in 3-mo-old FHH (n=9), FHL (n=10), 
and ACI rats (n=9) rats. Values are means ± SE (error bars) ... p < 0.05, FHH 
compared with FHL and ACI. 
103 
Renal blood flow in Fawn-Hooded rats 
Pressure diuretic and natriuretic responses 
The relations between water and sodium excretion and RPP in FHH, FHL, and 
ACI rats are summarized in Figure 2 A and B, respectively. The diuretic and 
natriuretic responses to changes in RPP were not significantly different among 
the strains. Urine flow and sodium excretion increased 6- to 12-fold in these rats 
when RPP was increased from 100 to 150 mmHg. The slopes of the best-fit linear 
regression line relating urine flow and RPP averaged 0.85 ± 0.32, 0.79 ± 0.10, 
and 0.56 ± 0.12 mllminlgkwt/mmHg in FHH, FHL, and ACI rats, respectively. 
The slopes of these lines were not significantly different. The slopes of the 
regression line relating sodium excretion and RPP were also not significantly 
different among the strains and averaged 0.13 ± 0.06, 0.12 ± 0.03, and 0.10 ± 
0.05 mmollminlgkwt/mmHg in FHH, FHL, and ACI rats, respectively. The 
pressure diuretic and natriuretic responses in the 36-wk-old FHH rats with 
advanced glomemlar disease were markedly weaker compared with those seen in 
the younger animals. The slope of the regression line relating sodium excretion 
and RPP in old FHH rats was significantly lower than those observed in the other 
three groups and averaged only 0.014 ± 0.002 mmollmin/gkwt/mmHg 
Elevating RPP from 100 to 150 nllnHg increased fractional sodium excretion 
similarly from 0.6 ± 0.1 to 2.6 ± 0.5 % and from 0.5 ± 0.08 to 3.1 ± 0.8 % of the 
filtered sodium load in FHH and FHL rats, respectively (Fig. 3). These responses 
were significantly less than the corresponding response seen in ACI rats. In old 
FHH rats, the rise in fractional excretion of sodium was markedly blunted when 
RPP was elevated from 100 to 150 mmHg and it just increased from 0.38 ± 0.13 
to 1.41 ± 0.37% of the filtered load (not shown). Moreover, fractional excretion 
of sodium was reduced in old and young FHH and FHL rats compared with 
values in ACI rats at an elevated level ofRPP (150 mmHg). 
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Figure 2. Relationships between urine flow (UV; A) and sodium excretion (UN,v; 8) 
and RPP in FHH (A., n=9), FHL (+, n=10) and ACI (III, n=9) rats. Kidney weights (kwt) 
averaged 2.50 ± 0.03 g in FHH, 2.51 ± 0.06 9 in FHL, and 1.92 ± 0.02 g in ACI rats. 
Values are means ± SE (error bars). 
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Figure 3. Relalionship between fraclional sodium excretion (FEN,) in percentage of 
filtered load and RPP in FHH (A. n=9). FHL (+. n=10) and ACI (III, n=9) rats. Values 
are means ± SE (error bars). 
Glomerular filtration rate 
Whole kidney GFR was significantly higher in young FHH than in FHL and 
ACI at every RPP studied and reached 2.37 ± 0.10 mllmin/gkwt at an 150 mmHg 
RPP (Figure 4A). GFR was also greater in FHL than in ACI rats at an RPP of 125 
mmHg and averaged 1.23 ± 0.03 vs. 0.56 ± 0.07 mllmin/gkwt, respectively. In 
old FHH rats, GFR was markedly reduced compared with values seen in all three 
groups of young animals. Similarly, RBF was lower in old FHH rats than the 
corresponding values observed in the other groups (not shown). The GFR 
autoregulatory indexes (Figure SA) showed no significant differences between 
the three strains in the pressure range of 125 and 150 mmHg, whereas these 
indexes were significantly higher in FHH and ACI rats compared with FHL rats. 
The RBF autoregulatory indexes during the pressure natriuresis study (Figure 5B) 
were similar to those in the autoregulatory studies between RPPs of 125 and 150 
mmHg. 
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A 
B 
Figure 4. Relationships between glomerular filtration rate (GFR; A) and renal blood 
flow (RSF) (S) and renal perfusion pressure (RPP) in FHH (ii., n=9), FHL (+, n=10) 
and ACI (III, n=9) rats. Kidney weights averaged 2.50 ± 0.03 9 in FHH, 2.51 ± 0.06 9 in 
FHL, and 1.92 ± 0.02 9 in ACI rats. Values are means ± SE. All differences were 
statistically significant (p < 0.05), except for RSF differences at 125 mmHg between 
FHL and ACI. 
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Figure 5. GFR (A) and RBF (B) autoregulatory indexes in the range of RPP from 100 
to 125 and from 125 to 150 mmHg in 3-mo-old FHH (n=9), FHL (n=10) and ACI (n=9) 
rats. Values are means ± SE .• P < 0.05, FHL rats compared with FHH and ACI rats. 
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Pressure-protein uric responses 
A comparison of urinary protein excretion as a function of RPP in FHH, FHL, 
and ACI rats is presented in Figure 6. Basal protein excretion at an RPP of 100 
nunHg was greater in FHH rats than in FHL and ACI rats and averaged 27 ± 2, 
16 ± 2, and II ± I fIg/min, respectively. An elevation of RPP to 150 mmHg 
increased protein excretion to 87 ± 3 fIg/min in FHH rats, whereas protein 
excretion was not significantly altered in FHL and ACI rats. 
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Figure 6. Relationship between urinary protein excretion (UpV) in 3-mo-old FHH (..t., 
n=9), FHL (+, n=10), and ACI (III, n=9) rats. Values are means ± SE ... P < 0.05, FHH 
compared with FHL and ACI. • p < 0.05, FHL compared with ACI. 
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Measurement of arterial pressure 
MAPs measured in conscious 12-wk-old FHH rats were slightly but 
significantly higher than those obtained in FHL rats. In FHH rats (n=5) the values 
for MAP, SBP, and DBP were 121 ± 4, 153 ± 3, and 98 ± 6 mmHg vs. 109 ± 6, 
141 ± 6, and 89 ± 6 InmHg measured in FHL rats, respectively. Mean pulse 
pressures averaged 55 ± 7 mmHg in FHH and 54 ± 3 InmHg in FHL rats; mean 
heat1 rate 411 ± 25 beats/min in FHH and 436 ± 17 beats/min in FHL, and they 
were not significantly different. In 36-wk-old FHH rats, MAP was not 
significantly different from that measured in the younger FHH rats. However, 
MAP rose in the old FHH rats from 125 ± 4 to 142 ± 4 mlnHg (n=4) when they 
were fed a high-salt diet (8% NaCl) for 7 days. 
Assessment of glomerular injury 
Kidney weights were similar in FHH and FHL rats (2.50 ± 0.03 vs. 2.51 ± 0.06 
g), and both were higher than those seen in ACI rats (1.92 ± 0.02 g). The 
percentage of glomeruli exhibiting any signs of injury were not significantly 
different in the three strains and averaged 1.8 ± 0.5 % in FHH, 1.1 ± 0.5 % in 
FHL, and 0.9 ± 0.6 % in ACI rats. This indicates that the rats in these groups 
were studied at an age before the development of significant glomerular injlllY. In 
contrast, the kidneys of 36-wk-old FHH rats exhibited severe glomerulosclerosis 
and the percentage of injured glomeruli averaged 66 ± 8%. 
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DISCUSSION 
The present study c.ompared renal hem.odynamics and the pressure natriuretic 
resp.onses in relatively y.oung (12-wk-.old) FHH with FHL and in ACI rats in 
.order t.o determine whether an abn.ormality in the aut.oregulati.on .of RBF might 
precede the devel.opment .of pr.oteinuria and gl.omerular damage in the FHH rat. 
Our maj.or findings are that RBF and GFR were markedly elevated in FHH rats 
c.ompared with values .observed in FHL and ACI rats and that FHH rats did n.ot 
aut.oregulate RBF as well as the c.ontrol strains in the range .of pressures from 100 
t.o 150 mmHg. Indeed, the RBF aut.oregulat.ory index in FHH rats was 
significantly higher than th.ose measured in b.oth c.ontrol strains, and averaged 
0.96 ± 0.12, which is indicative .of a system with a fixed vascular resistance.23 
These results are c.onsistent with previ.ous rep.orts indicating that GFR and PGC are 
elevated in the kidney .of FHH rats and indicate that these animals probably 
exhibit a failure .of the afferent arteri.ole t.o c.onstrict in resp.onse t.o elevati.ons in 
RPP .6,25 Presumably this c.ould involve an abn.ormality in myogenic mechanisms, 
tubulogl.omemlar feedback (TGF), .or b.oth. Because TGF has recently been 
rep.orted t.o be relatively n.ormal in the FHH rat, the m.ost likely explanati.on f.or 
the impairment in RBF aut.oregulati.on in FHH rats in the present study is an 
altered myogenic resp.onse.31 In this regard, we have recently .obtained direct 
evidence that the my.ogenic resp.onse .of is.olated perfused pregl.omemlar arteri.oles 
t.o elevati.ons in transmural pressure is absent in vessels .obtained from the kidneys 
.ofFHH rats?9 These studies are als.o described in chapter 6 .of this thesis. 
We als.o .observed that urinary protein excreti.on was directly dependent .on the 
changes in RPP in FHH rats. The mechanism inv.olved in this unusual pressure 
pr.oteinuric resp.onse may be dependent .on the GFR and the impaired 
aut.oregulati.on .of RBF and GFR in resp.onse t.o elevati.ons in RPP. Thus the high 
baseline filtered l.oad .of pr.otein and the increment seen when RPP is elevated, 
likely increased the delivered l.oad .of pr.otein t.o a level that exceeds the transp.ort 
maximum for reabs.orpti.on .of protein in the proximal tubule. The present 
.observati.on that protein excreti.on is directly dependent .on the level .of RPP in 
FHH rats is als.o c.onsistent with previ.ous rep.orts menti.oning that pharmac.ol.ogic 
agents that l.ower bl.o.od pressure reduce the degree .of pr.oteinuria and delay the 
.onset.of gl.omerular disease in FHH rats.30 Similarly, pharmac.ol.ogical agents that 
raise systemic bl.o.od pressure in the Fawn-H.o.oded rat w.orsen the severity .of 
gl.omerular damage and proteinuria.27,28 
In the present study, we als.o c.ompared the pressure natriuretic resp.onses in the 
three strains .of rats. Previ.ous studies have indicated that the pressure natriuretic 
relati.onship is blunted .or reset t.o a higher level .of RPP in evety genetic m.odel .of 
hypertensi.on examined t.o date.5,21 H.owever, in the present study the relati.onship 
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between urine flow, sodium excretion, and RPP was not altered in 12-wk-old 
FHH rats relative to values seen in FHL and ACI rats primarily because GFR is 
elevated in these rats. The slope of the relationship between the fractional 
excretion of sodiulll and RPP was significantly reduced in FHH rats relative to 
ACI rats; however, it was not different from the levels seen in FHL rats that do 
not develop hypertension. From this data we have to conclude that the pressure 
natriuresis relationship is not blunted in 12-wk-old FHH rats. We also measured 
arterial pressure and the pressure natriuretic response in an additional group of 
36-wk-old FHH rats with severe proteinuria and glomerular damage. As would be 
expected, RBF and GFR were markedly reduced and the pressure natriuresis 
response was blunted in these rats. 
The lack of resetting of the pressure natriuresis relationship in young FHH rats 
initially was surprising, but is consistent with the chronic measurements of 
arterial pressure obtained in the present study. Although we found that MAP was 
significantly greater in FHH than FHL rats, the level of MAP in FHH rats (121 
mmHg) can be considered being in the normal range of pressures that we have 
previously reported in normotensive strains of rats. 14,2 1,26 Moreover, in this study, 
we found that MAPs measured in old FHH rats with established glomerular 
disease on a normal-salt diet were also in this range. However, as would be 
expected from the low GFR and blunted pressure natriuresis response, these rats 
were salt-sensitive and MAP rose from 125 ± 4 to 142 ± 4 mmHg during a 7-day 
period when the rats were fed a high-salt diet (8% NaCI), 
The present study provides the first long-term (24 h) measurements of arterial 
pressure in conscious FHH rats recorded in their home cage under unstressed 
conditions, All previous measurements of pressure with this strain were done 
using the tail cuff in restrained rats, Actually, the Ineasurements of systolic 
pressure in our study are very similar to those previously reported, although 
diastolic pressure is rather low in this strain. The FHH rat may also be more 
responsive to stress and may be able to transmit a greater percentage of the 
systolic pressure to the tail. This would be consistent with a strain of rat that 
exhibits impaired myogenic tone not only in the kidney but throughout the 
systemic circulation, 
Previous studies have documented that urinary protein excretion rates for these 
strains at 3 mo of age average 100,30, and 15 mg/24h for FHH, FHL, and ACI 
rats, respectively?4,25,27,28 As confirmed in the present study, FI-IH rats do not 
exhibit pronounced histological evidence of glomerulosclerosis at 12 wk of age. 
These findings in combination with the present measurement of atierial pressure 
indicate that the development of proteinuria in FJ-IH rats precedes the 
development of outspoken hypeliension and histological development of 
glomerular injUlY, These data also fit with previous observations that the severity 
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of hypel1ension in FHH is relatively modest: (a) until the animal is quite old, or 
(b) when a reduced mass-like form of hypertension due to severe 
glomerulosclerosis develops, or (c) when the progression of glomerular injury is 
accelerated by uninephrectomy, or (d) when blood pressure is pharmacologically 
elevated using N"-nitro-L-arginine methyl ester.24,27 These studies are also 
described in chapters 2 through 4 of this thesis, 
Glomerular hyperfiltration and PGC have been implicated as factors 
determining the susceptibility to develop glomerulosclerosis in hypertension, An 
impairment in the efficiency of autoregulation obviously could contribute to a 
greater transmission in pressure to the glomerulus and therefore may contribute to 
the differences in the incidence of glomerular disease seen in different models of 
hypertension, For example, autoregulation of RBF and GFR is not impaired in 
spontaneously hypertensive rats but is highly efficient and is shifted to higher 
pressures, These animals do not exhibited elevated PGC 01' develop 
glomerulosclerosis until very late in the disease process, In contrast, 
autoregulation of RBF and GFR is impaired in DOCA-salt and reduced renal 
mass models of hypertension, 2,13 P GC is elevated in both models, and they rapidly 
develop severe proteinuria and glomerulosclerosis, Autoregulation of RBF and 
GFR is also impaired and PGC is elevated in the streptozocin-induced insulin-
dependent model of diabetes, which develops a severe form of 
glomerulosclerosis, The only exception is the Dahl Salt-sensitive model of 
hypertension, These animals also rapidly develop glomerulosclerosis, but PGC is 
still relatively normal and they exhibit no impairment ofRBF autoregulation,21 
Perspectives 
In summa1Y, the present study indicates that autoregulation of RBF is impaired 
in FHH rats, which leads to hyperfiltration, proteinuria, and the subsequent 
development of glomerulosclerosis, The mechanisms involved remain to be 
determined, but may be due to an impairment in the myogenic response in 
preglomerular renal arterioles, Further experiments need to be performed to hy 
and link these functional abnormalities in renal hemodynamics observed in the 
FHH rat with the renal failure genes previously identified on chromosome one 
and other chromosomes, A better understanding of the physiology and genetics in 
this unique genetic animal model of end-stage renal failure (ESRF) may provide 
insight into the pathogenesis and treatment ofESRF in humans, 
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CHAPTER 6 
ALTERED RENAL HEMODYNAMICS AND IMPAIRED 
MYOGENIC RESPONSES IN THE FAWN-HOODED RAT 
American Journal of Physiology 1999;276(3}:R855-R863 
Richard P.E. van Dokkum, Cheng-Wen Sun, Richard J. Roman, 
Howard J. Jacob, and Abraham P. Provoost 
Impaired myogenic responses in Fawn-Hooded rats 
ABSTRACT 
The present study examined whether an abnormality in the myogenic response 
of renal arterioles impairing autoregulation of renal blood flow (RBF) and 
glomerular capillaty pressure (P Ge) contributes to the development of renal 
damage in Fawn-Hooded Hypertensive (FHH) rats. Autoregulation of whole 
kidney, c0l1ical and medullary blood flow and PGC were compared in young (12-
wk-old) FHH and Fawn-Hooded Low blood pressure (FHL) rats in volume-
replete and volume-expanded conditions. Baseline RBF, c0l1ical and medullaty 
blood flow, and PGe were significantly greater in FHH than in FHL rats. 
Autoregulation of renal and cortical blood flow was significantly impaired in 
FHH rats compared with results obtained in FHL rats. Myogenically mediated 
autoregulation of PGe was significantly greater in FHL than in FHH rats. In 
FHH rats, P GC rose from 46 ± I to 71 ± 2 mmHg in response to an increase in 
renal perfusion pressure from 100 to 150 mmHg, whereas it only increased from 
39 ± 2 to 53 ± I mmHg in FHL rats. Isolated perfused renal interlobular arteries 
from FHL rats constricted by 10% in response to elevations in transmural 
pressure from 70 to 120 nuuHg. In contrast, the diameter of vessels from FHH 
rats increased by 15%. These results indicate that the myogenic response of 
small renal arteries is altered in FI-IH rats, and that this contributes to impaired 
autoregulation of renal blood flow and elevations in PGe in this strain. 
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INTRODUCTION 
The Fawn-Hooded Hypertensive (FHH) rat is a genetic model of hypeltension-
associated renal failure that develops systolic hypertension, severe albuminuria, 
and focal glomerulosclerosis (FGS).23 A closely related control strain of Fawn-
Hooded Low blood pressure (FHL) rats does not develop hypertension or renal 
failure. Previous studies have indicated that elevations in renal blood flow (REF), 
glomerular filtration rate (GFR) and glomerular capillary pressure (Poc) precede 
the development of glomerular disease in FI-U-I rats. IO,25,26 Recently, we repOlted 
that autoregulation of REF and GFR is impaired in Fl-II-I rats. I I This study is also 
described in chapter 5 of this thesis. We surmised that afferent autoregulation is 
impaired in FHH rats, Previous studies by Simons et. al,26 indicating that Poe is 
related to the level of arterial pressure in FHH treated with various 
antihypertensive agents, indeed suggest that these animals fail to regulate afferent 
arteriolar resistance appropriately in response to changes in arterial pressure, 
Potentially, this could be due to an abnormality in tubuloglomerular feedback 
(TGF) and/or in the myogenic mechanisms that regulate renal vascular tone in the 
preglomerular vasculature of the kidney, 
In this regard, Verseput et. al. 28 have recently reported that TGF responses are 
intact in FHH. Therefore, in the present study, we examined whether the 
myogenic response of the renal vasculature is altered before the development of 
FGS in young (12-wk-old) FHH rats and whether this abnormality might 
contribute to an impairment in autoregulation of REF and elevations in Pac in 
these animals, Such a defect should be especially evident after acute volume 
expansion or in rats fed a high-salt diet, both of which diminish the contribution 
of TGF to autoregulation of REF and GFR, Changes in REF, cOltical and 
medullaty blood flow, and PGC in response to elevations in renal perfusion 
pressure (RPP) were therefore compared in volume-expanded and volume-replete 
12-wk-old male FHH and FHL rats. In addition, the myogenic response of renal 
interlobular arteries microdissected from the kidneys of these animals was 
directly studied in vitro, 
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METHODS 
General 
Experiments were performed in male FHH and FHL rats matched for age and 
body weight. They were allI2-wk-old and weighed -300 gram at the time of the 
acute experiments. FHH rats at this age do not yet exhibit significant FGS. The 
rats were obtained from colonies maintained at the Medical College of 
Wisconsin, which were derived from the original colony at Erasmus University 
Rotterdam (FHHlEUR and FI-ILIEUR) maintained by Dr. Provoost. The rats were 
housed in an American Association for the Accreditation of Laboratory Animal 
Care approved animal care facility at the Medical College of Wisconsin, and had 
free access to food and water throughout the study. On the night before the acute 
experiments, food intake was restricted to facilitate surgical procedures. 
General surgical procedures. 
Rats were anesthetized with an intramuscular injection of ketamine (Ketaset, 
Foti Dodge Laboratories, Fort Dodge, IA) in a dose of 10 mg/kg, followed by a 
30 mg/kg intraperitoneal injection of 5-sec-butyl-5-ethyl-2-thiobarbituric acid 
(Inactin, Byk-Gulden, Konstanz, Germany). The animals were placed on a 
servocontrolled heated surgical table to maintain body temperature at 37°C. The 
trachea was cannulated using PE-240 tubing to facilitate breathing, and cannulas 
were placed in the carotid and femoral arteries for measurement of arterial 
pressure above and below the left renal art ely, using a model P23 Gould Statham 
pressure transducer (Recording System Division; Gould, Cleveland, OI-I) 
comlected to a model RPS 7C8A Grass amplifier (Grass Inshuments, Quincy, 
MA). Another catheter was placed in the left external jugular vein for constant 
intravenous infusion, and 1% BSA in 0.9% NaCI was infused at a rate of 100 
j.llImin throughout the experiment. Because the FI-II-I and FHL rat strains have a 
bleeding disorder, we had to use a higher infusion rate to replace surgical and 
fluid losses and maintain a volume-replete state. The left ureter was cannulated 
for urine collections, and the left kidney was immobilized for micropuncture by 
placing it in a stainless steel kidney cup. A 1.5- or 2.0-nnn flow probe was placed 
around the left renal artelY to allow for measurement of RBF using an 
electromagnetic flowmeter (Carolina Medical Electronics, King, NC). The left 
kidney was denervated by stripping all visible nerves from the renal artelY and 
the artery was coated with a 5% solution of phenol in ethanol. A micro-Blalock 
clamp was placed on the aorta above the renal arteries, and ligatures were placed 
122 
Chapter 6 
around the superior mesenteric and celiac artery to allow for control of RPP. 
Circulating levels of vasopressin and norepinephrine were fixed at high levels by 
intravenous infusion (vasopressin, 2.4 U/mllmin; norepinephrine, 100 nglmin; 
obtained from Sigma, st. Louis, MO). 
Protocol 1,' Autoregulation of whole kidney, cortical and medullary blood 
flow 
After surgety and a 30-min equilibration period, the relationships between 
whole kidney, cortical and papillaty blood flow and RPP were determined. These 
studies were performed in volume-replete FHH and FHL rats prepared as 
described above and in other rats that were volume-expanded by intravenous 
infusion of 6 ml of a 0.9% NaCI solution containing 6% BSA. The degree of 
volume expansion was similar in all rats. In each animal, systemic arterial 
pressure was first increased -25 mmHg by ligating the celiac and mesenteric 
arteries. Next, RBF and laser-Doppler red blood cell (RBC) flux signals obtained 
from the renal cotiex and the inner medulla were recorded as RPP was lowered 
from 150 to 50 nunHg in 10 mmHg steps by tightening the clamp on the aorta 
above the renal atieries. The kidney was perfused at each RPP for 5 min or until 
steady-state blood flow signals were recorded. 
RBF was measured using an electromagnetic flowmeter and laser-Doppler 
RBC flux in the renal cortex was measured using a special large-diameter fiber-
optic integrating probe (Pf 342) and a dual-channel laser-Doppler flowmeter 
(model PO; Perimed, Stockholm, Sweden). Medullary RBC flux was 
simultaneously measured using a second PO laser-Doppler flowmeter and a F316 
fiber-optic probe coupled to an optical fiber that was implanted at a depth of 5 
nun in the kidney and secured using a drop of cyanoacrylic adhesive as 
previously described?' The exact location of the implanted fiber at the junction 
of the outer and inner medulla was verified at the end of each experiment by 
dissecting the kidney and viewing the regions surrounding the tip of the fiber. To 
allow for comparisons of laser-Doppler flow signals between instruments, both 
laser-Doppler flowmeters were calibrated by placing the probes in a standard 
solution containing a colloidal suspension of lO-rttn latex microspheres (PflOO; 
Perimed, Stockholm, Sweden) to read a flux value of 2.5 V, and the shifted light 
intensity was adjusted to read a normalized value of 7.75 V. This calibration is 
necessary for these instruments to produce a signal proportional to RBC flux 
rather than velocity alone. 
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Protocol 2: Micropuncture experiments 
These experiments were performed in volume-replete FHH and FHL rats, 
which were surgically prepared as described above, and the left kidney was 
placed in a stainless steel kidney cup and surrounded with 2.5% agar (Sigma). 
The surface of the kidney was constantly bathed with warm (37°C) 0.9% NaCI 
solution. In each animal, RPP was adjusted to 100, 125, and 150 mmHg by 
adjusting the resistance of the clamp on the aorta, and hydrostatic pressures were 
measured in three to five peritubular capillaries, proximal tubules [proximal 
tubular pressure (PT)], and star vessels [efferent arteriolar pressure (PEl] using a 
7-fun-OD glass micropipette filled with 2 M NaCI containing Fast Green 
(Sigma). The pressures were measured using a model 900 servo-null 
micropressure system (World Precision Instmments, Sarasota, FL) and recorded 
using a polygraph (Grass Instnnnents, Quincy, MA). Values for Pac were 
estimated in four to six different nephrons at each level of RPP using the 
proximal stop-flow technique. In these experiments, an early proximal tubule was 
blocked with Sudan-black stained bone wax (Ethicon, W31-G) using a 10- to 12-
[lm-OD micropipette cotUlected to a hydraulic microdrive unit (Stoelting 
Instruments). The servo-null pressure-sensing pipette was then introduced 
upstream of the wax block, and the stop-flow hydrostatic pressure measured. 
Protocol 3: Isolated perfused vessels 
Rats were anesthetized with a 50 mg/kg intraperitoneal injection of 
pentobarbital and sodium, and the left kidney was rapidly removed and placed in 
ice-cold (4°C), bicarbonate-buffered physiological salt solution (PSS) containing 
(in mM): 144 Na+, 124 cr, 2.5 Ca2+, 4.7 K+, 1.2 Mg2+, 1.2 P04., 15 HCOl ., II 
glucose, 10 HEPES, and 0.026 EDTA at pH 7.4. The kidney was hemisected, and 
interlobular atieries (70-100 [1m) were microdissected near the junction of the 
cortex and outer medulla by using a stereomicroscope (x60). One vessel was 
isolated from the kidney of each animal. Arterial segments 8-10 mm in length 
were placed in a perfilsion chamber, cannulated at both ends with glass pipettes, 
and secured in place with 10.0 silk suture (Ethicon). Side branches, when present, 
were ligated with the same suture. The arterial segments were perfil sed and 
superperfilsed with PSS at 37°C. The inflow cannula was connected in series 
with a pressure reservoir and a transducer (Spectramed, Oxnard, CAl. During the 
measurements, the outflow cannula was clamped off to maintain a given level of 
transmural pressure as previously described. 16,19 
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The internal diameter of the vessel was monitored using a television camera 
(model KP130; Hitachi, Denshi, Tokyo, Japan) and a stereomicroscope (model 
ORC; Zeiss, Oberkochen, Germany). The image was displayed on a monitor 
(model CVM-1271; Sony, Tokyo, Japan), and vessel diameters were measured 
using a video dimension analyzer (VIA-l 00; Boeckeler Instruments, Tucson, 
AZ). Magnification on the screen was approximately x180, and the measurement 
system was calibrated with a micrometer to a diameter within ± 2.0 11m. 
Cannulated rat renal interlobular arteries were maintained at 80 mmHg during 
a 3D-min equilibration period. After an equilibration period of 30 min, the 
viability of each vessel was tested by constructing a cumulative dose-response 
curve to phenylephrine (PE) followed by acetylcholine (ACh). Next, a control 
myogenic response curve was constructed by measuring internal diameter of the 
vessels as transmural pressure was varied from SO to I SO mmHg in steps of 10 
mmHg. After this control relationship was determined, the procedure was 
repeated using Ca2+-free PSS. After a 3D-min eqUilibration period, the pressure-
diameter curves were redetermined to obtain the passive properties of the vessel. 
Glomerular Morphology 
After completion of each in vivo study, coronal sections of both kidneys were 
immersed in 3% Formalin. After fixation, 2- to 3-mm slices of renal tissue were 
embedded in paraffin and prepared for light microscopy. The extent of 
glomerular damage was determined in 3-11m sections stained with periodic acid-
Schiff reagent. In each animal, SO glomeruli were scored for the presence of 
sclerotic lesions, mesangial matrix expansion, and adhesion formation between 
tuft and Bowman's capsule. The extent of glomerular damage was expressed as 
percentage of glomeruli exhibiting one or more of these features. The incidence 
of rats exhibiting the different types of renal damage was not assessed separately. 
Calculations and statistics 
Data are presented as mean values ± I SE. Whole kidney blood flow data were 
factored per gram of kidney weight. RBF autoregulatory indexes over the range 
of pressures from 100 to 140 (volume-replete) or ISO lluuHg (volume-expanded) 
were calculated as the percentage change in the electromagnetic flow signal 
divided by the percentage change of RPP. The laser-Doppler flow data are 
presented as absolute REF flux values in volts, and the autoregulatory indexes 
were calculated as described above. 
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Plasma protein concentrations were measured using a clinical refractometer 
(model N; Atago), and glometular capillary oncotic pressure was assumed to 
equal the oncotic pressure of arterial blood. Plasma oncotic pressure was 
calculated from the plasma protein concentration using the Landis-Pappenheimer 
equation20 
where C is concentration in units of grams per dl (valid over the range of 4-10 
gldl) and 1t is plasma oncotic pressure in nunHg. 
Active tension in the vascular wall was calculated from the measured active 
and passive vessel diameters using the following equation22 
T, (dyne/cm) = - 1,333 (dyne/cm2 x mmHg) x P x (R, - Rp) x 10.4 (cm/J.lm) 
where T, is the active wall tension, P is the transmural pressure in mmHg, and R, 
and Rp are the radii of the vessel in micrometers measured in PSS and calcium-
free PSS. Vascular diameters are presented as percentages of the control diameter 
measured in each vessel when it was perfused and bathed with PSS at a 
transmural pressure of 70 mmHg (pressure at which these vessels exhibited a 
maximal diameter). The level of relaxation in response to increasing doses of 
ACh was calculated as percent of PE (10.5 mollL) preconstricted inner diameter 
(10). The inhibitory effect ofPE is expressed as the change in diameter reduction 
in active tension measured in the vessels during the control period at a pressure of 
80mmHg. 
Significance of differences in measured values was evaluated using a two-way 
ANOVA for repeated measures followed by Duncan's multiple range test. A 
value of p < 0.05 was considered to be statistically significant. 
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RESULTS 
RBF responses 
Autoregulation of RBF was studied in volume-replete FHH and FHL rats, and 
after plasma volume was expanded, to minimize the contribution of TGF to the 
RBF response. The results in volume-replete rats are presented in Figure IA. 
Control mean arterial pressures (MAP) averaged 149 ± 4 and 131 ± 4 mmHg in 
FHH (n=12) and FHL (n=9) rats. Baseline RBF measured at these pressures was 
significantly greater in FHH than in FHL rats, and averaged 9.3 ± 0.5, and 6.9 ± 
0.3 mVminig kidney wt, respectively. RBF was autoregulated in both FHL and 
FHH rats over the range of pressures from 100 to 150 mmHg under these 
experimental conditions. However, autoregulation of RBF was less efficient in 
volume-replete FHH than in FHL rats. This is reflected in the autoregulatory 
indexes that were significantly different in volume-replete FHH and FHL rats and 
averaged 0.36 ± 0.12 VS. 0.19 ± 0.09, respectively. We also noted that the time 
course of the autoregulatory respo'nse differed in volume-replete FHH and FHL 
rats. Autoregulation of RBF was complete within 10 s after a fall in RPP in FHL 
rats, whereas the time course of the autoregulatory response was different in 
volume-replete FHH rats, and it generally took 3-4 min for RBF to return to 
control values after a fall in RPP. 
A comparison of the relationships between RPP and whole kidney blood flow 
after plasma volume expansion in FHH and FHL rats is presented in Figure lB. 
Baseline MAP in these rats measured before abdominal surgery averaged 147 ± 3 
(n= 12) and 132 ± 2 mmHg (n=9). Baseline RBF increased significantly more in 
FHH than in FHL rats after volume expansion and averaged 11.2 ± 0.5 and 6.7 ± 
0.9 mVminig kidney wt, respectively. RBF was not well autoregulated after 
plasma volume expansion in FHH rats, and the RBF autoregulatory index 
averaged 0.96 ± 0.12 over a range of RPPs from 100 to 150 mmHg. In contrast, 
FHL rats retained some ability to autoregulate RBF after plasma volume 
expansion, and the autoregulatory index averaged 0.42 ± 0.04. 
The relationship between RPP and cortical blood flow measured by laser-
Doppler flowmetry in volume-replete FHH and FHL rats is presented in Figure 
2A. Baseline MAP measured before abdominal surgery averaged 154 ± 3 and 129 
± 2 nun1:-lg in volume-replete FHH (n=7) and FHL (n=7) rats, respectively. 
Baseline cortical blood flow under this condition was significantly higher in FHH 
than in FHL rats and averaged 3.20 ± 0.25 and 2.94 ± 0.05 V, respectively. 
Autoregulation of cortical blood flow was less efficient in volume-replete FHH 
compared with volume-replete FHL rats. Autoregulatory indexes over the 
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pressure range of 100-140 mmI-lg in FI-II-I and FI-IL rats averaged 0.30 ± 0.17 and 
0.19 ± 0.06, respectively. 
The relationship between RPP and medullary blood flow measured by laser-
Doppler flowmetry in volume-replete FI-II-I and FHL rats is presented in Figure 
2B. Autoregulation of blood flow was significantly less efficient in the medulla 
of FI-II-I (n=7) compared with FHL rats (n=7), with indexes over the pressure 
range of 100-140 llllnI-lg 0[0.78 ± 0.29 and 0.37 ± 0.23, respectively. 
The relationship between RPP and cortical blood flow in the volume-expanded 
state is shown in Figure 3A. Somewhat higher perfusioll pressures could be 
obtained in the volume-expanded compared with the volume-replete state. Blood 
flow over the pressure range of 100-150 nllnI-lg was not efficiently autoregulated 
under this condition in FHI-I rats (n=7), with an index of 0.86 ± 0.30. In contrast, 
blow flow in the cortex of volume-expanded FHL rats (n=5) was more efficiently 
autoregulated with an index of 0.37 ± 0.20. 
Baseline medullaty blood flow after acute volume expansion, shown in Figure 
3B, was significantly higher in FI-IH than in FI-IL rats and averaged 1.71 ± 0.04 
and 1.24 ± 0.32 V, respectively. Medullary blood flow was less efficiently 
autoregulated in volume-expanded FHI-I rats (n=7) than in FHL rats (n=5), with 
indexes over the pressure range of 100-150 mmI-lg of 1.06 ± 0.26, and 0.72 ± 
0.20, respectively. 
128 
Chapter 6 
10 
A 
9 
X 
'" 
8 
-c: ~+tt1+' 'E 7 '" .§. l!.. 6 
ro 
rf1 ex:: 5 
4 
40 60 80 100 120 140 
12 B 
X10 
Ql 
c: 
E 8 
'" 
---+--+-t +-+-+ .§. l!.. 
ro 6 t-+--' ex:: 
4 
40 60 80 100 120 140 
Renal Perfusion Pressure (mmHg) 
Figure lA. Relationship between renal perfusion pressure (RPP) and whole kidney 
renal blood flow (RBF) in ml per minute per gram of kidney weight in volume-replete, 
and B. volume-expanded Fawn-Hooded Hypertensive (FHH, III, n=12) rats and Fawn-
Hooded Low blood pressure (FHL, e, n=9) rats. Kidney weights averaged 2.50 ± 0.03, 
and 2.51 ± 0.06 g in FHH and FHL rats, respectively. Values are means ± SE. 
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Figure 2A. Relationship between RPP and cortical and B. medullary laser-Doppler flux 
(LDF) in volume-replete FHH (Ill, n=7) rats and FHL (0, n=7) rats. Values are means ± 
SE. 
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Figure 3A. Relationship between RPP, cortical and B. medullary LDF in volume-
expanded FHH (III, n=7) rats and FHL (e, n=5) rats. Values are means ± SE. 
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Micropuncture experiments 
A comparison of pressures measured in proximal tubules (PT), star vessels 
corresponding with the pressure in efferent arterioles (PE), and Poc estimated 
from proximal tubular stop flow pressures (Psrl in FHH and FHL rats is 
presented in Figures 4 and 5. Control MAP averaged 159 ± 4 mmHg (n~9) in 
FHH rats and 130 ± 2 mmHg (n~6) in FI-!L rats. Pressures measured in proximal 
tubules (Figure 4A) were similar and averaged 22 ± 2, 23 ± 2, and 24 ± 2 nlluHg 
in FHH rats and 19 ± 2, 20 ± 2, and 21 ± 2 mmHg in FHL rats at an RPP of 100, 
125, and 150 lmuHg, respectively. PE (Figure 4B) at an RPP of 100 and 125 
nllnHg averaged 23 ± 2 and 25 ± 2 mmHg in FHH rats and 22 ± 2 and 23 ± 2 
mmHg in FHL rats, respectively. At a higher RPP of 150 mmHg, PE was not 
autoregulated and rose to 34 ± 1 11l1ni-ig in FHI-! rats. This value was significantly 
higher than the corresponding value measured in FHL rats (24 ± 2 mmHg). In 
FHH rats, Poc (Figure 5) increased dramatically as RPP was elevated and 
averaged 46 ± I mmi-ig at an RPP of 100 mmHg, 58 ± 2 nlluHg at an RPP of 125 
mmHg, and 71 ± I nlluHg at an RPP of 150 mmHg. The rise in P oc with an 
increase in RPP was less dramatic in FHL rats and averaged 39 ± 1,47 ± 2, and 
53 ± I nllnHg at an RPP of 100, 125, and 150 mmHg, respectively. The relative 
change in Poc as a ftmction of the relative change in RPP (Poc autoregulatory 
index) averaged 0.78 ± 0.11 in FHL vs. 1.06 ± 0.23 in FHH rats, and showed 
better preservation of P GC in FHL than in FI-!I-! rats. 
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Figure 4A. Relationship between RPP, proximal tubular pressure (Pr) in mmHg, and 
B. efferenl arteriolar pressure (PE) in mmHg in FHH (III, n=9) and FHL (e, n=6) rats. 
Values are means ± SE .• P < 0.05, FHH rats compared wilh FHL rats. 
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Figure 5. Relationship between RPP and glomerular capillary pressure (Pee) in FHH 
(III. n=9) rats and FHL (~. n=6) rats. Values are means ± SE. • P < 0.05, FHH rats 
compared with FHL rats. 
Myogenic response of renal interlobular arteries 
Pressure-diameter relationships in renal interlobular arteries of FHH (n=5) 
and FHL (n=5) rats are presented in Figure 6A. Baseline diameters of interlobular 
arteries of FHH and FHL rats at a transmural pressure of 70 mmHg were not 
significantly different and averaged 99.6 ± 24.3 and 109.5 ± 13.6 fun, 
respectively. Vessels obtained from the kidneys of FHL rats exhibited a typical 
myogenic response, and the inner diameter of these vessels decreased to 92.2 ± 
2.1 % of control in response to an elevation in transmural pressure from 70 to 120 
mmHg. After removal of calcium from the bath, the diameter of these vessels 
increased as the transmural pressure was varied over this same range. In contrast, 
renal interlobular arteries obtained from the kidneys of FHH rats did not constrict 
in response to an elevation in transmural pressure. More than that, the diameter of 
these vessels increased significantly, to 113.1 ± 1.7% of control when pressure 
was elevated from 70 to 120 mmHg. 
The increase in vessel diameter with no calcium in the bath was similar in 
FI-IH and FHL vessels, although values were numerically higher in FHH 
compared with FHL. This might indicate that the inner diameter from vessels 
from FHH rats increased more in response to an increase in transmural pressure 
and therefore dilate more in response to increases in transmural pressure in the 
absence of calcium than vessels from FHL rats. 
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A comparison of the relationship between the percentage change in active wall 
tension and transmural pressure in vessels obtained from the kidneys of FHH and 
FHL rats is presented in Figure 6B. Active wall tension rose from 78 to 597% of 
active tension at 80 mmHg in response to an increase in transmural pressure from 
70 to 120 mmHg in vessels obtained from the kidneys of FHL rats. In contrast, 
vessels obtained from the kidneys of FHH rats (n=5) failed to respond, and active 
tension did not increase significantly as pressure was increased over this same 
range. 
To exclude the possibility that the failure of FHH vessels to respond to 
elevations in transmural pressure was due to nonspecific vascular injury, the 
vasoconstrictor responses of FHH and FHL rat vessels to phenylephrine were 
compared. The results of these experiments are presented in Figure 7A. Vessels 
from the kidneys of FHH and FHL rats constricted similarly to increasing doses 
of PE. The only significant difference in the dose-response curve was a slightly 
diminished response in vessels from FHH kidneys at a concentration of 10-7 
mollL. 
The responses of FHH and FHL renal interlobular arteries to ACh were also 
compared because endothelial dysfunction has been reported to be common in 
many experimental and genetic models of hypertension. The results of these 
experiments are presented in Figure 7B. Acetylcholine increased the diameter of 
interlobular arteries obtained from the kidneys of FHL rats in a dose-dependent 
manner to 80% of control. In contrast, vessels obtained from the kidneys of FHH 
rats did not respond to even relatively high concentrations of ACh (10.6 mollL). 
Glomerular Injury 
Total kidney weight was not significantly different in FHH and FHL rats, and 
averaged 2.50 ± 0.03 and 2.5\ ± 0.06 g, respectively. The incidence of 
glomellliosclerosis in the kidneys of these 3-mo-old FHH and FHL rats was not 
significantly different. Only 1.6 ± 0.6% of the glomeruli exhibited signs of 
glomellliosclerosis in the kidneys of FHH rats vs. an incidence of 1.2 ± 0.4% 
observed in the kidneys of FHL rats. 
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Figure 6A. Relationship between perfusion pressure and inner diameter (10) of 
interlobular arteries in %10 at 70 mmHg in calcium containing (closed symbols) and 
calcium-free (open symbols) medium in interlobular arteries of FHH (III and D, n=5) 
and FHL (_ and O. n=5) rats. B. Relationship between perfusion pressure and 
pressure-active tension (T,) in % T, at 80 mmHg in interlobular arteries of FHH (III, 
n=5) and FHL (_, n=5) rats. Values are means ± SE. • P < 0.05, FHL rats compared 
with FHH rats. 
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Figure 7A. Relationship between responses to increasing doses of phenylephrine (PE) 
and 10 in % change (delta) from 100 in interlobular arteries of FHH (III, n=5) rats and 
FHL (iii, n=5) rats. B. Relationship between responses to increasing doses of ACh in 
log mol/L and 10 expressed as %PE (10.5 mol/L) constricted 10 in interlobular arteries 
of FHH (II1II, n=5) and FHL (iii, n=5) rats. Values are means ± SE. • P < 0.05, FHL rats 
compared with FHH rats. 
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DISCUSSION 
The present study compared changes in REF and cortical and medullary blood 
flow in response to alterations in RPP in the kidneys of FHL and FHH rats to 
determine whether an impairment in the myogenic component of renal 
autoregulation might contribute to the development of glomerular failure in FHH 
rats. We found that baseline REF was significantly greater in volume-replete 
FHH than in FHL rats. Under this experimental condition, FHH and FHL rats 
both autoregulated REF. However, the efficiency of autoregulation was slightly 
but significantly greater in FHL than in FHH rats. The most striking difference 
was seen in the time course of the response. AutoregulatOlY adjustments in renal 
vascular resistance were complete within seconds in FHL after a reduction in 
RPP, whereas it typically took more than 3-4 min for REF to retul'll to control in 
FHH rats. This finding suggests that the rapid myogenic component of 
autoregulation may be impaired in FHH rats but that the TOF component ofrenal 
autoregulation, which exhibits a much longer time constant, is still intact. This 
view is also consistent with the recent findings of Verseput et. al.,28 who found 
and intact TOF response in FHH rats studied at about the same age as those used 
in the present study. 
This hypothesis is further supported by the results of experiments performed in 
volume-expanded FHH and FHL rats to minimize the contribution of TOF to 
autoregulation of REF. IS Baseline whole kidney, cortical, and medullaly blood 
flows were markedly elevated in volume-expanded FHH rats. Under these 
conditions, FHH rats did not autoregulate whole kidney, cortical or medullaty 
blood flow as efficient as FHL rats. Overall, these results suggest that the 
myogenic response of the preglomerular vasculature to changes in transmural 
pressure is markedly impaired in FHH rats. 
Micropuncture experiments were performed to further evaluate this 
hypothesis. Pac was estimated from proximal tubule stop flow pressures and 
compared in volume-replete FHH and FHL rats at different levels of RPP. Under 
these conditions, flow to the macula densa is interrupted and the contribution of 
TOF to the autoregulation of Pac is eliminated. Our results indicate that volume-
expanded FHL rats retain some ability to autoregulate Pac via activation of 
myogenic mechanisms but FHH rats do not. Indeed, the percentage change in Pac 
as a function ofRPP (Pac autoregulatOty index) averaged 0.78 in FHL rats versus 
1.06 in FHH rats. Another interesting observation is that, although Pac was not 
autoregulated and markedly elevated in FHH rats, there was little difference in 
the relationship between pressures in the peritubular capillaries and RPP in FHH 
and FHL rats. This implies that the resistance of the efferent arteriole must have 
increased in FHH rats because RPP was elevated. This may be related to some 
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capacity of the efferent arteriole to respond actively to elevations in P oc, or to 
some unknown mechanism that remains to be explored. 
The hypothesis that the myogenic response of the preglomerular vasculature is 
altered in FHH rats was directly tested using isolated perfused renal interlobular 
arteries. The results of these studies indicate that vessels obtained from FHL rats 
constricted and active wall tension increased in response to an elevation in 
transmural pressure, whereas vessels obtained from FHH rats failed to exhibit a 
myogenic response. Indeed, the diameter of these vessels increased in response to 
an elevation in transmural pressure, and there was no significant difference in the 
pressure-diameter curve in these vessels studied in the presence and absence of 
calcium in the bath. These isolated vessel data further support the micropuncture 
data and indicate that an impairment in the myogenic response of the 
preglomerular vasculature of FHH rats contributes to the lack of autoregulation 
of RBF and P oc in these animals, especially after acute volume expansion. 
However, impairment of the myogenic responses in interlobular arteries alone 
should not have that much impact on autoregulation ofRBF or Poe because in the 
rat, most of the preglomerular pressure drops occur along the afferent arteriole. 
For this reason, we believe that myogenic response must be impaired throughout 
the preglomerular renal vasculature and particularly in the afferent at1eriole in the 
kidney of the FHH rat. 
The inability of renal interlobular arteries from FHH rats to respond to 
elevations in transmural pressure was not due to nonspecific vascular damage, 
because they exhibited a normal vasoconstrictor response to PE. We did, 
however, find that the vasodilator response to acetylcholine was blunted in FHH 
rats. The impo11ance of this observation remains to be determined, but it is 
consistent with a large body of emerging evidence indicating that hypertension is 
often associated with endothelial dysfunction.5,7,8,19,24 
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Perspectives. 
The results of the present study indicate that the myogenic response of 
preglomerular renal al1eries is impaired in FHH rats, and that they exhibit an 
impaired ability to buffer changes in intraglomerular pressure, especially in 
response to rapid fluctuations in arterial pressUl'e. This defect in the myogenic 
response of the preglomerular vasculatUl'e, in combination with the previously 
reported increased efferent vascular resistance that elevated baseline P GC, 25.26 and 
the tendency of these animals to develop systolic hypel1ension, promotes the 
transmission of elevated pressures to the glomerulus. Because elevations in Poe 
have been previously linked to the development of glomemlosclerosis in many 
different experimental models of renal disease,2.14.25 it is likely that these also 
contribute to the development of proteinuria and renal faiIUI'e in FHH rats as well, 
and probably greatly depend on the genetic susceptibility of this rat strain to 
develop renal failure.4.12,13 
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General discussion, conclusions, and perspectives 
7.1 GENERAL DISCUSSION 
Evidence in humans and experimental and genetic animal models of 
hypertension and renal failure suggest that the development of hypertension-
associated renal failure depends on the genetic background?9,31,32,52,63,99 The 
Fawn-Hooded Hypertensive (FHH) rat is a genetic model for hypertension-
associated renal failure and develops systolic and intraglomerular hypertension, 
leading to proteinuria (Up V) and focal glomerulosclerosis (FGS), whereas the 
Fawn-Hooded Low blood pressure (FHL) rat does not. 72 The FHH rat has several 
genes for renal failure (at least five) and hypertension (at least twO).17,82 
Experiments described in this thesis examined the susceptibility for renal damage 
after L-NAME-induced hypel1ension in rat strains with different genetic 
backgrounds. Physiological experiments were described studying the impact of 
increases in renal perfusion pressure on renal failure in FHH and FHL rats. 
7.1.1 Physiology, genetics, and the susceptibility to renal damage 
The FHH and FHL rat cany two genes involved in the development of renal 
failure, Rf 1 and Rf2, but have a different susceptibility to develop renal damage 
after the induction of hypertension. This might be caused by a differenlmutation 
in the Rfgenes in the FHL rat or by the interaction of these genes with other 
genes that protect the kidney of the FHL rat from developing intraglomel1llar 
hypet1ension. The difference might also be due to the lower blood pressure level 
in FHL rats. Heterozygous F 1 rats from a cross of the FHH rat and the renal 
damage resistant ACI rat, develop less renal damage upon blood pressure 
elevation than FHL rats, although we found a significant increase in renal 
damage. This increase was observed when systemic blood pressure exceeds a 
certain threshold level, which might be related to baroreceptor function. 
Surmising that the gene for this receptor is mutated in FHH rats, this means that 
being heterozygous for the gene as in F 1 rats needs a certain pressure level for the 
mutation to become apparent. 
In rats, only one study, by Churchill et al., has directly investigated the genetic 
susceptibility to develop renal damage. Transplantation of a kidney from a 
congenic SHR, carrying a region from chromosome one of the Brown-Norway 
rat, indicated the presence of one or more genes modifying the susceptibility to 
hypertension-related renal failure. 20 At least one of the chromosomal regions 
identified by Brown et al. 17 overlaps with a segment of chromosome one that has 
recently been reported to contain a gene influencing susceptibility to stroke in the 
stroke-prone SHR.77 Interestingly, this area on chromosome 1 contains the Rf2 
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region. This might indicate that chromosome one contains genes increasing the 
risk for hypettension-induced vascular injury, not only in the kidney, but also in 
the brain.77 This points towards common mechanisms in the development of end-
organ damage, and the vascular abnormalities observed in the FHH rat might very 
well be present in other organ systems. Therefore, it might be useful to evaluate 
other organ systems for their regulatoty abilities, for instance, to measure 
autoregulation of cerebral blood flow. Finally, studies in transgenic and gene 
knock-out mice revealed increased susceptibility to develop renal damage.65•86 
7.1.2 L-NAME, hemodynamics, and the susceptibility to renal damage 
The different responses to L-NAME-induced hypertension in the rat strains 
with two kidneys and after unilateral nephrectomy (UNX) observed in this thesis 
are summarized in Table I. Most previous studies do not directly assess the 
relation between blood pressure and renal damage and are difficult to compare 
with our studies, also because blood pressure measurements and glomerular 
injury scores were different. The doses used were much higher than the doses 
used in our studies, yet the animals developed less hypertension and renal 
damage.5,85,91 
Table 1. Comparison of several parameters in different strains used in this thesis after 
L-NAME-induced hypertension. 
Strain time dose n SBP UaV FGS Ch. 
FHH-2K 7 9 15 209 ± 20 211 ± 89 31 ± 7 3 
FHL-2K 7 23 6 199 ± 11 191 ± 72 25 ± 5 2 
F,-2K 7 13 10 201 ± 16 30 ± 25 20 ± 4 3 
ACI-2K 11 18 6 206 ± 18 13 ± 9 7±2 2, 3 
F,-UNX 12 13 10 212 ± 12 109 ± 48 24 ± 4 4 
ACI-UNX 12 8 10 165 ± 15 22 ± 9 10 ± 6 4 
FHH, Fawn-Hooded Hypertensive rat; FHL, Fawn-Hooded Low blood pressure rat; F" 
(FHH x ACI) rat; ACI, August x Copenhagen Irish rat; 2K, two kidneys; UNX, unilateral 
nephrectomy; time, weeks after start of treatment; n, number of rats; SBP, systolic 
blood pressure measured by tall-cuff; UaV, urinary albumin excretion in mg/24h; FGS, 
focal glomerulosclerosis (% incidence); Ch., chapter of this thesis. 
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Table I shows equal functional and structural renal damage in two-kidney 
FHH and FHL rats at similar blood pressure levels. However, in FHL rats, higher 
L-NAME doses induced similar blood pressure levels as in FI-IH rats. Differences 
in basal SBP level between FHH rat and FHL rats most likely account for this 
phenomenon. A similar level of renal damage at similar SBP in both Fawn-
Hooded strains might indicate that these strains share most of their genome with 
regard to the Rfgenes. The functional renal damage in both Fawn-Hooded strains 
is much larger than that of F, (FHl-I x ACI) rats at similar blood pressure levels. 
However, the structural renal damage in FHL and F, rats is similar. The F, rats in 
tUt'll develop more renal damage than the ACI rats. This was even more 
pronounced after UNX, although ACI rats did not receive the same amount of L-
NAME and did not develop the same blood pressure level as the F, rats. Thus, 
with regard to the susceptibility to renal damage after similar levels of L-NAME-
induced hypertension, we can give the following equation: 
FHH = FHL» F, > ACI. 
Simons et al. showed that FHH rats treated with L-NAME exhibit high 
systemic blood pressure, heavy UpY, fmiher elevation of the ultrafiltration 
pressure with a decrease in the ultrafiltration coefficient, and high incidence of 
FGS after only eight weeks of treatment.85 Glomemlar filtration and perfusion 
were diminished and single nephron filtration fraction increased.83 Total renal 
vascular resistance was increased threefold, and proportional increases in afferent 
and efferent atieriolar resistance were observed. These observations are in 
agreement with previous findings in two-kidne/,33 and remnant Munich-Wistar 
rats.33 Rats responding to renal mass reduction by an increase in the ultrafiltration 
coefficient, while maintaining normal PGC , are protected from progressive 
glomerular injury. The Wistar-Kyoto (WKY) rat is exemplary as well: UNX25 
and remnant WKY rats? show a compensatory increase in single nepln'on 
glomerular filtration rate (GFR), which is mainly due to an increase in the 
ultrafiltration coefficient, whereas PGC remains at a normal level. Both models of 
renal ablation in WKY rats are remarkably resistant to the development of 
FGS.?·25 Ono et al., studying L-NAME treated SHR rats, found that single 
nephron plasma flow and the ultrafiltration coefficient were reduced despite an 
unchanged single nephron GFR and PGc•6?68 This may be explained by the 
severely increased afferent resistance and a lesser increase in efferent resistance 
associated with the reduced single nephron plasma flow. In support of these 
findings, Herrera-Acosta et al. also reported a sharper increase in afferent 
resistance and a greater decrease of single nephron glomerular filtration rate with 
L-NAME in Goldblatt hypertensive rats compared with normotensive rats. 43 In 
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contrast, FHH rats treated with L-NAME do not show increased afferent 
resistance that prevent the elevated levels of systemic blood pressure from 
entering their glomerular (micro )circulation. 
The findings by Simons e/ al. in UNX-FHI-! rats treated with L-NAME may 
indicate that the mechanism maintaining a stable PGC is less effective.55.83 
It remains to be determined, however, whether the observed PGC differences are 
to some extent due to suppression of the tubuloglomerular feedback (TOF) 
response during stop-flow conditions or due to altered autoregulation as a 
consequence ofUNX.7o The L-NAME studies described in chapters 2, 3, and 4 of 
this thesis are well in accordance with these observations. Although P GC was not 
assessed in the rats used in these studies, the susceptibility to develop renal 
damage might be directly related to the PGC level. The homozygous PHI-! rat in 
our studies appeared to be extremely susceptible to renal damage due to high P GC' 
Susceptibility to renal damage in the FHL rat is probably also related to elevated 
PGC levels after L-NAME-induced hypertension. An important observation in this 
regard is that FHL rats have slightly elevated PGC levels under normal 
conditions.84 The heterozygous FI rat seems to develop renal damage above a 
certain pressure level (chapter 3). Beyond this level, PGC could probably not be 
maintained at low levels, initiating the development of renal damage. The renal 
damage resistant ACI rat is able to maintain low OFR levels (chapter 5 of this 
thesis), which might indicate that these rats are also capable to maintain low Pac 
levels, even after considerable blood pressure elevation. The data indicate that the 
development of renal failure is related to genetic susceptibility to elevated PGC, 
which is possibly related to the ability of the afferent arteriole to respond 
adequately to changes in systemic blood pressure. Moreover, an inherited 
weakness in the structure of the capillary wall may be another factor. 54.55 The 
studies described in chapter 6 of this thesis seem to confirm this hypothesis. 
7.1.3 Hemodynamic studies 
Data from animal models indicate that preservation of normal glomerular 
hemodynamics is fundamental to minimize the progression of glomerular damage 
in hypertension,13 diabetes,45 and after reductions in renal mass. I.2•46 As stated 
before in this thesis, glomerular damage develops differently in different strains 
of hypertensive rats. For example, SHR rats have a filtration area similar to that 
in control WKY rats, but show a reduced filtration rate before the development of 
hypertension, possibly due to a reduced ultrafiltration coefficient. SHR rats 
present with early hypertrophy of the afferent arteriole, which increases its 
resistance and protects the glomerulus from elevations in P GC and glomerular 
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blood flow when hypertension develops. In contrast, the FHH rat develops only 
mild systemic hype11ension (chapter 5), but shows increased efferent mieriolar 
resistance in combination with the inability to increase afferent vascular tone, 
resulting in glomentlar hypertension.95 The data fl'Om the FHH rat so far indicate 
that abnormalities in the control of renal vascular resistance may playa greater 
role in the development of renal failure than the presence of hypertension pel' se. 
Data generated by Verse put el al. 96 and by Simons el al. 84 together with the 
results described in chapter 6 of this thesis, indicate that operating Poc in the 
young FHH rat is elevated during normal flow to the macula dens a, whereas 
operating PGC in SHR and MHS rats is normaI.
8
,18,23,71 However, in the MNS rat 
the development of FOS is thought to be caused by impaired TOF,8 which also 
leads to increases in P GC and histologic damage, similar to that in the FHH rat. 54 
A relatively high TOF responsiveness is thought to contribute to the development 
of hypeliension on account of an associated depression of single nephron OFR.9 
The diminished resistance of the afferent arterioles in FHH rats allows PGC and 
OFR to be elevated at lower systemic pressures than in other hype11ensive strains. 
The glol11elular hemodynamics in the FHH rat may thus limit the degree of 
systemic hypertension, though at the cost of increasing the risk to develop FOS.95 
The fact that the efferent arteriolar pressure in FHH rats significantly increased 
when renal perfusion pressure was raised from 125 to ISO mmHg (chapter 6) is in 
accordance with a threshold level for the systemic pressure to be transmitted into 
the glomeruli, as observed in F I (FHH rat x ACI) rats (chapter 3). 
It remains to be determined why in the FHH rat, afferent at1eriolar resistance is 
low and control by the TOF system relatively inefficient. These phenomena may 
be related to a generalized abnormality in mechanisms controlling myogenic tone 
in the preglomerular vasculature as indicated by our isolated vessel data in 
chapter 6 of this thesis. In this respect, the behavioral characteristics of the renal 
vasculature in the FHH rat resemble that of diabetic and galactose-fed rats. 30,40 
Altered glomel1llar hemodynamics in the FHH rat, such as impaired myogenic 
response and impaired autoregulation of renal blood flow (RBF), PGC, and OFR 
(chapter 6) are also observed in spontaneous and induced rat models of diabetes 
and rats with glomel1llonephritis.27,38,5o,69,81 However, these abnormalities might 
be of different origin. The hypothesis presented here, i. e., impaired autoregulation 
leads to renal failure, is a novel approach compared to that reported in most 
papers, supporting the hypothesis that glomel1llar failure leads to impaired renal 
autoregulation. 
Hypeltension in the FHH rat is very sensitive to blockers of the renin-
angiotensin system,85,98 indicating impOltant interaction in the (micro)vasculature, 
between the abnormality in vascular reactivity and the prevailing levels of 
angiotensin II (Ang II). Since high Ang II activity is associated with enhanced 
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TGF activity in hypertensive models such as the two-kidney, one-clip model9 and 
the transgenic mRen-2 rat,65 one could surmise that, in the FHH rat, the 
endogenous defense against the afferent at1eriolar constriction by Ang II is 
characterized by a paracrine disturbance. In this respect, the bleeding diathesis 
and platelet dysfunction due to defective serotonin and adenosine di-phosphate 
(ADP) release,92,93 and the increased urinaty excretion of eicosanoids21 might be 
important. 42,95 
The Poc level in FHL rats was found to be higher than in other normotensive 
strains,84 Moreover, autoregulation ofRBF and Poc was less efficient in FHL rats 
compared with other normotensive strains,25,84 The data indicate that the FHL rat 
also has some degree of abnormal renal hemodynamics similar to the FHH rat, 
but might be protected because of low systemic blood pressure or different 
mutations in the R}areas. Indeed, levels for GFR, Poc, and RBF in the FHL rat in 
response to changes in renal perfusion pressure were in between those for ACI 
and FHH rats. 
The studies in interlobular arteries of FHH rats showed numerically higher 
increases in vessel diameter compared with FHL rats in the absence of calcium. 
This might indicate an increased calcium-independent dilation in vessels from 
FHH rats in response to increases in transmural pressure, This might also explain 
the decreased efficacy of calcium antagonists in the prevention and treatment of 
renal disease in FHH rats compared with ACEi.98 Therefore, an impairment 
might be present in the fimction of the calcium-dependent potassium channels 
(Kc,), which are thought to buffer vasoconstrictor responsiveness to a variety of 
agonists,16,24,78.80 A large body of evidence shows increased activity and 
upregulation of these channels in different models ofhypertension.26,28,56,57 Patch-
clamp studies need to be performed in order to compare single-channel Kc, 
channel currents between isolated membrane patches of renal vascular smooth 
muscle cells from FHH and normotensive control rats. Recent studies describing 
the involvement of NO and cytochrome PA50 metabolites of arachidonic acid 
(AA) in the activation of the Kc, channels and the regulation of vascular 
tone36,37,47 might provide other avenues for investigating the abnormalities in 
control of renal vascular tone in the Fawn-Hooded rat. 15,39-4 I 
Recent genetic analysis by Stelzner e/ al. showed the presence of an unknown 
genetic locus on chromosome one, called PHI, which was linked to pulmonary 
hype11ension in the FHlIR rat.88,89 However, genetic linkage with the earlier 
found increased ET -I production by FHlIR rat lung endothelium could not be 
established.88,89 
The pulmonaty artelY of the FHlIR rat used by Ashmore e/ ai.'l also exhibited 
increased constrictor sensitivity to serotonin (5-HT), which may also contribute to 
h d ' I ' I I' . f I' t 5394 t e para oXlca responses to aggregatmg pate ets III artenes o· t liS ra, , 
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Similar to ADP, 5-HT may also stimulate release of an endothelium-derived 
constrictor. 58·60 Alternatively, although the overall response to 5-HT in rat vessels 
is constriction, the endothelium may modulate these responses by the release of 
endothelium-derived relaxing factor (EDRF).58.60 Therefore, 5-HT-induced 
release of EDRF may be impaired in the FHH rat, as in humans.J •14 PreliminalY 
data on the responses of isolated renal arteries of FHH rats to various 
pharmacological agents showed no profound differences in response to 
constrictor or dilator agents compared with FHL and Wistar control rats. This 
suggests that there is no specific phannacological pathway involved in the 
impairment of the myogenic response in the FHH rat, favoring an impairment in 
pressure-induced mechanosensor mechanisms. Also, the impaired dilatOlY 
response of FHH rat interlobular arteries to acetylcholine (chapter 6) deserves to 
be explored fut1her. 
Findings by Roman et al. suggest that inhibition of 20-HETE, a potent 
vasoconstrictor formed from AA by the cytochrome P-450 enzyme, contributes to 
the cyclic OMP independent actions of NO and mediates myogenic 
responses.48,76,101 Thus, in the Fl-IH rat, vasodilatory epoxy-eicosatrienoic acids 
(EETs) may be elevated and 20-HETE production reduced in FHH vessels, 
PreliminatY data from Roman et al. in kidneys of FHH rats show that this might 
actually be hue. 
In general, the release of NO is impaired in animal models of 
hypertension.49,58,64 Therefore, an impairment in the production or release of 
EDRFs could explain the effect seen in the renal vessels of the FHH rat (chapter 
6). Because studies in this rat showed increased resistance of the efferent 
arteriole, this impairment might be due to the inability of producing relaxing 
factors or to a decreased vascular responsiveness to nitric oxide in this arteriole, 
In addition, the increased susceptibility to the effects of NOi in the FHH rat 
(chapter 3) might be due to the inability of the afferent arteriole to constrict in 
response to NOi because of increased levels of EDRF,85 Indeed, Resch et al. 
rep0l1ed increased NO synthase activity in the macula densa of the FHH rat. 75 On 
the other hand, the reduced responses to acetylcholine in renal arterioles of the 
FHH kidney (chapter 6) are in favor of a decreased NO release, as observed in 
the Dahl salt-sensitive rat and in the hypertension-prone Sabra rat,39,58,74 
dependent on which NO synthase gene is expressed, The expression of this gene 
might also be important in the FHH rat. The SI-IR, however, is thought to have an 
increased production of endothelium-derived hyperpolarizing factor, but not a 
deceased NO production, The DOCA-salt model of hypertension, which shares 
altered renal hemodynamic responses such as impaired autoregulation of RBF 
and impairments in the myogenic response 40 with the FHH rat, showed an 
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enhanced expression of endothelin-l in blood vessels and glomeruli, especially in 
mesangial cells.22 
7.1.4 Impact of gene discovery on renal failure in rat and man 
The finding that the genetic background controls the development of renal 
failure in a hypertensive animal model, raises the possibility that the same may be 
tme for humans with' hypertension who develop renal failure. Clinical and 
epidemiological data support this hypothesis, because improved blood pressure 
control has reduced the incidence of heart failure and stroke, but not ESRF. 
Moreover, renal failure only occurs in a subset of patients with hypertension. 
Familial clustering of hypertension-associated complications has not been 
extensively studied, although a few reports suggest familial correlation.29•52 
Hypertension results in renal damage in a limited percentage of patients only. 
Apparently other - genetic - factors are important in determining the susceptibility 
to develop renal failure. The Rfloci revealed in the genetic studies with the FHH 
rat may be important contributors to the development of renal failure. However, 
the question remains whether this renal failure is hypertension-associated. The 
strongest evidence provided so far, is that renal failure in the FHH rat is 
prevented by antihypertensive treatment with ACEi, although this protection 
could be independent of its effects on blood pressure.97 However, this does not 
exclude the possibility that Rfgenes may cause renal impairment in both 
hypeliensive and normotensive humans and animals when the Rfloci are general 
loci affecting renal function. As all forms of renal disease are exacerbated by 
increases in blood pressure, II it is possible that the effect of Rfgenes on renal 
physiology only becomes readily apparent later in life in the presence of high 
blood pressure. 
The Rf2 locus is interesting because its differential effect on plasma albumin 
levels is substantially larger than for Rf 1, suggesting that this index of severe 
renal impairment may be independent of Up V. Although the effect of Rf2 on 
plasma albumin alone could be explained by a gene affecting albumin synthesis 
rather than renal impairment, the fact that Rf2 also affected the macroscopic 
renal index score suggests that it acts at the level of the kidney. Because Rf2 
maps near another factor affecting blood pressure, it was difficult to assess the 
effect of this gene on blood pressure. Therefore, Rf2 might act through a 
mechanism other than a direct effect on blood pressure. Rf2 maps to the same 
region as the platelet storage-pool bleeding disorder in the fawn-hooded rat and 
could be identical with the gene causing this disorder and may have an impact on 
renal hemodynamics. There are several reports of patients with renal failure and 
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various platelet disorders including a platelet storage pool disease.34•35 However, 
the FHlIR rat also has prolonged bleeding times but does not develop renal 
failure. Furthermore, the region containing Rf2 is homologous to a region on 
mouse chromosome 7 that contains loci involved in renal failure associated with 
systemic lupus erythematosus.66 
Genetic susceptibility for end-organ damage independent from blood pressure 
is not restricted to the kidney. In recent years, others have reported on QTLs 
affecting cardiac hypertrophy and stroke.77 End-organ damage in susceptible 
individuals may develop with normal blood pressure, but is usually accelerated 
when hypertension is present. In complex situations, animal models can be useful 
to reduce the complexity and help to elucidate mechanisms that may be important 
in the progression of human renal disease. 
Cloning of the Rfgenes will allow isolation of the mouse and human 
homologues and allow direct examination of variation in the genes in patients and 
families. In fact, studies are ongoing in which the genetic material of a large 
population of patients on hemodialysis with no underlying primary renal disease 
is tested for markers of the synthenic Rfregions of the FHH rat. Several 
physiological parameters can subsequently be tested in these patients, so that the 
relation between phenotype and genotype may be determined. 
7.1.5 Independent control of renal impairment 
The identification of genes that determine the development of renal failure in 
animal models62 with or without hypertension may help to understand why some 
hypel1ensive patients develop renal disease.6.9o Many investigators support the 
theory that hypertension callses renal failure. Establishing the causative element, 
both clinically and experimentally, is problematic because hypertension is known 
to accelerate renal failure. l9.29 
Brown et al. showed that hypertension alone is not enough to cause renal 
impairment. l7 The fact that the major loci explaining renal impairment in the 
FHH x ACI backcross are not the same as those causing high blood pressure 
indicates that the majority of animals in the backcross have blood pressure levels 
that simply accelerate the development of renal damage. In such a setting, the 
development of renal impairment appears to depend on the inheritance of 
downstream susceptibility factors. The fact that systemic blood pressure alone 
does not determine subsequent renal damage is consistent with previous 
observations done in other rat crosses. For example, MNS rats develop renal 
sclerosis, whereas MHS rats do not, despite higher blood pressure levels. lo.87 
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Studies in the Os/+ mouse, a model of reduced nephron number,lOo revealed 
that the susceptibility to develop FGS is controlled by multiple recessive loci 
independent of blood pressure, glomemlar size, and number of glomeruli. 
Multiple recessive traits (at least 8-10 loci) were hypothesized to be involved, 
which illustrates that in a severe complication of diseases such as diabetes 
mellitus, FGS affects only a minority of patients. In this regard, a locus on 
chromosome 19q 13 for focal segmental glomerulosclerosis with autosomal 
dominant inheritance was found in a family with no histmy ofhypertension.61 
Another QTL for Up V was reported in a cross of BuffalolMna and WKY 
rats.62 This QTL was detected on chromosome 13 near the renin locus and is 
different from the R.f 1 to R.f5 QTLs found in the FHH rat so far. The studies in 
rats and mice point towards extreme complex patterns of inherited factors 
determining the increased susceptibility to develop renal damage. As a 
consequence, the quest for genetic factors influencing the progression of renal 
failure in humans and experimental models has not yet resulted in any definitive 
conclusion. Our studies in the FHH model are at the forefront of the current 
experimental knowledge in this field. These studies show, however, that even a 
relatively simple homogeneous model such as the FHH rat, appears to be 
extremely elaborate. No less than five genes appear to affect the initiation and 
progression of renal failure. It is to be expected that the genes will show complex 
gene-gene and gene-environmental interactions. Thus, not only the function of 
each individual gene, but all gene-gene and gene-environmental interactions need 
to be studied to get the full picture of progressive chronic renal failure. Congenic 
rats are ideally suited for the fi.lrther studies into the role of the individual genes 
as well as their interactions. We fully anticipate being able to use the animals that 
are currently constructed for many future critical studies. 
A complete understanding of the renal failure genes will clearly require their 
isolation. The rat genetic map that was available when the study by Brown e/ al. 
was published, included no obvious candidate genes in the region. 17,51 At present, 
however, we can combine our knowledge on the renal abnormalities in the FHR 
with the genetic analysis by Brown e/ al. 17 and Shiozawa e/ al. 82 Using the 
currently available databases, we can combine physiology and genetics and 
compare ~r-regions to homologous areas in the mouse and in humans. Because 
the impairment in the myogenic response is most likely the major player in the 
development of renal damage in the FHH rat, we can screen for genes that are 
involved in vascular tone regulation. Although there are various genes in the 
homologous R.fregions, the most likely candidates involve several potassium 
channels, adrenergic receptors, and members of the cytochrome P-450 family 
(internet: http://www.ncbi.nlm.nih.gov/OmimlHomology). 
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7.2 CONCLUSIONS 
Combining physiology and genetics in the Fawn-Hooded rat from present and 
previous studies results in the following conclusions: 
(1) The genetic background together with the blood pressure level determine 
the course and severity of the development of renal failure. 
(a) The inheritance of the susceptibility genes in homozygous form as in the 
FHH rat means rapid development of severe renal damage upon blood pressure 
elevation. 
(b) The inheritance of the susceptibility genes in heterozygous form as in the 
F I (FHH x ACI) rat means the development of renal damage beyond a threshold 
level of systemic blood pressure. 
(c) The absence of susceptibility genes as in the ACl rat means that little or no 
renal damage will develop upon blood pressure elevation. 
(d) The FHL rat, which shares a substantial part of its genome with that of the 
FHH rat, develops severe renal damage upon blood pressure elevation. 
(e) Rats with one kidney, being heterozygous for the susceptibility genes, 
develop more renal damage upon blood pressure elevation compared with rats 
that have none of these genes. 
(II) The normotensive FHL rat is susceptible to the development of renal 
damage upon blood pressure elevation. 
(III) De presence of a genetic background for renal failure in heterozygous 
form does not imply complete protection from the development of renal damage. 
(IV) Blood pressure rather than the specific NO-synthase inhibitor used 
determine the development of renal damage after L-NAME-induced 
hypertension. 
(V) A defect in the ability to regulate afferent arteriolar tone causes a severely 
impaired renal autoregulation in the FHH rat. 
(VI) Genes that are important in the regulation of renal hemodynamics, are in 
mutated form responsible for the phenotype of the FHH rat. 
Although it is difficult to extrapolate results from animal models to the 
development of renal failure in humans, similar mechanism may apply to 
hypertensive patients. This might explain why only a limited number of 
hypertensives eventually develop progressive renal failure. 
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7.3 PERSPECTIVES 
7.3.1. From linkage to locus for polygenic traits 
Although there are indications about possible candidate genes for renal 
impairment in the FHH rat, it is important to know how to proceed from the 
initial detection of linkage to the definitive identification of a trait determined by 
multiple genes. The reader is therefore provided with a brief description of the 
approach to clone a QTL based on position.51 First, the linkage data from the 
(FHH x ACI) FHH backcross generated by Brown et al. 17 were confirmed in a 
larger F2 crosS.82 Secondly, a small region containing the QTL (R.fl) allele was 
moved from the FHH to the ACI rat by successive backcrossing. Thus congenic 
strains are now being constructed differing only in the region of the QTL. To 
ensure the introgression of the QTL allele from FHH, progeny was selected that 
inherited alleles of genetic markers within and flanking the QTL. To accelerate 
the removal of FHH alleles elsewhere in the genome, genetic markers in other 
regions were used to identiry and select animals that have lost more than the 
expected 50% proportion ACI alleles per generation (marker-assisted selection). 
The number of backcross generations required for introgression can thus be 
limited. Comparing congenics with parental strains, we can make detailed 
physiological studies, and examine the separate and interacting effects of the 
QTLs, and their mode of inheritance. Thirdly, using the congenic strains and a 
denser map of genetic markers we want to narrow down the R.fregions. Fourth, a 
physical map will be constmcted and genes in the region will be identified by 
selecting and testing plausible candidate genes in the region, using the results of 
the physiological studies. This is the critical point for the implementation of 
physiological and genetic data: physiological genomics. Fifth, to prove that a 
candidate gene corresponds to a QTL, we have to use homologous recombination 
to constmct gene knockouts in strains carrying a dominant allele (which can than 
be tested for loss of dominance at the QTL) or to substitute the FHH allele into 
ACI and demonstrate that the QTL effect has been transferred as wel1.51 
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7.3.2 Congenics of the renal failure genes 
Further studies are needed to identifY the precise genes at each of the Rf loci, 
their function, the interaction between the various loci and between genetic and 
environmental factors, such as blood pressure and dietaty intake. For this 
purpose, congenic strains will be developed carrying each of the Rfloci 
homozygous from the FHH rat on the renal damage resistant background of the 
ACI rat. To study the interaction with hypertension, similar FHH congenic rats 
could be constructed on an SHR background. Finally, FHH rats will be rescued 
from developing renal failure by moving the various Rfloci from the ACI rats 
into the FHH genome, thus by making reverse congenic strains. Currently, we are 
generating congenic strains carrying Rfl and Rf4 regions separately and a 
double congenic strain carrying both loci. Detailed physiological studies ahead of 
gene identification, as well as their separate and interacting effects on the 
development of renal damage can thus be performed. Chronic studies will be 
done under three conditions: (a) during aging, (b) after UNX, and (c) by 
increasing blood pressure with chronic L-NAME treatment. Acute in vivo studies 
into the autoregulation of RBF and P GC will be done, as well as in vivo and ill 
vitro studies on renal vascular activity. 
Although fimctional defects within the FHH kidney play an important role in 
the development of renal damage, it is not yet clear whether the genetic 
susceptibility of the FHl-I rat resides completely within the kidney or is partially 
related to genetic defects in the rest of the body. This may be unraveled by 
studying kidney transplantation, as a means of organ-specific genome transfer.20 
Congenic rats are highly suitable for such studies as they share the genes of the 
major histocompatibility complex. 
7.3.3 Further characterization oflhe Fawn-Hooded rat 
Because vascular abnormalities seem to have a common ground in the 
pathologic findings observed in the FHI-! rat, studies into the exact mechanism of 
mainly the vascular smooth muscle cell in this model, such as patch-clamp 
studies, have to be carried out in order to elucidate alterations in both calcium ion 
regulation and in voltage-dependent calcium channels of vascular smooth muscle 
cells in FHH and congenic rats. Furthermore, several in vitro models to evaluate 
renal function, such as juxtamedullmy nephron preparations, isolated perfil sed 
hydronephrotic kidneys, and isolated afferent arterioles, have to be evaluated in 
FHH and Rfcongenic rats. The vascular abnormalities found in FBI-! kidneys 
might vety well be present in other organ systems, and it might be useful to 
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evaluate these systems for their function. For instance, measurement of cerebral 
blood flow autoregulation may provide useful information on the properties of 
other vascular beds in FHH rats. 
Furthermore, the mechanism underlying the development of hypertension in 
the FHH rat needs to be elucidated. For instance, measurement of cardiac output 
at different ages and disease states might reveal how changes in the peripheral 
resistance contribute to the development of hypertension in the FHH rat. 
Furthermore, more chronic blood pressure measurements in FHH and FHL rats 
must be performed because all studies so far were based on tail-cuff 
measurements. It would be wise to characterize renal function in the FHH and 
FHL rat compared with additional control strains. For instance, the FHlIR rat, 
which does not develop any hypertension or renal damage, could prove to be a 
useful control animal. FHL rats should be studied as well, both genetically and 
physiologically, as they are less susceptible to renal damage than FHH rat rats, 
though more susceptible to the development of renal failure than other rat strains. 
Hence, additional genetic studies will have to be carried out to find the origin of 
the differences between both Fawn-Hooded strains. 
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Chapter 1 introduces the reader to the thesis and the subjects that are related 
to hypettension-associated renal failure. It gives an overview of the current 
literature on the Fawn-Hooded rat and contains the scope and outline of the 
thesis. 
Chapter 2 describes experiments in which the susceptibility to hypertension 
and renal failure in the normotensive FHL and ACI rat strains was investigated. 
These strains were treated with the nitric oxide synthase inhibitor, N"-L-arginine 
methyl ester (L-NAME), to induce increases in systemic blood pressure. The 
FHL strain, which is genetically identical to the FHH strain, does not develop 
hypertension or renal damage with age under normal conditions. In this 
experiment, under the influence of L-NAME-induced hypeltension, the FHL rat 
developed significantly more functional and structural renal damage than the ACI 
rat at similar blood pressure levels. It was concluded that there is an interaction 
between blood pressme and the genetic susceptibility to renal failme in the FHL 
rat and that the susceptibility to renal damage is genetically determined in rats. 
Chapter 3 describes experiments under similar conditions, in which the 
susceptibility to develop renal damage was studied in F I (FHH x ACI) rats and in 
both parental strains. At similar blood pressure levels FHH rats developed severe 
renal damage and showed high mortality, in contrast to ACI rats, which did not 
develop renal damage. Values for blood pressme and renal damage in the F I rats 
were intermediate, being closer to values in ACI than in FHH rats, and increased 
over an SBP level of 180 mmHg. The F I rats, being heterozygous for the renal 
failure genes, were largely, but not completely, protected from the development 
of L-NAME-induced renal damage. From these findings it was concluded that 
susceptibility to hypettension-associated renal damage in rats primarily depends 
on the presence of predisposing genes for renal failure. 
Chapter 4 describes the relationship between blood pressme level and the 
susceptibility to develop renal damage after unilateral nephrectomy in F I and ACI 
rats. In this study, NO synthase was chronically blocked with L-NAME, while 
blood pressure was normalized using the angiotensin-converting enzyme 
inhibitor, lisinopril. Results of the study were similar to results obtained in two 
kidney FI and ACI rats, i.e., the FI rats developed more renal damage compared 
with ACI rats. As in the previous studies, a positive correlation between blood 
pressure and functional and structural renal damage was found, which increased 
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with time and was more severe in F I than in ACI rats. The conclusion of this 
study was that the development of renal damage is directly related to the level of 
blood pressure or indirectly dependent on actions of the renin-angiotensin system. 
Chapter 5 describes experiments performed to elucidate the mechanisms 
underlying the renal abnormalities in the Fawn-Hooded rat. The responses to 
changes in renal perfusion pressure (RPP) were measured in FHH, FHL, and ACI 
rats to determine whether an abnormality in autoregulation of renal blood flow 
(RBF) may contribute to the development of glomerulosclerosis in the FHH rat. 
Moreover, the first long-term blood pressure measurements in chronically 
instrumented FHH and FHL rats were presented. Apart from the fact that RBF 
was significantly greater in FHH rats compared with FHL and ACI rats, RBF was 
not autoregulated in FHH rats. Glomerular filtration rate was also significantly 
higher by 20-30% in FHH rats than in FHL and ACI rats at every RPP studied. 
Urinaty protein excretion correlated with RPP in FI-IH rats, but not in FHL and 
ACI rats. However, no differences were observed in the pressure-natriuresis 
studies that were also performed. This could explain the mild elevation of SBP in 
the FHH rat measlll'ed in the long-term blood pressure recordings. The conclusion 
of the study was that autoregulation of RBF is impaired in FHH rats, and that the 
abnormality may contribute to the development of hyperfiltration and proteinuria, 
before any glomemlosclerosis develops in these animals. The data provide 
evidence for the development of intrinsic hemodynamic abnormalities in the 
kidney of the FHH rat and for the phenomenon that the abnormalities in renal 
hemodynamics precede the development of severe hypertension and renal failure 
in the FHH rat. 
Chapter 6 describes additional studies performed to examine whether an 
abnormality in the myogenic response of preglomerular renal arterioles impairing 
autoregulation ofRBF and glomerular capillary pressure (Pac), contributes to the 
development of glomerulosclerosis in the FH rat. Autoregulation ofRBF, cortical 
and medullaty blood flow and Pac were compared in volume-replete and volume-
expanded FHH and FHL rats to minimize the influence of tubuloglomerular 
feedback on these responses. In volume-expanded rats, baseline RBF, cortical 
and medullaty blood flow were all significantly greater in FHH than in FHL rats. 
Autoregulation of whole kidney, cortical, and medullary blood flow was 
significantly impaired in FHH compared with FHL rats. Myogenically-mediated 
autoregulation of Poc was also impaired in FHH compared with FHL rats. 
Furthermore, studies in isolated perfitsed interlobular at1eries showed that vessels 
of FHH rats were unable to constrict in response to increases in transmural 
pressure. Vessels of these rats even dilated in response to the same increase in 
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perfusion pressure. The normal responses of arterioles from FHH rats to the 
vasoconstrictor compound phenylephrine showed that the vascular abnormalities 
were not due to nonspecific vascular injlllY. However, the vasodilator responses 
to acetylcholine in these vessels were severely impaired compared with arterioles 
ofFHL rats, pointing towards endothelial dysfunction in FI-IH rats. 
Chapter 7 contains the general discussion and conclusion of this thesis, 
followed by the perspectives. Combining physiology and genetics with regard to 
blood pressure and renal failure in the Fawn-Hooded rat, results in the following 
conclusions: 
(I) The genetic background and the blood pressure level determine the initiation 
and progression of renal damage. 
(II) The normotensive FHL rat is susceptible to renal damage upon blood 
pressure elevation. 
(III) The presence of a genetic background in heterozygous form does not imply 
complete protection from the development of renal damage. 
(IV) The level of blood pressure and not the specific NO-synthase inhibitor used 
determine the level of renal damage after L-NAME-induced hypertension. 
(V) A defect in the ability to regulate afferent arteriolar tone causes a severely 
impaired renal autoregulation in the FHH rat. 
(VI) Genes that are important in the regulation of renal hemodynamics, are in 
mutated form responsible for the phenotype of the FHH rat. 
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De Fawn-Hooded Hypertensieve (FHH) rat is een genetisch model voor 
nierschade die geassocieerd is met hoge bloeddmk (hypertensie). Deze rat 
ontwikkelt reeds op jonge leeftijd systolische en glomerulaire hypellensie, 
pl'Oteinurie (eiwit in de urine; UpV) en [oeale glomeruloselerose (FOS). De FHH 
rat bezit tenminste vij f genen voor niersehade en tenminste twee genen voor 
hypertensie. In dit pl'Oefschrift worden een aantal experimenten besehreven die 
tot doel hadden de gevoeligheid voor het ontwikkelen van nierschade te 
onderzoeken. Verder worden een aantal experimenten beschreven die tot doel 
hadden te onderzoeken welke mechanismen ten gl'Ondslag liggen aan het ontstaan 
van de niersehade in de FHH rat. 
De genetisehe en pathotysiologische aspecten van hypertensie en nierschade, 
alsmede andere eerder gevonden anvijkingen in dit diennodel, worden 
besehreven in Hoofdstllk 1 en gerelateerd aan de beschikbare Iiteratuur. 
Om versehillen in gevoeligheid voor het ontwikkelen van nierschade te 
onderzoeken, werd als eerste de Fawn-Hooded Lage bloeddruk (FHL) rat 
onderzocht, die genetisch identiek is aan de FHH rat, maar geen hypertensie en 
nierschade ontwikkelt met de leeftijd. De FHL rat werd vergeleken met de 
normotensieve August x Copenhagen Irish (ACI) rat. Dit experiment wordt 
besehreven in Hoofdstuk 2. Damloe werd in beide stammen door toediening van 
een stof die de aanmaak van stikstofoxide remt, N"-L-arginine methyl ester (L-
NAME), de bloeddruk verhoogd. De FHL rat ontwikkelde meer functionele en 
structurele nierschade dan de ACI rat bij vergelijkbare bloeddl'llkniveaus. De 
eonclusie van dit experiment was dat er in de FHL rat een interactie is tussen 
bloeddmk en de genetisehe gevoeligheid voor het ontwikkelen van 
nieranvijkingen, en dat deze rat gevoeliger is voor het ontwikkelen ervan dan de 
ACI rat. 
In een vergelijkbare pl'Oefopzet besehreven in Hoofdstuk 3, werd de 
gevoeligheid voor het ontwikkelen van niersehade in de FHH en de ACI rat, en in 
een F 1 (FI-lH x ACI) kruising van deze beide stammen onderzoeht. Bij 
vergelijkbare bloeddrukniveaus ontwikkelde de FHH rat de meeste en de ACI rat 
de minste nierschade, terwijl de waarden van de F 1 (FHH x ACI) ratten tussen de 
waarden van de beide oudersta111men inlagen, 111aar diehter bij die van de ACI 
dan die van de FHH ratten. Boven een bloeddrukniveau van 180 millimeter kwik 
werd een toename van de niersehade gevonden. Het bleek dat F 1 ratten, die 
hetel'Ozygoot zijn voor de genen verantwoordelijk voor niersehade, slechts 
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gedeeltelijk beschermd zijn tegen de ontwikkeling van hypeltensie-gernduceerde 
nierschade. De conclusie was dat volledige gevoeligheid voor hypertensie-
geassocieerde nierschade in ratten primair afhankelijk is van de aanwezigheid 
van genen die het risico op het ontwikkelen van nierschade verhogen, zelfs na 
een significante stijging van de bloeddruk. 
In Hoofdstuk 4 worden experimenten beschreven waarbij de 1'01 van een 
toegenomen hemodynamische last op de glomeruli op het ontstaan van 
nierschade door de combinatie van eenzijdige nierverwijdering (unilaterale 
nefrectomie, UNX) en L-NAME-gernduceerde hypertensie in F I (FHH x ACI) en 
ACI ratten. VerdeI' werd onderzocht of een algemeen toxisch effect van L-
NAME, onaihankelijk van de bloeddruk, nierschade veroorzaakte in F I ratten. 
Daartoe werden deze ratten tegelijkeltijd behandeld met L-NAME en lisinopril, 
een stof die de aanmaak van angiotensine-converting enzym remt. In 
overeenstemming met de resultaten van de studies in ratten met twee nieren, 
ontwikkelden de F I (FHH x ACI) meer nierschade dan de ACI ratten. Er werd 
een positieve relatie gevonden tussen het bloeddrukniveau en de hoeveelheid 
functionele en structurele nierschade. In de F I ratten die met lisinopril waren 
behandeld, werd geen significante nierschade gevonden bij een laag 
bloeddrukniveau, hetgeen aangeeft dat nierschade in hypertensieve F I ratten niet 
een direct effect is van de L-NAME behandeling, maar het resultaat is van de 
hoge bloeddruk of een andere werking afhankelijk van de werking van het 
renine-angiotensine systeem. De conciusie van dit experiment luidde dat in ratten 
die heterozygoot zijn voor de genen die de ontwikkeling van nierschade 
bernvloeden in de FHH rat, de gevoeligheid van de nier voor het ontwikkelen van 
schade na UNX en systemische hypertensie is toegenomen. 
De effectiviteit van de autoregulatie van de nierdoorbloeding en het niveau 
van de glomerulaire filtratiesnelheid in FHH, FHL, en ACI ratten werd 
onderzocht door de I'esponsen van de nier op vel'anderingen in renale 
perfusiedruk te meten, en worden beschreven in Hoofdstuk 5. Het bas ale niveau 
van de nierdoorbloeding in de FHH rat bleek significant hoger te liggen dan in de 
FHL en ACI rat, hetgeen mogelijk veroorzaakt wordt door een permanente 
verwijding van de nierarterie in de FHI-I rat. VerdeI' werd gevonden dat de nier 
van de FHH rat niet in staat is de bloed flow naar de nier acceptabel laag te 
houden, hetgeen duidt op een defect in de autoregulatie van de nier. De FHL en 
de ACI rat waren betel' in staat de nierdoorbloeding te regllieren. De glomerulaire 
filtratiesnelheid in beide fawn-hooded stammen nam toe met een toename in de 
renale perfusiedrllk, en was 20-30% hoger in de FHH ratten vergeleken met FHL 
en de ACI ratten bij iedere gemeten renale perfllsiedruk. De hoeveelheid eiwit in 
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de urine was ook lineair gecorreleerd mel de rena Ie perfusiedruk in de FHH 
rallen, maar niel in de FHL en ACI rallen. De incidenlie van de 
glomerulosclerose was niel verschillend tussen de beide stammen en geeft aan dat 
de gemeten verschillen al aanwezig waren voordat de nieren slructurele schade 
ontwikkelden. De conclusie was dat aUloregulalie van de nierdoorbloeding in de 
FHH rat af\vijkend is, en dal dit deze af\vijking bijdraagt tol de ontwikkeling van 
hyperfiltratie van de glomeruli en proteinurie, voordat er struclurele nierschade 
aanwezig is. 
De waargenomen af\vijkingen aan de nieren van de FHH rat werden verder 
gelmplementeerd in Hoofdstuk 6, waar werd onderzocht of een af\vijking in de 
myogene respons in nierarteriolen, die de autoregulalie van de nierdoorbloeding 
en de intraglomerulaire druk (Pac) aantasl, bijdraagt tot het ontstaan van 
glomerulosclerose in de FHH rat. Autoregulatie van de nierdoorbloeding werd op 
drie verschillende niveaus onderzocht. Afgezien van het feit dat de 
nierdoorbloeding in de FHH rat significant hoger was vergeleken met de FHL rat, 
vertoonde de autoregulatie in de FHH rat op elk niveau af\vijkingen vergeleken 
mel de FHL rat. In micropunclie experimenten werd de directe relatie tussen de 
renale perfusiedruk en de intraglomerulaire druk onderzocht. Deze bleek een 
significante correlatie te vertonen: een slijging in de rena Ie perfusiedruk 
veroorzaakte een stijging in de Pac, en dit leidde tot de conclusie dat er geen 
adequate autoregulatie van de Pac in de FHH rat aanwezig is. Tenslotte werd 
onderzocht of de gevonden af\vijkingen verklaard zouden kunnen worden uit een 
af\vijking in de myogene respons van nierarteriolen van de FHH rat. Hieltoe 
werden arteriolen van beide FHH rat en FHL ratten ge'(soleerd en in vitro aan een 
toenemende perfusiedruk blootgesteld. Het bleek dat de arteriolen van de FHH 
rat, in tegenstelling tot die van de FHL rat, niet in staat waren adequaat te 
contraheren bij een toename in de perfusiedruk. Deze contractie is noodzakelijk 
voor het in stand houden van een constant niveau van nierdoorbloeding in vivo. 
Het berekende vennogen van de vaatwand om weerstand te bieden aan een 
toename in perfusiedruk bleek sterk verminderd in vaten van de FHH rat, waar 
zelfs enige vaalverwijding gemeten werd. Niervaten van de FHL rat daarentegen, 
waren in slaat weerstand te bieden aan een toename in perfusiedruk. De gevonden 
af\vijkingen in de vaten van de FHH rat zijn karakteristiek voor een defect in de 
myogene respons. Dat dit effect niel werd veroorzaakt door non-specifieke 
vaatschade bleek uit het feit dat de vaten normaal reageerden op de constrictoire 
stof fenylefrine. Opmcrkelijk was de bevinding dat de relaxatie van FHH vaten 
na toediening van acetylcholine geheel af\vezig was, terwij I arteriolen van de 
FHL rat toenemende relaxatie veltoonden bij een toenemende dosis van deze 
stof, mogelijk veroorzaakt door cen reeds aanwezige relaxatie. Vit de beschrevcn 
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experimenten werd geconcludeerd dat de myogene respons van nierarteriolen in 
de FI-Il-I verminderd is. De arteriolen zijn daat'door niet in staat de arteriele druk 
te bufferen en de P GC laag te houden. Dit defect in de myogene respons van de 
preglomerulaire vasculatuur, in combinatie met de eerder beschreven verhoogde 
weerstand van de efferente atieriole, leidt tot een verhoogde bas ale P GC' Hierdoor 
wordt de aanwezige systolische hypetiensie doorgelaten naar de glomeruli, 
hetgeen leidt tot de ontwikkeling van proteinurie en glomerulosclerose. 
In Hoofdstuk 7 werden de beschreven experimenten samengevat en werden de 
bevindingen in een algemene discussie aan de reeds bestaande literatuUt' 
gerelateerd. Daarbij werden de tysiologie en de genetica van de Fawn-Hooded rat 
gecombineerd, wat resulteerde in de volgende conclusies: 
(1) De genetische achtergrond en het bloeddrukniveau bepalen het ontstaan en 
beloop van nierschade. 
(II) De nonnotensieve FHL rat is gevoelig voor het ontstaan van nierschade 
wanneer de bloeddruk wordt verhoogd. 
(JIl) De bezit van een genetische aanleg voor nierschade in heterozygote vonn 
betekent nog geen volledige bescherming tegen de ontwikkeling van nierschade. 
(IV) De mate van nierschade door L-NAME-ge'induceerde hypetiensie wordt 
bepaald door het bloeddrukniveau en niet de gebruikte NO-synthase inhibitor 
zelf. 
(V) Een defect in het vermogen om de tonus van de a fferente arteriole te 
reguleren is de oorzaak van een ernstig gestoorde renale autoregulatie in de FHH 
rat. 
(VI) Genen die waarschijnlijk van belang zijn bij regulatie van de rena Ie 
hemodynamica, zijn in gemuteerde vonn verantwoordelijk voor het fenotype van 
de FHH rat. 
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